FINAL PROGRAMME THE MODERN FACE OF DERMATOLOGY MADRID, SPAIN October 2019 IFEMA Feria de Madrid EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Transcription

1 THE MODERN FACE OF DERMATOLOGY EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY MADRID, SPAIN 9 13 October 2019 IFEMA Feria de Madrid FINAL PROGRAMME

2 IMPRINT Editorial/Publisher European Academy of Dermatology and Venereology (EADV) Layout & Graphics MCI Printing Gerin Druck GmbH Press Date September 2019 Subject to alterations Find further information about the event Follow us on the social media and join the conversation using #EADV2019 Facebook Twitter LinkedIn eadveurope YouTube zmfhom_bh1nuvoyea Instagram

3 EADV TABLE OF CONTENTS n EADV I Welcome Message from the EADV President... 2 I The Academy... 3 I Continuing Medical Education Continuing Professional Development (CME-CPD)... 5 I Abstract Reviewers, Subspecialty and International Societies... 6 I Patient Associations... 7 n Scientific Programme I Welcome from the Scientific Programming Committee... 8 I Scientific Sessions by Theme n Wednesday, 9 October n Thursday, 10 October n Friday, 11 October n Saturday, 12 October n Sunday, 13 October n General Information I Congress General Information I Networking Symposium I Important Information on Pharmaceutical Advertising n Floor Plans I Congress Centre Floor Plans n Exhibitors and Sponsorship I Exhibitor List n Contributor Index

4 EADV WELCOME WORDS FROM THE EADV PRESIDENT Dear Friends and Colleagues, It is with immense pleasure that I welcome you to Madrid, also known as El Foro, or The Forum, an alias wholly appropriate for the location of the 2019 EADV Congress from 9-13 October This is an EADV Congress with many firsts: The first EADV Congress after record-breaking Paris 2018 with almost 13,000 participants. You will have the opportunity to listen to and exchange with more than 700 star speakers and engage with 150 stimulating sessions about the most up-to-date researches and developments in dermatology and venereology. Our speakers and audience represent more than 70 countries worldwide. The first EADV Congress with Controversy Sessions. These will take place in the Expert Forum tracks covering a range of topics from topical corticosteroids, to biologics in skin disease, drugs in acne, inflammatory diseases, long term antibiotics and many others. Different opinions are new things to learn, we will be stimulated by the healthy debate that will be sparked. The first EADV Congress taking place in Southern Europe since Lisbon 2011, giving us the opportunity to enjoy and feel the warmth of the vibrant city of Madrid. After your busy days in scientific sessions, take a moment in the evenings to feel the energy surging through the streets of the capital of Spain. As quoted by Ernest Hemingway, Don Ernesto, who fell in love with Madrid in as early as 1923, Nobody goes to bed in Madrid until they have killed the night. Enjoy a walk through the tightly packed streets close by the Plaza Mayor, or a quick visit before closing time to one of the famous museums, a leisurely bite in Museo Chicote or dine in Restaurante Botin, following the steps of the author of Fiesta, The sun also rises over a glass of tinto de verano. For sure it will be an event not-to-be-missed! I look forward to seeing you in Madrid! Prof. CARLE PAUL EADV President 2

5 EADV THE ACADEMY Founded in 1987, the European Academy of Dermatology and Venereology has grown to become the largest non-profit association in Europe focusing on clinical care, research, education and training in the fields of dermatology and venereology. Furthermore, the EADV supports the maintenance and enhancement of high standards of professions related to dermatology, venereology and public health services, and acts as the advocate and educator of patients with cutaneous or venereal diseases. Its scholarship and fellowship grants enable young dermatologists and venereologists from throughout Europe and around the world to gain access to the highest standards of education and training, thus enriching professional networks and knowledge-sharing between future leaders in the specialty. Also, regular training and fostering courses are offered to provide high quality education across Europe, as well as online teaching for CME-CPD and new e-learning based opportunities. The EADV actively promotes better awareness of skin and venereal diseases for patients by working closely with global and European policy-makers on public health campaigns to tackle occupational skin diseases, melanoma, sexually transmitted infections, and other maladies. The Academy s official publication is the Journal of the EADV (JEADV); its circulation extends beyond the actual number of EADV members. Join our annual Congresses and Spring Symposia, unique occasions that bring together specialists from different countries and cultures of Europe (and even further afield) and actively encourage an exchange of ideas, experiences and projects to improve care for patients. FUTURE EADV MEETINGS > 11 th EADV Dermatological Meeting in Ticino I 21 November Bellinzona, Switzerland > 16 th EADV Spring Symposium I 30 April - 02 May Porto, Portugal > 29 th EADV Congress I September Vienna, Austria > 17 th EADV Spring Symposium I May Ljubljana, Slovenia > 30 th EADV Congress I October Berlin, Germany > 18 th EADV Spring Symposium I May St. Julian s PTM, Malta > 31 st EADV Congress I 7-11 September Milan, Italy 3

6 EADV 16 th EADV SYMPOSIUM 30 April 2 May 2020 Porto, Portugal Come and discover the New format of the EADV Spring Symposium > Clinical > Problem > Breaking updates: focuses on clinical practical aspects of dermatology based learning: develops skills and knowledge on daily practice relevant problems through discussion news: provides an update in different rapidly changing fields of dermatology. 4

7 EADV CONTINUING MEDICAL EDUCATION CONTINUING PROFESSIONAL DEVELOPMENT (CME-CPD) The 28 th Congress of the European Academy of Dermatology and Venereology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), I The 28 th EADV Congress has been granted with a maximum of 22 European CME credits (ECMEC s) CME Credits Each medical specialist can claim only those hours of credit actually spent in the educational activity (as recorded by the scanning process). Here below please find the breakdown of credits per day: Thursday, 10 October 6 credits Friday, 11 October Saturday, 12 October Sunday, 13 October 6 credits 6 credits 4 credits The accreditation system is based on 1 ECMEC per hour and no credits will be guaranteed by the EADV to delegates participating in sessions organised by industry or by Subspecialty Societies. Procedure to gain your credits Scan your badge, complete the evaluation forms and download the CME-CPD Certificate. The EADV offers individual CME-CPD participation through the scanning of the QR-code and the speaker/session evaluation that will be available for a period of one month after the end of the Congress (until 10 November 2019). 1. Scan your badge as you pass through the entrance of each session hall 2. Complete the anonymous online evaluation for each session attended. Access the evaluation system via any of the following: > Visit the CME/CPD accreditation webpage on eadvmadrid2019.org/scientific/cme-cpd/ > Visit the evaluation section from the EADV Events App 3. Download your CME-CPD certificate and retain it for your personal records. Evaluation data is essential to our statistics and is of considerable help in the choice of future topics and speakers. Your feedback and comments are greatly appreciated. Conversion of credits Please refer to the national CME-CPD authority in your country of practice for the exchange into national credits/points. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits. Information on the process to convert EACCME credit to AMA credit can be found at Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. 5

8 EADV ABSTRACT REVIEWERS The EADV is grateful to the following reviewers who have given their time and expertise in reviewing the submitted abstracts: Werner Aberer (Austria), Maurice Adatto (Switzerland), Zsuzsanna Bata-Csorgo (Hungary), Jean-Luc Bernabo (Spain), Pavel Chernyshov (Ukraine), Renata Csoma Zsanett (Hungary), Nejib Doss (Tunisia), Azael Freites Martinez (Spain), Marjan Garmyn (Belgium), Jürg Hafner (Switzerland), Alexander Katoulis (Greece), Jana Kazandjieva (Bulgaria), Nicolas Kluger (Finland), Kateryna Kolyadenko (Ukraine), Ulrich Mrowietz (Germany), Arjen Fokko Nikkels (Belgium), Rodica Olteanu (Romania), Javier Pedraz Mun (Spain), Luis Miguel Soares de Almeida (Portugal), Efthymia Soura (Greece), Sundaramoorthy Srinivasan (India) SUBSPECIALTY AND INTERNATIONAL SOCIETIES Subspecialty Societies are independently organised groups that focus on the promotion and education of treatment and prevention options for specific diseases, or focus on promoting and educating about a specific treatment technology. The EADV provides session rooms on the Wednesday to allow Subspecialty Societies to present their own programme of current research in their specialised fields. Subspecialty meetings are open to all participants, however these are not EADV accredited sessions. No CME credits will be granted, unless specifically organised and arranged by the participating Subspecialty Society independently. AEDV CSD EADO ENS EHSF ESCAD ESDaP ESDP ESLD ESMS ESPD ETFAD EUROMELANOMA EURO-PDT EWDVS EXPS IDS IDS IHhS IPC PALD Spanish Academy of Dermatology and Venereology Chinese Society of Dermatology European Association of Dermato Oncology European Nail Society European Hidradenitis Suppurativa Foundation European Society for Cosmetic and Aesthetic Dermatology European Society of Dermatology and Psychiatry European Society of Dermatopathology European Society for Lasers and Energy Based Devices European Society for Micrographic Surgery European Society for Photodermatology European Task Force on Atopic Dermatitis Euromelanoma European Society for Photodynamic Therapy in Dermatology European Women Dermatological and Venereological Society European XP Society International Dermoscopy Society International Dermoscopy Society International Hyperhidrosis Society International Psoriasis Council Pan Arab League of Dermatologists 6

9 EADV PATIENT SOCIETY VILLAGE The EADV actively works to develop a synergic action between the patient community and the key healthcare providers. We invite all Congress attendees to visit the Patient Society Village located in Hall 9 on Thursday 10 and Friday 11 October In this dedicated area you have the opportunity to meet with leaders of the represented patient societies, discuss activities of common interest, explore different perspectives, needs and roles and discover how to integrate these into the larger world of European dermatology. We acknowledge and thank the below patient advocacy groups for their commitment and involvement during this year s Congress: Association Pemphigus Pemphigoïde France - France Enfants de la lune - Association d aide aux enfants atteints de XP ASAEXP - Tunisia Chronic Urticaria Patients Association AAUC - Spain Dutch Skin Patients Federation - Netherlands Dutch Vitiligo Patients Organisation - Netherlands European Federation of Allergy and Airways Diseases Patients Associations EFA - Belgium European Umbrella Organisation for Psoriasis Movements EUROPSO - Slovenia France Psoriasis - France French Vitiligo Association - France Global Allergy & Asthma Patient Platform GAAPP - Austria International Alliance of Dermatology Patient Organizations IAPDO - Canada International Federation of Psoriasis Associations IFPA - Sweden International Hyperhidrosis Society IHhS - USA Irish Skin Foundation - Ireland Psoriasis en Red - Spain Skin and Allergic Diseases - Russia Spanish Association for Giant Congenital Nevi ASONEVUS - Spain Spanish Association of Mastocytosis and Related Diseases AEDM - Spain Spanish Association of Patients with Hidrosadenitis Suppurativa Spanish Association of people affected by Atopic Dermatitits AADA - Spain 7

10 EADV WELCOME FROM THE EADV SCIENTIFIC PROGRAMMING COMMITTEE (SPC) Dear Colleagues and Friends, On behalf of the Scientific Programming Committee (SPC), it is my privilege to invite you to the annual EADV meeting 2019, which will take place in Madrid. The handsome Capital of Spain, which offers a unique combination of a glorious past with a lively present. Here beats the young heart of a sparkling city full of culture which makes it the perfect location for our meeting. This year will be my first programme as Scientific Programming Committee (SPC) chair and I m proud to present to our distinguished guests an utterly outstanding scientific content. In accordance with our vision of promoting education in dermatology and venerology, experts, trainees and stakeholders, as well as healthcare professionals from different fields, speakers and delegates, will be offered a unique opportunity to be informed on the latest developments and updates, innovative treatment modalities and new areas of clinical research and development, allowing physicians to deliver the highest quality of care to their patients. The intensive 4-day program will include approximately 150 stimulating sessions held by contributors originating from more than 50 different countries worldwide and arranged once again in the acknowledged track system. More than 700 speakers with established publication records and high presentation scores over the past years have been strategically included in the programme. Eminent global top-speakers and well-known guests from other disciplines will broaden our views and inspire us with their extensive knowledge and experience: How the dermatologist can influence the availability of new treatments Rosacea: From the new spectrum to the new therapies Comeback of the great imitator ESDR Plenary Lecture: Combing through the genetics of hair disorders The opening plenary lecture will focus on Artificial intelligence and medicine: The secrets for a good marriage. 8

11 Scientific Programme This year s hot topic will focus on skin imaging and cover areas such as confocal microscopy, sonography in dermatology, optical coherence tomography and computer vision (machine and deep learning). Challenges, state-of-the art advances, future opportunities and the age-old question can computer do it better than the dermatologist? will all be addressed and discussed. New this year in Madrid is the introduction of controversy sessions in the Expert Forum tracks. On Saturday 12 th of October, we will host the first EADV Nurse Day, a full-day dedicated to nurses who truly are the heart of healthcare and we all appreciate their hard work and commitment every day. We have prepared a track with a mixed faculty of dermatologists and nurses, ideally to bring together both parties and learn about the respective fields of interest. The two major topics will be hand dermatitis and wound healing, as well as an update on biologics. Another high quality, motivating programme will be waiting for you at EADV s Aesthetic Sunday, covering items from the basics to advanced and hot topics in Energy-based devices, fillers, botulinum toxin, peels, scars, practice management and much more in 4 parallel tracks. Mention must also go to our strong relationship with our sister societies and partners. We are thrilled to welcome our American colleagues back to Europe for a joint EADV/AAD Symposium, as well as our European researchers from the ESDR, who will host a stimulating session in the programme. We look forward to a great meeting with stimulating lectures and inspiring discussions. Prof. BRIGITTE DRÉNO EADV Scientific Programming Committee Chair 9

12 SCIENTIFIC PROGRAMME 10

13 THEMATIC INDEX Scientific Programme Code Session Title Date Start End Room 01 Acne and Related Disorders, Hidradenitis Suppurativa SS16 EHSF - European Hidradenitis Suppurativa Foundation 9/10/19 13:30 17:30 N103 D2T11.2 Acne vulgaris and rosacea 10/10/19 08:30 10:00 Hall 9 Picasso D1T04.1 Acne vulgaris and rosacea 10/10/19 10:15 11:45 Hall 9 Picasso D1T04.2 Hidradenitis suppurativa 10/10/19 13:15 14:45 Hall 9 Picasso FC08 Drugs in acne 10/10/19 13:15 14:45 N D1T04.3 Hidradenitis suppurativa 10/10/19 15:00 16:30 Hall 9 Picasso D1T04.4 Hidradenitis suppurativa 10/10/19 15:00 16:30 N D1T09.4 Red face: Other diagnoses 10/10/19 15:00 16:30 N103 D1T09.3 Acne and rosacea 11/10/19 10:15 11:45 N D1T06.4 Free communications in acne and related disorders 12/10/19 15:00 16:30 N Adverse Drug Reactions, TEN D1T11.3 Drug reactions 10/10/19 13:15 14:45 N D3T07.1 Management of adverse drug reactions 12/10/19 08:30 10:00 N Allergology and Immunology D1T14.1 Advanced allergology workshop 10/10/19 08:30 11:45 N Angiology, Haemangiomas, Vascular Malformations, Vasculitis D1T08.3 Vasculitis and vasculopathies 10/10/19 13:15 14:45 N D1T08.4 Vasculitis and vasculopathies 10/10/19 15:00 16:30 N D3T05.4 Vascular malformations and tumours 12/10/19 15:00 16:30 Hall 9 Sorolla 05 Atopic Dermatitis/Eczema SS17 ETFAD - European Task Force on Atopic Dermatitis 9/10/19 13:30 17:30 N104 D1T11.1 Eczemas: Atopic dermatitis 10/10/19 08:30 10:00 N D1T11.2 Eczemas 10/10/19 10:15 11:45 N D1T01.2 Atopic dermatitis 10/10/19 13:15 14:45 Hall 10 Dalí D1T01.3 Atopic dermatitis 10/10/19 15:00 16:30 Hall 10 Dalí 11

14 SCIENTIFIC PROGRAMME Code Session Title Date Start End Room FC07 Free communications in Atopic dermatitis and urticaria 12/10/19 13:15 14:45 N D3T04.3 Contact eczemas 12/10/19 13:15 14:45 Hall 9 Picasso 06 Autoimmune Bullous Diseases D2T11.3 Autoimmune disorders 11/10/19 13:15 14:45 N D2T11.4 Autoimmune disorders 11/10/19 15:00 16:30 N D3T03.1 Autoinflammatory diseases 12/10/19 08:30 10:00 Hall 10 Velázquez D3T03.3 Autoimmune bullous diseases 12/10/19 13:15 14:45 Hall 10 Velázquez D3T03.4 Autoimmune bullous diseases: Neutrophilic and pustular dermatoses 12/10/19 15:00 16:30 Hall 10 Velázquez 07 Autoimmune Connective Tissue Disorders D2T11.3 Autoimmune disorders 11/10/19 13:15 14:45 N D2T11.4 Autoimmune disorders 11/10/19 15:00 16:30 N D3T03.1 Autoinflammatory diseases 12/10/19 08:30 10:00 Hall 10 Velázquez D3T03.2 Connective tissue diseases 12/10/19 10:15 11:45 Hall 10 Velázquez 08 Biologics, Immunotherapy, Molecularly Targeted Therapy D1T09.2 Biologics in skin disease 10/10/19 10:15 11:45 N FC03 Free communications in Therapy 10/10/19 13:15 14:45 N FC04 Free communications in Therapy 10/10/19 15:00 16:30 N OP03 Oral e-poster presentations in Therapy 11/10/19 13:45 14:45 OP04 Oral e-poster presentations in Therapy 11/10/19 15:00 16:00 Oral e-poster presentation Room Oral e-poster presentation Room 10 Contact and Occupational Dermatitis D3T13.1 Nurse Day - Part 1 12/10/19 08:30 10:00 N D3T04.3 Contact eczemas 12/10/19 13:15 14:45 Hall 9 Picasso D3T13.3 Nurse Day - Afternoon interactive sessions 12/10/19 14:00 16:30 N D3T04.4 Occupational dermatoses 12/10/19 15:00 16:30 Hall 9 Picasso 11 Corrective, Aesthetic and Cosmetic Dermatology SS03 ESCAD - European Society for Cosmetic and Aesthetic Dermatology 9/10/19 09:00 13:00 Hall 9 Picasso D1T08.1 Scars and keloids 10/10/19 08:30 10:00 N D2T15.1 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (morning) 11/10/19 08:30 11:45 N

15 Code Session Title Date Start End Room D2T15.2 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (afternoon) 11/10/19 13:15 16:30 N D3T02.1 Skin ageing 12/10/19 08:30 10:00 Hall 10 Coello Scientific Programme D3T02.2 Skin ageing 12/10/19 10:15 11:45 Hall 10 Coello D3T02.3 Basic scientific cosmetology 12/10/19 13:15 14:45 Hall 10 Coello D3T02.4 Basic scientific cosmetology 12/10/19 15:00 16:30 Hall 10 Coello D3T07.4 Body art 12/10/19 15:00 16:30 N104 D4T04.1 Aesthetic dermatology for medical indications 13/10/19 08:30 10:00 N D4T02.1 Fillers I 13/10/19 08:30 10:00 N104 D4T01.1 Non-invasive body contouring 13/10/19 08:30 10:00 N103 D4T03.1 Peels 13/10/19 08:30 10:00 N D4T02.2 Fillers II 13/10/19 10:15 11:45 N104 D4T04.2 Practice management, including psychology 13/10/19 10:15 11:45 N D4T03.2 Botulinum toxin I 13/10/19 10:15 11:45 N D4T01.2 Energy based devices I, including lasers 13/10/19 10:15 11:45 N103 D4T04.3 Hot topics: Interactive strategies 13/10/19 12:00 13:30 N D4T03.3 Botulinum toxin II, including complications 13/10/19 12:00 13:30 N D4T01.3 Energy based devices II, including lasers 13/10/19 12:00 13:30 N103 D4T02.3 Scars 13/10/19 12:00 13:30 N Cutaneous Oncology SS18 Euromelanoma - EADO: European Association of Dermato Oncology 9/10/19 13:30 17:30 N D1T10.1 Non-melanoma skin cancer 10/10/19 08:30 10:00 N D1T10.2 Non-melanoma skin cancer 10/10/19 10:15 11:45 N D1T10.3 Melanoma 10/10/19 13:15 14:45 N D1T10.4 Melanoma 10/10/19 15:00 16:30 N D2T01.2 Melanoma 11/10/19 13:15 14:45 Hall 10 Dalí D2T01.3 Melanoma 11/10/19 15:00 16:30 Hall 10 Dalí D2T05.4 Acral skin tumours 11/10/19 15:00 16:30 Hall 9 Sorolla D3T06.1 NMSC: Basal cell carcinoma 12/10/19 08:30 10:00 N103 D3T06.2 NMSC: Actinic keratosis 12/10/19 10:15 11:45 N103 D3T06.3 NMSC: Squamous cell carincoma 12/10/19 13:15 14:45 N103 D3T06.4 Other skin cancers 12/10/19 15:00 16:30 N103 13

16 SCIENTIFIC PROGRAMME Code Session Title Date Start End Room 13 Dermatological Practice Management D1T13.3 Practical pearls from private office 10/10/19 13:15 14:55 N Dermatological Surgery SS15 ESMS - European Society for Micrographic Surgery 9/10/19 13:30 17:30 Hall 9 Sorolla D1T15.1 Basic surgery workshop (morning) 10/10/19 08:30 11:45 N D1T15.2 Basic surgery workshop (afternoon) 10/10/19 13:15 16:30 N D2T12.1 Surgical therapy 11/10/19 08:30 10:00 N D2T03.1 Mohs surgery 11/10/19 08:30 10:00 Hall 10 Velázquez D2T02.3 Dermatosurgery (Part 1) 11/10/19 13:15 14:45 Hall 10 Coello D2T02.4 Dermatosurgery (Part 2) 11/10/19 15:00 16:30 Hall 10 Coello D3T15.1 Advanced surgery workshop (morning) 12/10/19 08:30 11:45 N D3T15.2 Advanced surgery workshop (afternoon) 12/10/19 13:15 16:30 N Dermatology and Internal Medicine, including Skin Manifestations of Systemic Diseases D1T07.1 D1T07.2 Acute life-threatening diseases in dermatology: The skin as a sentinal Acute life-threatening diseases in dermatology: Red flags and emergencies in dermatology 10/10/19 08:30 10:00 N104 10/10/19 10:15 11:45 N104 D3T07.2 Microbiote and skin: A new therapeutic area 12/10/19 10:15 11:45 N Dermatopathology SS13 ESDP - European Society of Dermatopathology 9/10/19 13:30 17:30 Hall 10 Velázquez D2T02.1 Interactive dermatopathology 11/10/19 08:30 10:00 Hall 10 Coello D2T02.2 Interactive dermatopathology 11/10/19 10:15 11:45 Hall 10 Coello D2T12.3 Dermatopathology 11/10/19 13:15 14:45 N D2T12.4 Dermatopathology 11/10/19 15:00 16:30 N Dermoscopy SS04 IDS - International Dermoscopy Society 9/10/19 09:00 13:00 Hall 9 Sorolla D1T02.1 Interactive dermoscopy 10/10/19 08:30 10:00 Hall 10 Coello D1T02.2 Interactive dermoscopy 10/10/19 10:15 11:45 Hall 10 Coello D1T02.3 Interactive nail dermoscopy 10/10/19 13:15 14:45 Hall 10 Coello D1T02.4 Interactive trichoscopy 10/10/19 15:00 16:30 Hall 10 Coello 14

17 Code Session Title Date Start End Room 23 Hair Disorders/Diseases Scientific Programme D2T05.1 Hair and scalp disorders 11/10/19 08:30 10:00 Hall 9 Sorolla D2T05.2 Hair and scalp disorders 11/10/19 10:15 11:45 Hall 9 Sorolla D3T11.2 Hair disorders 12/10/19 10:15 11:45 N History of D/V D1T13.4 History of dermatology 10/10/19 15:00 16:30 N Infectious Diseases, Parasitic Diseases, Infestations D2T08.2 Skin infections (bacterial) 11/10/19 13:15 14:45 N D2T08.3 Skin infections (viral, parasitic and fungal) 11/10/19 15:00 16:30 N D3T10.1 Infectious diseases 12/10/19 08:30 10:00 N Inflammatory Skin Diseases OP01 OP02 Oral e-poster presentations in inflammatory skin diseases Oral e-poster presentations in inflammatory skin diseases 11/10/19 09:00 10:00 11/10/19 10:15 11:15 D3T09.1 Inflammatory diseases 12/10/19 08:30 10:00 N D3T09.2 Inflammatory diseases 12/10/19 10:15 11:45 N Oral e-poster presentation Room Oral e-poster presentation Room 28 Lasers SS14 ESLD - European Society for Lasers and Energy Based Devices 9/10/19 13:30 17:30 Hall 9 Picasso D2T14.1 Laser therapy workshop 11/10/19 08:30 11:45 N D4T01.2 Energy based devices I, including lasers 13/10/19 10:15 11:45 N103 D4T01.3 Energy based devices II, including lasers 13/10/19 12:00 13:30 N Media, Information and Communication Technology (ICT) D1T13.1 Media session - How to give a good presentation 10/10/19 08:45 11:45 N D2T13.1 Building the doctor-patient relationship through effective communication 11/10/19 08:30 11:45 N D2T09.3 e-dermatology 11/10/19 13:15 14:45 N

18 SCIENTIFIC PROGRAMME Code Session Title Date Start End Room 30 Miscellaneous SS06 AEDV - Spanish Academy of Dermatology and Venereology 9/10/19 09:00 13:00 N104 SS05 ISD - International Society of Dermatology 9/10/19 09:00 13:00 N103 SS07 CSD - Chinese Society of Dermatology 9/10/19 09:00 13:00 N SS08 IHhS - International Hyperhidrosis Society 9/10/19 09:00 13:00 N SS11 PALD - Pan Arab League of Dermatologists 9/10/19 11:00 13:00 N SS19 EWDVS - European Women Dermatological and Venereological Society 9/10/19 13:30 17:30 N PLNS Opening Plenary Lecture 9/10/19 17:45 18:15 Hall 10 Dalí D1T01.1 Spotlights 1 10/10/19 08:30 11:45 Hall 10 Dalí PL-A Plenary Lectures A 10/10/19 12:00 12:45 Hall 10 Dalí D2T01.1 Spotlights 2 11/10/19 08:30 11:45 Hall 10 Dalí D2T10.1 Pain 11/10/19 08:30 10:00 N D2T07.1 Skin imaging: Confocal microscopy 11/10/19 08:30 10:00 N104 D2T06.1 Topographic dermatology: Face 11/10/19 08:30 10:00 N103 D2T10.2 Joint EADV/AAD session 11/10/19 10:15 11:45 N D2T12.2 Non-surgical therapy 11/10/19 10:15 11:45 N D2T09.2 Medical devices 11/10/19 10:15 11:45 N D2T07.2 Skin imaging: Sonography in dermatology 11/10/19 10:15 11:45 N104 D2T06.2 Topographic dermatology: Genital 11/10/19 10:15 11:45 N103 D2T13.3 Hot European research topics supported by the EADV (PPRC) 11/10/19 13:15 14:55 N D2T10.3 ESDR session 11/10/19 13:15 14:45 N D2T04.3 Geriatric dermatology 11/10/19 13:15 14:45 Hall 9 Picasso D2T07.3 Skin imaging: Optical coherence tomography 11/10/19 13:15 14:45 N104 D2T06.3 Topographic dermatology: Hands and feet 11/10/19 13:15 14:45 N103 D2T14.2 Ultrasound: Practical hands-on dermatology workshop 11/10/19 13:15 16:30 N D2T13.4 Editors' pick of the year a global comparison 11/10/19 15:00 16:30 N D2T09.4 Artificial intelligence and big data 11/10/19 15:00 16:30 N D2T04.4 Geriatric dermatology 11/10/19 15:00 16:30 Hall 9 Picasso D2T07.4 Skin imaging: Computer vision (machine and deep learning) 11/10/19 15:00 16:30 N104 D3T08.1 Rising stars session 12/10/19 08:30 10:00 N D3T01.1 Late breaking news 12/10/19 08:30 11:45 Hall 10 Dalí FC05 Free communications in Miscellaneous 12/10/19 08:30 10:00 N

19 Code Session Title Date Start End Room OP05 Oral e-poster presentations in Miscellaneous 12/10/19 10:15 11:15 FC06 Free communications in Miscellaneous 12/10/19 10:15 11:45 N D3T08.2 EADV President's Symposium: Skin and brain: Unraveled connections 12/10/19 10:15 11:45 N Oral e-poster presentation Room PL-B Plenary Lectures B 12/10/19 12:00 12:45 Hall 10 Dalí Scientific Programme D3T07.3 Holistic approach in dermatology 12/10/19 13:15 14:45 N104 D3T05.3 Skin diseases in transplant patients 12/10/19 13:15 14:45 Hall 9 Sorolla D3T09.3 Advantages of a multidisciplinary approach 12/10/19 13:15 14:45 N D3T08.3 Lessons from registries 12/10/19 13:15 14:45 N OP06 Oral e-poster presentations in Miscellaneous 12/10/19 13:45 14:45 D3T08.4 Quality assurance in daily practice 12/10/19 15:00 16:30 N D3T09.4 Advantages of a multidisciplinary approach 12/10/19 15:00 16:30 N Oral e-poster presentation Room 31 Nail Disorders/Diseases SS20 ENS - European Nail Society 9/10/19 13:30 17:30 N D1T03.4 Nail dyschromia 10/10/19 15:00 16:30 Hall 10 Velázquez D2T05.3 Nail disorders 11/10/19 13:15 14:45 Hall 9 Sorolla D3T11.1 Nail disorders 12/10/19 08:30 10:00 N Oral Mucosa and other Skin-adjacent Mucous Membranes D3T05.1 Mucosal inflammatory diseases 12/10/19 08:30 10:00 Hall 9 Sorolla D3T05.2 Mucosal neoplasia 12/10/19 10:15 11:45 Hall 9 Sorolla 33 Paediatric Dermatology D2T04.1 Paediatric dermatology 11/10/19 08:30 10:00 Hall 9 Picasso D2T04.2 Paediatric dermatology 11/10/19 10:15 11:45 Hall 9 Picasso D3T11.3 Paediatric dermatology 12/10/19 13:15 14:45 N D3T11.4 Paediatric dermatology 12/10/19 15:00 16:30 N Pharmacology and Skin-related Toxicology, Phlebology D2T06.4 Interventional phlebology 11/10/19 15:00 16:30 N103 D2T10.4 Pharmacoeconomics and patient access to innovative drugs 11/10/19 15:00 16:30 N D3T14.1 Phlebology workshop (beginners) 12/10/19 08:30 11:45 N D3T14.2 Phlebology workshop (advanced) 12/10/19 13:15 16:30 N

20 SCIENTIFIC PROGRAMME Code Session Title Date Start End Room 35 Photobiology and Photoallergy SS12 ESPD - European Society for Photodermatology 9/10/19 13:45 17:30 Hall 10 Coello D2T03.3 Photodermatology 11/10/19 13:15 14:45 Hall 10 Velázquez D2T03.4 Photodermatology 11/10/19 15:00 16:30 Hall 10 Velázquez 36 Phototherapy, Photodynamic Therapy SS21 EURO-PDT - European Society for Photodynamic Therapy in Dermatology 9/10/19 13:30 17:30 N Pigmentary Diseases SS09 EXPS - European XP Society 9/10/19 09:00 13:00 N D1T03.1 Hypopigmentation 10/10/19 08:30 10:00 Hall 10 Velázquez D1T03.2 Hyperpigmentation 10/10/19 10:15 11:45 Hall 10 Velázquez D1T03.3 Vitiligo 10/10/19 13:15 14:45 Hall 10 Velázquez 38 Pregnancy-related Dermatoses D1T06.1 Pregnancy and skin diseases: How to manage 10/10/19 08:30 10:00 N103 D1T06.2 Pregnancy and skin diseases: How to manage 10/10/19 10:15 11:45 N103 D1T06.3 Pregnancy and skin diseases: How to manage 10/10/19 13:15 14:45 N Pruritus D2T08.1 Pruritus 11/10/19 08:30 10:00 N Psoriasis SS10 IPC - International Psoriasis Council 9/10/19 09:00 13:00 N FC01 Free communications in Psoriasis 10/10/19 08:30 10:00 N FC02 Free communications in Psoriasis 10/10/19 10:15 11:45 N D2T11.1 Psoriasis 11/10/19 08:30 10:00 N D3T01.2 Psoriasis treatment 12/10/19 13:15 14:45 Hall 10 Dalí D3T01.3 Psoriasis treatment 12/10/19 15:00 16:30 Hall 10 Dalí 41 Psychodermatology SS22 ESDaP - European Society of Dermatology and Psychiatry 9/10/19 13:30 17:30 N D3T04.1 Psychodermatology 12/10/19 08:30 10:00 Hall 9 Picasso D3T04.2 Psychodermatology 12/10/19 10:15 11:45 Hall 9 Picasso 18

21 Code Session Title Date Start End Room 44 Sexually Transmitted Infections, HIV/AIDS Scientific Programme D1T05.1 STIs 10/10/19 08:30 10:00 Hall 9 Sorolla D1T05.2 STIs 10/10/19 10:15 11:45 Hall 9 Sorolla D1T05.3 HIV 10/10/19 13:15 14:45 Hall 9 Sorolla D1T05.4 HPV 10/10/19 15:00 16:30 Hall 9 Sorolla D3T10.2 STIs 12/10/19 10:15 11:45 N Systemic Treatment FC03 Free communications in Therapy 10/10/19 13:15 14:45 N FC04 Free communications in Therapy 10/10/19 15:00 16:30 N D2T09.1 Systemic treatment in dermatology: Old and new 11/10/19 08:30 10:00 N OP03 Oral e-poster presentations in Therapy 11/10/19 13:45 14:45 OP04 Oral e-poster presentations in Therapy 11/10/19 15:00 16:00 D3T10.3 Topical and systemic therapies of skin diseases 12/10/19 13:15 14:45 N D3T10.4 Topical and systemic therapies of skin diseases 12/10/19 15:00 16:30 N Oral e-poster presentation Room Oral e-poster presentation Room 46 Topical Therapy D1T09.1 Topical corticosteroids 10/10/19 08:30 10:00 N FC03 Free communications in Therapy 10/10/19 13:15 14:45 N FC04 Free communications in Therapy 10/10/19 15:00 16:30 N OP03 Oral e-poster presentations in Therapy 11/10/19 13:45 14:45 OP04 Oral e-poster presentations in Therapy 11/10/19 15:00 16:00 D3T10.3 Topical and systemic therapies of skin diseases 12/10/19 13:15 14:45 N D3T10.4 Topical and systemic therapies of skin diseases 12/10/19 15:00 16:30 N Oral e-poster presentation Room Oral e-poster presentation Room 47 Tropical Dermatovenereology D1T07.3 Diseases in migrating populations 10/10/19 13:15 14:45 N104 D1T07.4 Diseases in travellers 10/10/19 15:00 16:30 N Urticaria, Angioedema D1T11.4 Urticaria 10/10/19 15:00 16:30 N D2T03.2 Urticaria 11/10/19 10:15 11:45 Hall 10 Velázquez 19

22 SCIENTIFIC PROGRAMME Code Session Title Date Start End Room 49 Wounds, Chronic Wounds, Wound Healing, Ulcer D1T08.1 Scars and keloids 10/10/19 08:30 10:00 N D1T08.2 Ulcers 10/10/19 10:15 11:45 N D1T14.2 Wound healing workshop 10/10/19 13:15 16:30 N D3T13.2 Nurse Day - Part 2 12/10/19 10:15 12:15 N D3T13.3 Nurse Day - Afternoon interactive sessions 12/10/19 14:00 16:30 N D4T02.3 Scars 13/10/19 12:00 13:30 N104 20

23 Download the App 28th EADV CONGRESS 9 13 October 2019 Madrid, Spain Scientific Programme All you need in your hand Scientific programme Access the full programme and create your own agenda Abstracts Browse and share abstracts from your device Exhibition Find all exhibitor profiles and locate them easily Session evaluations Evaluate all sessions and gain your CME-CPD credits The EADV Events App will bring the 28 th EADV Congress to your iphone or Android phone and can also be used partially offline. Interactivity Give your opinion, vote, interact with other participants Search for «EADV Events» in your store Visite the official website of the 28 th EADV Congress to find out more about the event Free WiFi is available in all areas 21

24 WEDNESDAY 9 OCTOBER Room Name Hall 10 Dalí Hall 10 Coello Hall 10 Velázquez Hall 9 Picasso Hall 9 Sorolla N103 Capacity SS01 SS02 SS03 ESCAD: European Society for Cosmetic and Aesthetic Dermatology SS04 IDS: International Dermoscopy Society SS05 ISD: International Society of Dermatology 13: SS12 ESPD: European Society for Photodermatology SS13 ESDP: European Society of Dermatopathology SS14 ESLD: European Society for Lasers and Energy Based Devices SS15 ESMS: European Society for Micrographic Surgery SS16 EHSF: European Hidradenitis Suppurativa Foundation 17:30-17: PLNS - Opening Plenary Lecture Networking Symposium 22

25 N104 N N N N N N Wednesday, 9 October SS06 AEDV: Spanish Academy of Dermatology and Venereology. SS07 CSD: Chinese Society of Dermatology SS08 IHhS: International Hyperhidrosis Society SS09 EXPS: European XP Society SS10 IPC: International Psoriasis Council SS11 PALD: Pan Arab League of Dermatologists SS17 ETFAD: European Task Force on Atopic Dermatitis. SS18 Euromelanoma - EADO: European Association of Dermato Oncology SS19 EWDVS: European Women Dermatological and Venereological Society SS20 ENS: European Nail Society SS21 EURO-PDT: European Society for Photodynamic Therapy in Dermatology SS22 ESDaP: European Society of Dermatology and Psychiatry 23

26 WEDNESDAY 9 OCTOBER Subspecialty/International Society Meeting Hall 9 Picasso SS03 SS03.01 SS03.02 SS03.03 SS03.04 SS03.05 SS03.06 SS03.07 SS03.08 SS03.09 SS03.10 SS03.11 SS03.12 SS03.13 SS03.14 SS03.15 SS03.16 SS03.17 SS03.18 SS03.19 SS :00 13:00 ESCAD - European Society for Cosmetic and Aesthetic Dermatology Chairs: Andreas Katsambas (Athens, Greece) Ashraf Badawi (Oakville, Canada) Peter Velthuis (Rotterdam, Netherlands) 09:00 Botulinum toxin-a: Lower face Andreas Katsambas (Athens, Greece) 09:10 BTX for the periorbital area Ines Verner Rashkovsky (Savyon, Israel) 09:20 The science behind the use of botulinum toxin as a complementary treatment of depression Katlein Franca (Miami, United States) 09:30 Advanced indications. How can we find exactly the correct injection points Peter Velthuis (Rotterdam, Netherlands) 09:40 Microbiota, microbiome and Botulinum toxins - an amazing connection Torello M. Lotti (Rome, Italy) 09:50 Simple yet important tool every practitioner injecting filler must know Leonie Schelke (Amsterdam, Netherlands) 10:00 Chemical peeling in cases of melasma, what to do and what not to do? Oliver Kreyden (Basel, Switzerland) 10:10 PRP: Do we know how to get the best results? Ahmed Sadek (Cairo, Egypt) 10:20 Five tips and tricks in dermatological surgery procedures at your office Leonardo Marini (Trieste, Italy) 10:30 Interactions between fillers and energy based devices and lasers Hugues Cartier (Arras, France) 10:40 My protocol for scar management Keyvan Nouri (Miami, United States) 10:50 Quality of life in aesthetic dermatology Aleksandra Vojvodic (Belgrade, Serbia) 11:00 Water in aesthetic dermatology Belma Tursen (Mersin, Turkey) 11:10 Paradoxes in aesthetic dermatology Umit Tursen (Mersin, Turkey) 11:20 How to spot the patients you do not want to do aesthetic procedure for? Ashraf Badawi (Oakville, Canada) 11:30 Thread lifting for the lower face Albina Kajaia (Tbilisi, Georgia) 11:40 Thread lifting, expectiation & reality. View of doctor and patient Albina Kajaia (Tbilisi, Georgia) 11:50 The use of PRP and CO2 laser in the treatment of rolling scars Vesna Pljakoska (Skopje, Macedonia) 12:00 Vulval aesthetics from dermatology perspective Beata Cybulska (Nowa Sol, Poland) 12:10 Panel discussion: Glutathione injection for skin whitening and FDA warning - When not to do threads - Non vascular complications of fillers 24

27 Subspecialty/International Society Meeting Hall 9 Sorolla SS04 SS :00 13:00 IDS - International Dermoscopy Society Chairs: Iris Zalaudek (Graz, Austria) Aimilios Lallas (Thessaloniki, Greece) 09:00 Lichen planus-like keratosis vs regressed melanoma Alicia Barreiro Capurro (Barcelona, Spain) SS04.02 SS :15 Irritated seborrheic keratosis vs well differentiated squamous cell carcinoma Cryssoula Papageorgiou (Thessaloniki, Greece) 09:30 Selective vs total body imaging Philipp Tschandl (Vienna, Austria) Wednesday, 9 October SS04.04 SS04.05 SS04.06 SS04.07 SS04.08 SS04.09 SS04.10 SS04.11 SS04.12 SS04.13 SS04.14 SS04.15 SS :45 Experts 1 vs Experts 2 - Cases by: Ruzica Jurakic Toncic (Croatia) Ruzica Jurakic Toncic (Zagreb, Croatia) 10:00 Thin nodular melanoma vs other nodular tumors Dimitris Sgouros (Athens, Greece) 10:15 Basal cell carcinoma vs adnexal tumors Ayelet Risphon (Tel Aviv, Israel) 10:30 Follow up vs re-treatment of residual basal cell carcinoma John Paoli (Gothenburg, Sweden) 10:45 Experts 3 vs Experts 4 - Cases by: Claudio Conforti (Italy) Claudio Conforti (Trieste, Italy) 11:00 Bowen s disease vs superficial basal cell carcinoma Sonia Segura (Barcelona, Spain) 11:15 Actinic keratosis vs early squamous cell carcinoma Paola Corneli (Trieste, Italy) 11:30 Wide excision vs adjuvant treatments for lentigo maligna Gabriella Brancaccio (Naples, Italy) 11:45 Experts 5 vs Experts 6 - Cases by: Danica Tiodorovic (Serbia) Danica Tiodorovic (Nis, Serbia) 12:00 Erythroplasia Queyrat vs balanitis Enzo Errichetti (Udine, Italy) 12:15 In situ melanoma vs atypical nevus Elisavet Lazaridou (Thessaloniki, Greece) 12:30 Artificial intelligence vs natural intelligence for melanoma diagnosis Konstantinos Liopyris (New York, United States) 12:45 Experts 7 vs Experts 8 - Cases by: Ahmed Sadek (Egypt) Ahmed Sadek (Cairo, Egypt) Subspecialty/International Society Meeting N103 SS05 SS05.01 SS05.02 SS :00-13:00 ISD - International Society of Dermatology Chairs: George Reizner (Madison, United States) Abdul-Ghani Kibbi (Beirut, Lebanon) 09:00 Welcome George Reizner (Madison, United States) 09:05 Complications with fillers Esperanza Welsh (San Pedro Garza Garcia, Mexico) 09:20 Autologous minigrafting in vitiligo Koushik Lahiri (Kolkata, India) 25

28 WEDNESDAY 9 OCTOBER SS05.04 SS05.05 SS05.06 SS :35 Cutaneous coccidioidomycosis, the great mimicker Jorge Ocampo-Candiani (Monterrey, Mexico) 09:50 Acquired dermal macular hyperpigmentation Vinay Keshava Murthy (Bangalore, India) 10:05 Cutaneous Leishmaniasis: Lessons from the scourge of war Abdul-Ghani Kibbi (Beirut, Lebanon) 10:20 When to think of leprosy Paulo Cunha (Sao Paulo, Brazil) 10:35 BREAK SS05.08 SS05.09 SS05.10 SS05.11 SS05.12 SS05.13 SS05.14 SS :50 Old new emerging infectious diseases in Mexico and Central America Jose Dario Martinez Villarreal (Monterrey, Mexico) 11:05 Elephanthiasis in hidradenitis suppurtiva Edyta Lelonek (Wrocław, Poland) 11:20 Dermatophytic disease from Tunisian clinical cases and beyond Fatma Jendoubi (Toulouse, France) 11:35 Climate change: The implications for dermatology Johannes Dayrit (Manila, Philippines) 11:50 Mentorship in dermatology Martin Kassir (Dallas, United States) 12:00 Status of the International Journal of Dermatology (IJD) Rokea el-azhary (Rochester, United States) 12:20 Best of the IJD - Out of Africa Lawrence Gibson (Rochester, United States) 12:40 Best of the IJD - Case Reports Kenneth Tomecki (Cleveland, United States) Subspecialty/International Society Meeting N104 SS06 SS06.01 SS06.02 SS06.03 SS06.04 SS :00-13:00 AEDV: Spanish Academy of Dermatology and Venereology Chairs: Beatriz Llombart Cussac (Campolivar-Godella, Spain) Yolanda Gilaberte Calzada (Zaragoza, Spain) 09:00 Welcome 09:10 Psoriasis: Overview and update on biologic therapy Pablo De la Cueva (Madrid, Spain) 09:30 Telomeres and melanoma Eduardo Nagore (Valencia, Spain) 09:50 Teledermatology and beyond: A present and futuristic view Lara Ferrándiz (Sevilla, Spain) 10:10 My approach to mosaic diseases Antonio Torrelo (Madrid, Spain) 10:30 BREAK SS06.06 SS06.07 SS :00 New frontiers in cutaneous lymphomas Ramon Pujol (Barcelona, Spain) 11:20 What s new in dermoscopy and confocal microscopy Susana Puig (Barcelona, Spain) 11:40 What s new in hair disorders Sergio Vaño-Galván (Madrid, Spain) 26

29 SS06.09 SS06.10 SS :00 The research unit of the AEDV Miguel Angel Descalzo (Madrid, Spain) 12:20 Aesthetic dermatology: A futuristic view Ricardo Ruiz-Villaverde (Granada, Spain) 12:40 Questions Subspecialty / International Society Meeting N SS07 09:00-13:00 CSD - Chinese Society of Dermatology Chairs: Furen Zhang (Jinan, China) Lin Ma (Beijing, China) Yu-Ping Ran (Chengdu, China) Wednesday, 9 October SS07.01 SS07.02 SS07.03 SS07.04 SS07.05 SS07.06 SS07.07 SS07.08 SS07.09 SS :00 Novel compound heterozygous mutations in FAM134B causing later-onset hereditary sensory and autonomic neuropathy type 2B in a Chinese family Diqing Luo (Guangzhou, China) 09:20 Altered intestinal microflora in the development of psoriasis vulgaris Ling Chen (Chongqing, China) 09:30 Skin resident memory T-cells in psoriatic recurrence Shen Zhu (Chengdu, China) 09:40 Aberrant htert promoter methylation predicts prognosis in Chinese patients with acral and mucosal melanoma XiaoJing Kang (Urumqi, China) 09:50 A large-scale stratification analysis on MHC region of early and late onset psoriasis in China Yujun Sheng (Hefei, China) 10:00 Autoantigen ttransglutaminase 3 participates in the pathogenesis ofatopic dermatitis by preferentially inducing Th1 cell reactivity via DC-SIGN Huichun Su (Fuzhou, China) 10:10 MSCs suppresses PTEN/AKT pathway to promote cell viability Liangcai Wu (Guangzhou, China) 10:20 Integrative analysis of lncrna and mrna profiles identified pathogenetic lncrnas in rosacea Xian Jiang (Chengdu, China) 10:30 Prevalence of co-infections with other STIs in patients newly diagnosed with anogenital warts in Guangzhou, China Liuyuan Wang (Guangzhou, China) 10:40 Betaine protects human melanocytes from H2O2-induced dysfunction and degeneration Wei Fang (Shanghai, China) 10:50 BREAK SS07.11 SS07.12 SS07.13 SS :10 Efficacy and safety of sirolimus in the treatment of blue rubber bleb nevus syndrome in pediatric patients Bin Zhang (Beijing, China) 11:20 Distinct skin microbiota imbalance and responses to clinical treatment in children with atopic dermatitis Ying Liu (Beijing, China) 11:30 Long-term effectiveness and safety of rituximab for the treatment of pemphigus in Chinese population Yuan Chang (Beijing, China) 11:40 Clinical efficacy and safety of using Minocycline in the treatment of unstable vitiligo Jin Wang (Chengdu, China) SS :50 An unique case series of recurrent abdominal painful erythema Jianfang Sun (Nanjing, China) 27

30 WEDNESDAY 9 OCTOBER SS :00 Dermatoscopy on infectious skin diseases - Chinese experience Yu-Ping Ran (Chengdu, China) 12:10 BREAK SS07.17 SS07.18 SS :20 The Research of Mongolia medicine Sendeng-4 nano-emulsion and its antimicrobial property Rina Wu (Huhehot, China) 12:30 Characteristics of congenital hemangiomas: A retrospective study Ping Li (Shenzhen, China) 12:40 The coexistence of vitiligo and psoriasis: By chance, or for a reason? Bingxue Bai (Haerbin, China) Subspecialty/International Society Meeting N SS08 SS08.01 SS08.02 SS08.03 SS08.04 SS :00 13:00 IHhS - International Hyperhidrosis Society Chairs: Dee Anna Glaser (Saint Louis, United States) David Pariser (Norfolk, United States) Lisa J. Pieretti (Center Valley, United States) 09:00 Understanding the impact of hyperhidrosis Lisa J. Pieretti (Center Valley, United States) 09:20 Defining and diagnosing hyperhidrosis: Differentiating primary and secondary hyperhidrosis in a step-wise approach Dee Anna Glaser (Saint Louis, United States) 09:35 Aluminum-based topical therapies: OTC and Rx David Pariser (Norfolk, United States) 09:45 Anticholinergic-based topical therapy: The newest innovation David Pariser (Norfolk, United States) 10:10 Iontophoresis: A palmar and plantar option David Pariser (Norfolk, United States) 10:25 BREAK SS08.06 SS08.07 SS08.08 SS08.09 SS08.10 SS08.11 SS08.12 SS :55 Injections for axillary hyperhidrosis: Techniques for improved efficacy & satisfaction Dee Anna Glaser (Saint Louis, United States) 11:10 Injections for non-axillary and gustatory hyperhidrosis: Employing a proven treatment in new ways Dee Anna Glaser (Saint Louis, United States) 11:35 Axillary microwave thermolysis of sweat glands: Addressing odor, hair and sweat Dee Anna Glaser (Saint Louis, United States) 11:50 Axillary liposuction, microneedling and local surgery Dee Anna Glaser (Saint Louis, United States) 12:00 Oral medications: What and when to use them Dee Anna Glaser (Saint Louis, United States) 12:15 ETS surgery: Option of last resort Dee Anna Glaser (Saint Louis, United States) 12:25 Special populations: Pediatric and geriatric patients David Pariser (Norfolk, United States) 12:40 Emerging treatments: A robust pipeline David Pariser (Norfolk, United States) 28

31 Subspecialty/International Society Meeting N SS09 SS :00 13:00 EXPS - European XP Society Chairs: Robert Sarkany (London, United Kingdom) Mark Berneburg (Regensburg, Germany) 09:00 Chairman s introduction Robert Sarkany (London, United Kingdom) SS09.02 SS :10 Can we personalise clinical management in XP by genotype? Hiva Fassihi (London, United Kingdom) 09:40 Biomarkers in XP in South Africa Mahlatse Kgokolo (Pretoria, South Africa) Wednesday, 9 October SS09.04 SS09.05 SS09.06 SS09.07 SS09.08 SS :55 Ocular surface neoplasms in XP patients in the United Kingdom John Vekinis (London, United Kingdom) 10:10 Whole genome sequencing of angiosarcoma enabling effective therapy in a patient with XP-C Sophie Momen (London, United Kingdom) 10:25 Clinical presentation #4 + Discussion 10:45 BREAK 11:15 Clinical presentation and genetic correlation in XP in Barcelona Susana Puig (Barcelona, Spain) 11:45 Xeroderma pigmentosum: Facts and perspectives Steffen Emmert (Rostock, Germany) 12:15 International collaborations between patient groups in XP Nicola Miller (Ashford, United Kingdom) Subspecialty/International Society Meeting N SS10 SS10.01 SS10.02 SS10.03 SS10.04 SS10.05 SS :00 13:00 IPC - International Psoriasis Council Chairs: Catherine Smith (London, United Kingdom) Bruce Strober (Farmington, United States) 09:00 Welcome and introduction Catherine Smith (London, United Kingdom) 09:05 PART 1: INNOVATIONS 09:05 Drug survival and sequential use of biologics Lone Skov (Hellerup, Denmark) 09:25 Classifying disease severity Bruce Strober (Farmington, United States) 09:45 The use of biosimilars in psoriasis Luís Puig (Barcelona, Spain) 10:05 Update on methotrexate Catherine Smith (London, United Kingdom) 10:25 Panel discussion and summary Catherine Smith (London, United Kingdom) 10:40 BREAK 10:55 PART II: CHALLENGING CASES SS :55 Challenging Case 1 Lone Skov (Hellerup, Denmark) SS :10 Challenging Case 2 Catherine Smith (London, United Kingdom) SS :25 Challenging Case 3 Luís Puig (Barcelona, Spain) SS :40 Challenging Case 4 Robert Strohal (Feldkirch, Austria) SS :55 Panel discussion and summary Bruce Strober (Farmington, United States) 29

32 WEDNESDAY 9 OCTOBER Subspecialty/International Society Meeting N SS11 SS11.01 SS11.02 SS11.03 SS11.04 SS11.05 SS11.06 SS11.07 SS11.08 SS11.09 SS11.10 SS11.11 SS :00 13:00 PALD - Pan Arab League of Dermatologists Chairs: Nejib Doss (Tunis, Tunisia) Riad Mashal (Ramallah, Palestine) Ibrahim Galadari (Dubai, United Arab Emirates) 11:00 Complications of fillers. What to do and how to manage? Medhat Abdel Malek (Amman, Jordan) 11:10 Psoriasis and obesity: What are the links? Omid Zargari (Rasht, Iran) 11:20 Low level laser therapy in hair loss Khaled Gharib (Zagazig, Egypt) 11:30 Towards standard patch tests in Libya Fathi Elkasah (Sirte, Libya) 11:40 Facial melanosis Khalifa Sharquie (Baghdad, Iraq) 11:50 Pearls in skin surgery and cosmetology Khalifa Sharquie (Baghdad, Iraq) 12:00 Cutaneous Leishmaniasis: Differential diagnosis and management Mohamed Abderraouf Dhaoui (Tunis, Tunisia) 12:10 Phototherapy: What you might not know Ahmed Alissa (Riyadh, Saudi Arabia) 12:20 Hair removal laser: What you might not know Ahmed Alissa (Riyadh, Saudi Arabia) 12:30 Homozygous variegate porphyria Spiro Tams (Jerusalem, Israel) 12:40 Intralesional bleomycin injection in management of vascular anomalies Aïcha Salhi (Algiers, Algeria) 12:50 Phenotypic aspects of psoriasis in children and guidelines for care Mahira El Sayed (Cairo, Egypt) Subspecialty/International Society Meeting Hall 10 Coello SS12 SS12.01 SS :45 17:30 ESPD - European Society for Photodermatology Chairs: Jean Krutmann (Dusseldorf, Germany) Christophe Bedane (Limoges, France) Giovanni Leone (Rome, Italy) Piergiacomo Calzavara-Pinton (Brescia, Italy) Sally Helen Ibbotson (Dundee, United Kingdom) Marjan Garmyn (Leuven, Belgium) 13:45 Photoageing in the 21 st Century Christopher Griffiths (Manchester, United Kingdom) 14:30 Photogenodermatoses Smaïl Hadj-Rabia (Paris, France) 15:00 BREAK SS12.03 SS12.04 SS :20 Photoinvestigation Sally Helen Ibbotson (Dundee, United Kingdom) 15:40 Antimicrobial PDT Yolanda Gilaberte Calzada (Zaragoza, ES) 16:00 Photoprotection: Psychological factors and behond Robert Sarkany (London, United Kingdom) 30

33 Subspecialty/International Society Meeting Hall 10 Velázquez SS13 SS :30 17:30 ESDP - European Society of Dermatopathology Chairs: Gürkan Kaya (Geneva, Switzerland) Carlo Francesco Tomasini (Pavia, Italy) 13:30 Welcome SS13.02 SS :45 European Society of Dermatopathology Gürkan Kaya (Geneva, Switzerland) 14:00 European Diploma of Dermatopathology Carlo Francesco Tomasini (Pavia, Italy) Wednesday, 9 October SS13.04 SS13.05 SS :15 Test Yourself - Dermatopathology Quiz Carlo Francesco Tomasini (Pavia, Italy) 15:45 Test Yourself - Dermatopathology Quiz Gürkan Kaya (Geneva, Switzerland) 17:15 Discussion - Concluding remarks Subspecialty/International Society Meeting Hall 9 Picasso SS14 SS14.01 SS14.02 SS14.03 SS14.04 SS14.05 SS14.06 SS14.07 SS14.08 SS14.09 SS14.10 SS14.11 SS14.12 SS14.13 SS :30 17:30 ESLD - European Society for Lasers and Energy Based Devices Chairs: Ashraf Badawi (Oakville, Canada) Hans Laubach (Geneva, Switzerland) 13:30 Uncommon complications and challenges with lasers and EBDs in the literature Anne Le Pillouer-Prost (Marseille, France) 13:45 Outcomes and controversies in port wine stain treatment Albert Wolkerstorfer (Vleuten, Netherlands) 14:00 Lasers in scars treatment, where are we standing? Keyvan Nouri (Miami, United States) 14:15 European laser Registry project Frederike Fransen (Edam, Netherlands) 14:30 Is low dose oral isotretinoin useful to optimize light and EBD-assisted treatments for acne and rosacea? Leonardo Marini (Trieste, Italy) 14:45 Uncommon indications for pulsed-dye laser Pablo Boixeda (Madrid, Spain) 15:00 Should melasma be treated with lasers and light based devices? Hugues Cartier (Arras, France) 15:15 Treatment of Striae Alba using Fractional Radiofrequency with and without lyophilized growth factors Ahmed Abd Elfattah Afify (Cairo, Egypt) 15:30 Small arterial malformations can exceptionally be treated with lasers, case report Agneta Troilius Rubin (Malmo, Sweden) 15:45 Pigmentation of facial vitiligo with combination therapy HIFUs, CO 2 laser and PRP Aura Ibeth Ruiz Rosas (Bogota, Colombia) 16:00 Fractional CO2 laser improving limited mouth opening in systemic sclerosis Muriel Creusot (Lasne, Belgium) 16:15 Complications after ablative fractional photothermolysis for the treatment of acid induced scar of the lower leg. Case report Jori Punchera (Geneva, Switzerland) 16:30 PDT, what did we learn over the past years? Rolf-Markus Szeimies (Recklinghausen, Germany) 16:45 Panel discussion Albert Wolkerstorfer (Vleuten, Netherlands) 31

34 WEDNESDAY 9 OCTOBER Subspecialty/International Society Meeting Hall 9 Sorolla SS15 13:30 17:30 ESMS - European Society for Micrographic Surgery Chairs: Severin Läuchli (Zurich, Switzerland) Luis Ríos Buceta (Madrid, Spain) 13:30 PART 1: Tips and tricks, reconstructions SS15.01 SS15.02 SS15.03 SS15.04 SS15.05 SS15.06 SS :30 Artificial intelligence in Mohs surgery Gertruud Krekels (Bladel, Netherlands) 13:50 Digital mapping Kai Munte (Rotterdam, Netherlands) 14:10 Tips and tricks Ally-Khan Somani (Indianapolis, United States) 14:30 Titanium meshes for nasal reconstruction Paula Fernandez Canga (Leon, Spain) 14:50 Dermal substitutes for covering extensive defects Michael Muhlstadt (Geneva, Switzerland) 15:10 My best reconstructions Pedro Redondo (Pamplona, Spain) 15:30 Scar revision Adrián Alegre Sánchez (Madrid, Spain) 15:50 PART 2: Indications and limitations SS15.08 SS15.09 SS15.10 SS15.11 SS :50 Mohs surgery for cutaneous sarcomas Beatriz Llombart Cussac (Campolivar-Godella, Spain) 16:10 SCC and Mohs Olivier Cogrel (Bordeaux, France) 16:30 ESMS position paper John Paoli (Gothenburg, Sweden) 16:45 Papers / cases from members 17:15 Honorary memberships Julian Conejo-Mir (Seville, Spain) Subspecialty / International Society Meeting N103 SS16 SS16.01 SS16.02 SS16.03 SS16.04 SS16.05 SS :30-17:30 EHSF - European Hidradenitis Suppurativa Foundation Chairs: Christos Zouboulis (Dessau, Germany) Marco Romanelli (Pisa, Italy) 13:30 A novel stop-gain Nicastrin mutation causes Hidradenitis Suppurativa associated with Dowling Degos disease: Is Notch signalling pathway guilty? Simone Garcovich (Rome, Italy) 13:45 Clinical and ultrasonographic characterization of HS: A real life experience of a single Italian center Antonella Di Cesare (Florence, Italy) 14:00 Ozonized olive oil-based dressings in Hidradenitis Suppurativa post surgical wound healing Marco Romanelli (Pisa, Italy) 14:15 Surgical management of Hidradenitis Suppurativa: Implications of ultrasonographic planning and concomitant biologic treatment Alejandro Molina-Leyva (Granada, Spain) 14:30 New approach in the combined conservative treatment of Hidradenitis Suppurativa Evgenyia Hristakieva (Stara Zagora, Bulgaria) 14:40 The significance of tough level and AAA in patients with Hidradenitis Suppurativa Afsaneh Alavi (Richmond Hill, Canada)

35 SS16.07 SS16.08 SS :55 Effectiveness and safety of adalimumab intensification in resistant HS patients Fernando Alfageme (Madrid, Spain) 15:10 First clinical experience with adalimumab biosimilar Imraldi in Hidradenitis Suppurativa Elia Rosi (Florence, Italy) 15:25 C5a inhibition in HS: Results from a randomized, double-blind, placebo-controlled, multicenter Phase IIB study Evangelos Giamarellos-Bourboulis (Athens, Greece) SS16.10 SS :40 IL-23 as a possible target in the treatment of Hidradenitis Suppurativa Maximilian Kovacs (Darmstadt, Germany) 15:55 Is there a role of antiadrogen treatment for Hidradenitis Suppurativa? A systematic review Georgios Nikolakis (Dessau, Germany) Wednesday, 9 October SS :10 Hidradenitis Suppurativa in children and adolescents: A monocentric German case series Christos Zouboulis (Dessau, Germany) Subspecialty / International Society Meeting N104 SS17 SS17.01 SS17.02 SS17.03 SS17.04 SS17.05 SS17.06 SS17.07 SS17.08 SS17.09 SS :30-17:30 ETFAD - European Task Force on Atopic Dermatitis Chairs: Thomas Werfel (Hannover, Germany) Phyllis Spuls (Amstelveen, Netherlands) Andreas Wollenberg (Munich, Germany) Sébastien Barbarot (Nantes, France) 13:30 Welcome and introduction Andreas Wollenberg (Munich, Germany) 13:33 Comparison of quality of life impairment in young children with atopic dermatitis and other skin diseases: Results of the international field tests of the InToDermQoL questionnaire Pavel Chernyshov (Kiev, Ukraine) 13:45 Atopic dermatits: The name is important! Carlo Gelmetti (Milan, Italy) 13:57 Real life experience regarding drug survival and peripheral blood T cell compartment changes after twelve months of dupilumab treatment Marjolein De Bruin-Weller (Utrecht, Netherlands) 14:09 Risk of developing atopic dermatitis according to parental history of atopic disease: A systematic review and meta-analysis Jacob Thyssen (Copenhagen, Denmark) 14:21 Endotyping of adult and paediatric atopic dermatitis; is it one disease? Marjolein De Bruin-Weller (Utrecht, Netherlands) 14:33 A metagenomic analysis of Staphylococcus aureus and the skin commensal microbiome in atopic dermatitis Carsten Flohr (London, United Kingdom) 14:45 A delegate s view report from the HOME VII meeting in Tokyo: Discussions, results and reflections on the current core outcome set for clinical trials in atopic eczema Phyllis Spuls (Amstelveen, Netherlands) 14:53 Atopic Dermatitis in sub-saharan Africa: Summary of the ISAD Geneva meeting and roadmap Alain Taieb (Bordeaux, France) 15:01 Interactive discussion: How to provide optimal quality of care for AD patients? Andreas Wollenberg (Munich, Germany) 15:25 BREAK SS17.11 SS :45 Histopathological findings in paradoxical dermatitis of the face and neck in atopic dermatitis patients treated with dupilumab: A case series Dirk Jan Hijnen (Utrecht, Netherlands) 15:57 De novo or exacerbations of head and neck dermatitis in patients treated with dupilumab for atopic dermatitis Sébastien Barbarot (Nantes, France) 33

36 WEDNESDAY 9 OCTOBER SS17.13 SS17.14 SS17.15 SS17.16 SS17.17 SS17.18 SS :09 Treatment of atopic dermatitis during preconception, pregnancy and lactation. A position paper from the European Task Force on Atopic Dermatitis Christian Vestergaard (Skoedstrup, Denmark) 16:21 Risk of osteoporosis and fracture in adults with atopic dermatitis: A registry-based cohort study Jacob Thyssen (Copenhagen, Denmark) 16:33 Baseline disease characteristics and systemic treatment of patients with atopic dermatitis included in the German AD registry TREATgermany Annice Heratizadeh (Hannover, Germany) 16:45 The European TREatment of Atopic eczema Taskforce (TREAT) Survey: Prescribing practices in Europe for photo- and systemic therapy in moderate-to-severe adult atopic eczema patients Phyllis Spuls (Amstelveen, Netherlands) 16:57 Self-Hypnosis through information technology reduces the use of topical therapy in atopic dermatitis to control itch (Hype-IT Study) Christian Vestergaard (Skoedstrup, Denmark) 17:09 Normal insulin sensitivity in adults with atopic dermatitis Jacob Thyssen (Copenhagen, Denmark) 17:21 Closing remarks Andreas Wollenberg (Munich, Germany) Subspecialty / International Society Meeting N SS18 13:30-17:30 Euromelanoma - EADO: European Association of Dermato Oncology Chairs: Del Marmol Veronique (Brussels, Belgium) Matilda Bylaite-Bucinskiene (Vilnius, Lithuania) Sara Gandini (Milan, Italy) Jean Jacques Grob (Marseille, France) Ricardo Vieira (Coimbra, Portugal) David Moreno-Ramirez (Sevilla, Spain) 13:30 PART 1: EADO SS18.01 SS18.02 SS18.03 SS18.04 SS18.05 SS18.06 SS18.07 SS18.08 SS18.09 SS18.10 SS18.11 SS18.12 SS :30 Update on current guidelines on melanoma and NMSC Claus Garbe (Tubingen, Germany) 13:50 Melanoma: What if recurrence happens while on or after adjuvant therapy? 14:10 Should we start offering conservative lymph node dissections for melanoma? David Moreno-Ramirez (Sevilla, Spain) 14:30 cscc: A practical approach to locally advanced and regional disease Ricardo Vieira (Coimbra, Portugal) 14:50 BCC: What if surgery is not the best frontline option? Ketty Peris (Rome, Italy) 15:10 Merkel cell carcinoma: Surgery and what else? Mahtab Samimi (Tours, France) 15:30 PART II: EUROMELANOMA 15:30 Welcome and introduction Del Marmol Veronique (Brussels, Belgium) 15:40 Euromelanoma campaign in Bulgaria - 13 years of challenge Vali Mateeva (Sofia, Bulgaria) 15:50 Euromelanoma in Lituania - 12 years of experience Matilda Bylaite-Bucinskiene (Vilnius, Lithuania) 16:00 Living with the sun Yolanda Gilaberte (Zaragoza, Spain) 16:15 New insights in NMSC and melanoma epidemiology Sara Gandini (Milan, Italy) 16:30 Sunbeds and melanoma: Time to ban the tan Mariano Suppa (Brussels, Belgium) 16:45 Sun, children and prevention: The millenial challenge Olivier Revol (Lyon, France)

37 SS18.14 SS :00 Euromelanoma A new campaign Philippe Pendaries (Tunbridge Wells, United Kingdom) 17:20 Conclusions Del Marmol Veronique (Brussels, Belgium) Subspecialty / International Society Meeting N SS19 13:30-17:30 EWDVS - European Women Dermatological and Venereological Society Chairs: Carmen Rodriguez-Cerdeira (Vigo, Spain) Gabriella Fabbrocini (Naples, Italy) Ardiana Sinani (Tirane, Albania) Wednesday, 9 October SS19.01 SS19.02 SS19.03 SS19.04 SS19.05 SS19.06 SS19.07 SS19.08 SS19.09 SS19.10 SS :30 Psoriasis comorbidities May El-Samahy (Cairo, Egypt) 13:50 Psoriasis and obesity: Do promising new biomarkers have clinical impact? Carmen Rodriguez-Cerdeira (Vigo, Spain) 14:10 Psoriasis in women Gabriella Fabbrocini (Naples, Italy) 14:30 Psorisasis and its stressful burden Ardiana Sinani (Tirane, Albania) 14:50 Biosimilars in dermatology: A review of the evidence and their place in the treatment algorithm Adriana López-Bárcenas (Morelia, Mexico) 15:10 The prevalence of onychomycosis in patients with psoriasis Erick Martínez-Herrera (Mexico City, Mexico) 15:30 Psoriatic erythrodermia: Part I Monika Fida (Tirana, Albania) 15:50 Psoriatic erythrodermia: Part II Brunilda Bardhi (Tirana, Albania) 16:10 Can we predict the right treatment for the right patient in psoriasis Nayera Moftah (Cairo, Egypt) 16:30 Psoriasis and pregnancy Mihaela Panduru (Bucharest, Romania) 17:00 Looking for the best project among women dermatologists Adriana López-Bárcenas (Morelia, Mexico) Subspecialty / International Society Meeting N SS20 SS20.01 SS20.02 SS20.03 SS20.04 SS20.05 SS20.06 SS20.07 SS :30-17:30 ENS - European Nail Society Chairs: Dimitrios Rigopoulos (Athens, Greece) Bianca Maria Piraccini (Bologna, Italy) 13:30 Approach to patient with nail disease Bianca Maria Piraccini (Bologna, Italy) 13:50 Non-invasive techniques: What, where, when Michela Starace (Bologna, Italy) 14:05 Equipment and surgical instruments in the perfectly equipped nail clinic David de Berker (Bristol, United Kingdom) 14:20 Nail plate histopathology Adam Rubin (Philadelphia, United States) 14:35 E-nail: Medical Aurora Alessandrini (Bologna, Italy) 14:55 Treatment of onychomycosis in real life Andre Lencastre (Lisboa, Portugal) 15:10 Treatment of nail psoriasis and lichen planus in real life Dimitrios Rigopoulos (Athens, Greece) 15:25 E-nail: Surgical Nilton Gioia Di Chiacchio (Sao Paulo, Brazil) 35

38 WEDNESDAY 9 OCTOBER SS20.09 SS20.10 SS20.11 SS20.12 SS20.13 SS20.14 SS :45 Nail biopsy for the beginners Bertrand Richert (Brussels, Belgium) 16:00 How to choose the best approach for ingrowing toenails Nilton Gioia Di Chiacchio (Sao Paulo, Brazil) 16:15 Dealing with follow-up after nail malignancies Robert Baran (Cannes, France) 16:30 Mechanical and traumatic diseases and the nail and occupational nail disease Tracey Vlaovic (Philadelphia, United States) 16:45 Inherited nail disease Matilde Iorizzo (Bellinzona, Switzerland) 17:00 Systemic therapy for nail unit inflammatory disorders in the pediatric population: Best evidence and personal tips Jane Bellet (Durham, United States) 17:15 ENS conclusion Dimitrios Rigopoulos (Athens, Greece) Subspecialty / International Society Meeting N SS21 13:30-17:30 EURO-PDT - European Society for Photodynamic Therapy in Dermatology Chairs: Lasse Braathen (Ittigen, Switzerland) Colin Morton (Perthshire, United Kingdom) Rolf-Markus Szeimies (Recklinghausen, Germany) SS21.01 SS :30 EURO-PDT - An educational platform for photodynamic therapy in dermatology Lasse Braathen (Ittigen, Switzerland) 14:00 An update on guidelines for PDT in dermatology Colin Morton (Perthshire, United Kingdom) SS :30 What is new in daylight PDT for 2019? Rolf-Markus Szeimies (Recklinghausen, Germany) SS21.04 SS21.05 SS21.06 SS21.07 SS :00 PDT in organ transplant recipients Stefano Piaserico (Padua, Italy) 15:30 PDT for actinic cheilitis Zoe Apalla (Thessaloniki, Greece) 16:00 Histological features of AK and corresponding molecular biology Thomas Dirschka (Wuppertal, Germany) 16:30 PDT against microorganisms Yolanda Gilaberte (Zaragoza, Spain) 17:00 Aesthetic photodynamic therapy Anne Le Pillouer-Prost (Marseille, France) Subspecialty / International Society Meeting N SS22 SS22.01 SS22.02 SS22.03 SS :30-17:30 ESDaP - European Society of Dermatology and Psychiatry Chairs: Lucia Tomas Aragones (Muniesa, Spain) Francoise Poot (Bruxelles, Belgium) Anthony Bewley (London, United Kingdom) 13:30 Welcome and update on ESDaP news Lucia Tomas Aragones (Muniesa, Spain) 13:45 Trichotillomania: Psychopathological perspectives and psychiatric comorbidity Mohammad Jafferany (Saginaw, United States) 14:00 Cumulative life course impairment in chronic inflammatory skin diseases Marta Garcia-Bustinduy (Tenerife, Spain) 14:15 Dissatisfaction with cutaneous body image: distinguishing and mediating mental health complains in dermatological disorders Dmitry Romanov (Moscow, Russian Federation) 36

39 SS22.05 SS22.06 SS :30 Stigmatisation in patients with skin disease: A European cross-sectional study Jörg Kupfer (Giessen, Germany) 14:45 Psoriasis: Doctor patient relationship as an art of patient care Francoise Poot (Bruxelles, Belgium) 15:00 Stigmatisation in acne patients Pavel Chernyshov (Kiev, Ukraine) SS22.08 SS :15 Exploring the EQ-5D dimension of pain/discomfort in dermatology outpatients from a multicentre study in 13 European countries Francesca Sampogna (Rome, Italy) 15:30 Quality of life burden in hidradenitis suppurativa: Data from a Spanish multicentre study Servando Marrón Moya (Muniesa, Spain) Wednesday, 9 October SS22.10 SS22.11 SS22.12 SS22.13 SS22.14 SS :45 Quality of life in patients with psoriatic arthritis taking basic medications to control the disease Oleksandra Havryliuk (Kharkiv, Ukraine) 16:00 Looking after psychodermatology patients: what are the risks? Maria-Angeliki Gkini (London, United Kingdom) 16:15 Psychological impairment in Atopic Dermatitis Sandra Ros (Barcelona, Spain) 16:30 Emotional differentiation in dermatologic patients: Results of cross-sectional study Anna Michenko (Moscow, Russian Federation) 16:45 Prevalence of anxiety, depression and attention deficit disorder in patients with primary hyperhidrosis Johannes Kristensen (Copenhagen S, Denmark) 17:00 Discussion and closing words Anthony Bewley (London, United Kingdom) Opening Plenary Lecture Hall 10 Dalí PLNS 17:45-18:15 Opening Plenary Lecture Chairs: Brigitte Dréno (Nantes, France) Carle Paul (Toulouse, France) 17:45 Artificial intelligence and medicine: The secrets for a good marriage Ignacio Hernández Medrano (Madrid, Spain) Neurologist at the Ramón y Cajal Hospital, Ignacio Medrano was considered by the specialised press among the most influential people in health in 2016, for his work promoting systemic changes in the sector through information technologies and big data. His curriculum includes several masters in health management, as well as a step by the Strategic Management of the Ramón y Cajal Institute of Health Research. After graduating in 2014 from Singularity University (NASA, Silicon Valley), he founded two emerging companies in artificial intelligence in healthcare: Savana (electronic medical record processing) and Mendelian (diagnosis and treatment of rare diseases). In 2018 he was chosen as the digital personality by the magazine Salud del año. Session Description - Big data allows computers to learn patterns, thanks to a technique called machine learning, which disrupts classical statistics. - Big data means finding correlations where human mind cannot do it, and allows the design of predictive algorithms. - Predictive algorithms based on artificial intelligence are about to disrupt healthcare. - The king of big data in medicine is genome sequencing, an exponential technology, catalysed by NGS, at very low price. - Systems biology integrated with machine learning are allowing precision medicine. Learning Objectives - Meaning of Big Data, machine learning, neural networks and artificial intelligence - State of art of AI in healthcare - Transition towards algorithmic based healthcare 37

40 THURSDAY 10 OCTOBER Room Name Hall 10 Dalí Hall 10 Coello Hall 10 Velázquez Hall 9 Picasso Hall 9 Sorolla N103 N104 Capacity Session type Hot topics Review and updates Review and updates Review and updates Review and updates Review and updates Review and updates Track no D1T02.1 Interactive dermoscopy D1T03.1 Hypopigmentation D1T04.1 Acne vulgaris and rosacea D1T05.1 STIs D1T06.1 Pregnancy and skin diseases: How to manage D1T07.1 Acute lifethreatening diseases in dermatology: The skin as a sentinel D1T01.1 Spotlights 1 D1T02.2 Interactive dermoscopy D1T03.2 Hyperpigmentation D1T04.2 Acne vulgaris and rosacea D1T05.2 STIs D1T06.2 Pregnancy and skin diseases: How to manage D1T07.2 Acute lifethreatening diseases in dermatology: Red flags and emergencies in dermatology PL-A Plenary Lectures D1T01.2 Atopic dermatitis D1T02.3 Interactive nail dermoscopy D1T03.3 Vitiligo D1T04.3 Hidradenitis suppurativa D1T05.3 HIV D1T06.3 Pregnancy and skin diseases: How to manage D1T07.3 Diseases in migrating populations D1T01.3 Atopic dermatitis D1T02.4 Interactive trichoscopy D1T03.4 Nail dyschromia D1T04.4 Hidradenitis suppurativa D1T05.4 HPV D1T06.4 Red face: Other diagnoses D1T07.4 Diseases in travellers Industry sessions 38

41 Reviews and updates Controversies Training and education forum Special interest meetings Practical workshops Hot topics Free communications N N N N N N N N Review and updates Controversies Training and education forum Training and education forum Free communications Special interest meetings Practical workshops Practical workshops Thursday, 10 October D1T08.1 Scars and keloids D1T09.1 Topical corticosteroids D1T10.1 Nonmelanoma skin cancer D1T11.1 Eczemas: Atopic dermatitis FC01 Free communications in Psoriasis D1T08.2 Ulcers D1T09.2 Biologics in skin disease D1T10.2 Nonmelanoma skin cancer D1T11.2 Eczemas FC02 Free communications in Psoriasis D1T13.1 Media session: How to give a good presentation D1T14.1 Advanced allergology workshop fully booked D1T15.1 Basic surgery workshop (morning) fully booked D1T08.3 Vasculitis and vasculopathies D1T09.3 Drugs in acne D1T10.3 Melanoma D1T11.3 Drug reactions FC03 Free communications in Therapy D1T13.3 Practical pearls from private office D1T08.4 Vasculitis and vasculopathies D1T09.4 Hidradenitis suppurativa D1T10.4 Melanoma D1T11.4 Urticaria FC04 Free communications in Therapy D1T13.4 History of dermatology D1T14.2 Wound Healing workshop fully booked D1T15. 2 Basic surgery workshop (afternoon) fully booked Industry sessions 39

42 THURSDAY, 10 OCTOBER Plenary Lectures Hall 10 Dalí 12:00-12:45 PL-A Plenary Lectures A Chairs: Alexander Stratigos (Athens, Greece) Martin Röcken (Tubingen, Germany) PL-A01 12:00 Combing through the genetics of hair disorders Eli Sprecher - Tel Aviv Medical Center, Tel Aviv Israel Eli Sprecher received his MD and PhD degrees from the Hebrew University of Jerusalem and specialized in dermatology at the Rambam Medical Center, Haifa. He spent a post-doctoral fellowship at Thomas Jefferson University, Philadelphia, and served as attending physician at the Rambam Medical Center until During this period he was Deputy Director for Academic affairs at the Rappaport Institute for Research at the Technion-Israel Institute of Technology, and founded as well as directed the Center for Translational Genetics at the same institution. He became Chair of the Department of Dermatology at the Tel Aviv Medical center in 2008, Professor of Dermatology at the Sackler Faculty of Medicine, Tel Aviv University in 2010, where he also received the Frederick Reiss chair of Dermatology in He also serves as Deputy Director General for Research and Development. He was named visiting professor of Dermatology at the Lee Kong Chian School of Medicine, Singapore, in He has co-authored over 300 scientific publications, has mentored over 40 students and has received numerous national and international prizes and honors. His research focuses on the genetic basis of skin diseases. His group aims at understanding the molecular genetics of both simple and complex traits, deciphering their pathogenesis and then attempting at translating this new knowledge into innovative therapeutic tools. Session Description The past years have witnessed dramatic advances in our understanding of the genetic basis of hereditary hair disorders. Through the study of these conditions, we have gained much insight into the nature and role of key mediators of hair follicle growth and differentiation. In addition, this new knowledge has not only far reaching implications for the counseling of individuals at risk for inherited hair diseases, it has also shed light on the genetic basis of common hair diseases and is being translated into innovative therapeutic tools. These paradigms will be discussed in this lecture in the context of inherited hypotrichoses and acquired forms of scarring alopecias. Learning objectives - Understanding the pathogenesis of selected genotrichoses - Appreciating the relevance of the study of rare disorders to the pathogenesis of common conditions - Getting acquainted with the translation of new genetic knowledge into innovative therapeutic tools 40

43 PL-A02 12:20 How the dermatologist can influence the availability of new treatments Georg Stingl - Vienna, Austria Georg Stingl is professor emeritus at the Department of Dermatology, Medical University of Vienna, Vienna, Austria. Prof. Stingl earned his MD from the University of Vienna Medical School in After his internship and residency training at the Department of Dermatology of Vienna s University Medical School, he worked as a postdoctoral fellow at the Dermatology Branch of the National Cancer Institute ( ) and as a guest scientist at the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases ( ) of the National Institutes of Health, Bethesda, MD, USA. From he served as Faculty member of the Department of Dermatology of Innsbruck s University Medical School and then moved to Vienna where he ultimately became Professor and Chairman of the Department of Dermatology at the Medical University. Prof. Stingl s major scientific accomplishments include the discovery of Langerhans cells as immunocytes and their role as targets of physicochemical agents, drugs and HIV; the first identification of the indigenous T cell population of rodent skin; the detection of anti-fcεr1 autoantibodies in the sera of patients with chronic urticaria; the use of genetically modified melanoma cells as vaccines for patients with far advanced disease; the induction of lytic molecules on dendritic cells after stimulation with TLR 7/8 ligands. In addition, he conducted many clinical trials investigating safety and efficacy of different immunomodulatory compounds. Thursday, 10 October His work is documented in more than 250 original publications, 200 reviews and book chapters as well as four books. Over the years, Prof. Stingl has appeared as Guest Professor at several medical universities and as invited speaker at many symposia and conferences. He is member of the Board of several scientific societies and organisations, advisory panels, scientific journals and committees. During his career he has received several prestigious awards such as the William Montagna Award and the Stephen Rothman Award of the Society for Investigative Dermatology and the Lifetime Achievement Award of the American Skin Association. In 1999, he received the Honorary Doctorate from the Semmelweis Medical University in Budapest and the Silver Decoration of Honour for Services to the Republic of Austria in Vienna. He is Honorary Member of the Society for Investigative Dermatology, the European Society for Dermatological Research and The Japanese Society for Investigative Dermatology. He is also Member of the Austrian and the German Academy of Sciences as well as Foreign Associate of the US National Academy of Medicine. Session Description A dermatologist is a physician whose traditional duty is to prevent and treat skin diseases. He/she uses medical knowledge and/or surgical skills to accomplish these goals. In the more recent past, dermatologists are increasingly involved in improving the look and appearance of skin, hair and nails and, thus, of a person in general. Although rarely considered a medical necessity, this aspect of attaining and maintaining healthy, youthful skin has become a priority for both patients and doctors and, as a consequence, has resulted in new treatment tools and procedures. In medical dermatology, physician scientists play(ed) a critical role in the availability of new therapies, either by pointing out unmet needs or by the active pursuit of basic and clinical research. The introduction of biologic and non-biologic immunomodulators in the treatment of inflammatory and neoplastic skin diseases, the synthesis of signal transduction pathway inhibitors for the treatment of melanoma and non-melanoma skin cancer, the development of different forms of phototherapy, the use of gene therapy for the correction of inborn blistering diseases as well as the production of a highly efficacious HPV vaccine are just a few examples of new therapies whose development was greatly influenced and, sometimes, even effectuated by dermatologists. Learning objectives: 1. To make the audience understand that academic dermatologists as M.D. scientists contribute greatly to the development and, thus, availability of new treatments. 2. To make the audience understand that nobody is better qualified to point to the unmet needs in the care and prevention of skin diseases than a well-trained dermatologist. He/she is therefore the best lobbyist for effective new therapies. 3. To make the audience understand how important it is for dermatology to have a strong and loud voice among health organisations and industry at both the national and the European level. 41

44 THURSDAY, 10 OCTOBER Review and Updates Hall 10 Dalí D1T :30-11:45 Spotlights 1 Chairs: Martin Röcken (Tubingen, Germany) Eduardo Nagore (Valencia, Spain) D1T01.1A D1T01.1B D1T01.1C D1T01.1D D1T01.1E D1T01.1F D1T01.1G D1T01.1H D1T01.1I 08:30 Emerging therapies for psoriasis Michel Gilliet (Lausanne, Switzerland) 08:50 Emerging therapies for atopic dermatitis Tilo Biedermann (Munich, Germany) 09:10 Dealing with skin diseases in migrants Valeska Padovese (Valletta, Malta) 09:30 Update in dermatosurgery Eduardo Nagore (Valencia, Spain) 09:50 Biologics in paediatric dermatology Marieke Seyger (Nijmegen, Netherlands) 10:10 Treatment resistance in metastatic melanoma Martin Röcken (Tubingen, Germany) 10:30 New start of gene therapy in epidermolysis bullosa Leena Bruckner-Tuderman (Freiburg, Germany) 10:50 Emerging treatments for onychomycosis Ditte Marie Saunte (Virum, Denmark) 11:10 Discussion, Q&A D1T01.2 D1T01.2A D1T01.2B D1T02.2C D1T02.2D D1T02.2E 13:15-14:45 Atopic dermatitis Chairs: Thomas Bieber (Bonn, Germany) Magdalena Czarnecka-Operacz (Poznan, Poland) 13:15 Different genotypes and phenotypes Thomas Bieber (Bonn, Germany) 13:35 Skin barrier and microbiome Dusan Buchvald (Bratislava, Slovakia) 13:55 Skin barrier and emolients Magdalena Czarnecka-Operacz (Poznan, Poland) 14:15 Classical drugs Franck Boralevi (Bordeaux, France) 14:35 Discussion, Q&A D1T01.3 D1T01.3A D1T01.3B D1T01.3C D1T01.3D D1T01.3E 15:00-16:30 Atopic dermatitis Chairs: Jose-Manuel Carrascosa (Badalona, Spain) Mette Sondergaard Deleuran (Abyhoj, Denmark) 15:00 Phototherapy and heliotherapy Jose-Manuel Carrascosa (Badalona, Spain) 15:20 Topical treatment: An update Mette Sondergaard Deleuran (Abyhoj, Denmark) 15:40 New oral small molecules: An update Andrea Szegedi (Debrecen, Hungary) 16:00 Antibody-based therapies in atopic dermatits: An update Carsten Flohr (London, United Kingdom) 16:20 Discussion, Q&A 42

45 Review and Updates Hall 10 Coello D1T :30-10:00 Interactive dermoscopy Chairs: Giuseppe Argenziano (Naples, Italy) Iris Zalaudek (Graz, Austria) D1T02.1A D1T02.1B D1T02.1C D1T02.1D D1T02.1E D1T :30 When clinical clues outweigh dermoscopy clues Giuseppe Argenziano (Naples, Italy) 08:50 Differences in the dermoscopy appearance between fair and dark skin types Bengu Nisa Akay (Ankara, Turkey) 09:10 Dermoscopy: Still an up-to-date method? Nicole Ariana Kukutsch (Leiden, Netherlands) 09:30 Diagnosis of skin infestations and infections Iris Zalaudek (Graz, Austria) 09:50 Discussion, Q&A 10:15-11:45 Interactive dermoscopy Chairs: Aimilios Lallas (Thessaloniki, Greece) Susana Puig (Barcelona, Spain) Thursday, 10 October D1T02.2A D1T02.2B D1T02.2C D1T02.2D D1T02.2E 10:15 Standards in melanoma screening: Disparities among Europe Ana-Maria Forsea (Bucharest, Romania) 10:35 Dermoscopy in treatment decision and monitoring Aimilios Lallas (Thessaloniki, Greece) 10:55 Clues for melanoma detection Danica Tiodorovic (Nis, Serbia) 11:15 Genes and melanocytic tumours Susana Puig (Barcelona, Spain) 11:35 Discussion, Q&A D1T02.3 D1T02.3A D1T02.3B D1T02.3C D1T02.3D D1T02.3E 13:15-14:45 Interactive nail dermoscopy Chairs: Maria Longo (Gainesville, United States) Michela Starace (Bologna, Italy) 13:15 Naevus or melanoma of the nail apparatus? Maria Longo (Gainesville, United States) 13:35 Non-pigmented nail tumours Bianca Maria Piraccini (Bologna, Italy) 13:55 Onychoscopy of inflammatory nail diseases Michela Starace (Bologna, Italy) 14:15 Onychomycosis Wilhelm Stolz (Munich, Germany) 14:35 Discussion, Q&A D1T02.4 D1T02.4A D1T02.4B D1T02.4C D1T02.4D D1T02.4E 15:00-16:30 Interactive trichoscopy Chairs: Lidia Rudnicka (Warsaw, Poland) Enzo Errichetti (Udine, Italy) 15:00 Diagnosis of inflammatory hair disorders Enzo Errichetti (Udine, Italy) 15:20 How trichoscopy can help in the diagnosis of alopecia Lidia Rudnicka (Warsaw, Poland) 15:40 Paediatric genodermatosis Carolina Gouveia (Bern, Switzerland) 16:00 Trichoscopy features of anagen and telogen effluvium André Laureano Oliveira (Lisbon, Portugal) 16:20 Discussion, Q&A 43

46 THURSDAY, 10 OCTOBER Review and Updates Hall 10 Velázquez D1T03.1 D1T03.1A D1T03.1B D1T03.1C D1T03.1D D1T03.1E 08:30-10:00 Hypopigmentation Chairs: Henning Hamm (Wurzburg, Germany) Gonzalo Segurado (Madrid, Spain) 08:30 Depigmentation: What is new at the pathophysiological level Davinder Parsad (Chandigarh, India) 08:50 Idiopathic guttate hypomelanosis: From etiology to treatment Carlos Gustavo Wambier (Hamden, United States) 09:10 Hypopigmented lesions in children other than vitiligo Henning Hamm (Wurzburg, Germany) 09:30 Surgery in hypopigmented lesions Gonzalo Segurado (Madrid, Spain) 09:50 Discussion, Q&A D1T03.2 D1T03.2A D1T03.2B D1T03.2C D1T03.2D D1T03.2D 10:15-11:45 Hyperpigmentation Chairs: Thierry Passeron (Nice, France) Albert Wolkerstorfer (Vleuten, Netherlands) 10:15 Update in the diagnosis and treatment of melasma Thierry Passeron (Nice, France) 10:35 Post inflammatory pigmentation in acne: How to prevent and treat Chee-Leok Goh (Singapore, Singapore) 10:55 Drug induced hyperpigmentation: How to manage Albert Wolkerstorfer (Vleuten, Netherlands) 11:15 True indication of laser for pigmented lesions Jean-Michel Mazer (Paris, France) 11:35 Discussion, Q&A D1T03.3 D1T03.3A D1T03.3B D1T03.3C D1T03.3D D1T03.3E 13:15-14:45 Vitiligo Chairs: Marcel Bekkenk (Amsterdam, Netherlands) Markus Böhm (Munster, Germany) 13:15 New measurement instruments to assess vitiligo (e.g. Vitiligo Extent Score) Nanja van Geel (Heusden, Belgium) 13:35 Current treatments for vitiligo Marcel Bekkenk (Amsterdam, Netherlands) 13:55 Can we propose an algorithm for treatment of vitiligo patients? Khaled Ezzedine (Paris, France) 14:15 Future of new drugs in vitiligo Markus Böhm (Münster, Germany) 14:35 Discussion, Q&A D1T03.4 D1T03.4A D1T03.4B D1T03.4C D1T03.4D D1T03.4E 15:00-16:30 Nail dyschromia Chairs: Bertrand Richert (Brussels, Belgium) Bianca Maria Piraccini (Bologna, Italy) 15:00 Yellow nails Robert Baran (Cannes, France) 15:20 Brown and black nails Myrto-Georgia Trakatelli (Brussels, Belgium) 15:40 White nails Bertrand Richert (Brussels, Belgium) 16:00 Green and blue nails Bianca Maria Piraccini (Bologna, Italy) 16:20 Discussion, Q&A 44

47 Review and Updates Hall 9 Picasso D1T :30-10:00 Acne vulgaris and rosacea Chairs: Brigitte Dréno (Nantes, France) Clio Dessinioti (Athens, Greece) D1T04.1A D1T04.1B D1T04.1C D1T04.1D D1T04.1E D1T :30 What s new about physiopathology of acne Brigitte Dréno (Nantes, France) 08:50 Management of acne associated with autoinflammatory syndromes in developing countries Vicente Torres Lozada (Mexico City, Mexico) 09:10 How to manage very severe acne Dae Hun Suh (Seoul, South Korea) 09:30 Future of treatment in acne Clio Dessinioti (Athens, Greece) 09:50 Discussion, Q&A 10:15-11:45 Acne vulgaris and rosacea Chairs: Jacob Thyssen (Copenhagen, Denmark) Jose Luis Lopez-Estebaranz (Madrid, Spain) Thursday, 10 October D1T04.2A D1T04.2B D1T04.2C D1T04.2D D1T04.2E 10:15 Practical and daily guide for the treatment of acne patients Antonio Augusto Fernandes Massa (Porto, Portugal) 10:35 Many subtypes under the rosacea umbrella: Clinical reflections on pathophysiology Jacob Thyssen (Copenhagen, Denmark) 10:55 Isotretinoin for acne and rosacea Pedro Mendes-Bastos (Lisbon, Portugal) 11:15 Lasers for acne and rosacea Jose Luis Lopez-Estebaranz (Madrid, Spain) 11:35 Discussion, Q&A D1T04.3 D1T04.3A D1T04.3B D1T04.3C D1T04.3D D1T04.3E 13:15-14:55 Hidradenitis suppurativa Chairs: Joana Cabete (Lisbon, Portugal) Øystein Grimstad (Tromso, Norway) 13:15 Immunopathogenesis, lessons learned from psoriasis Jonathan Barker (London, United Kingdom) 13:35 Genetics of HS Øystein Grimstad (Tromso, Norway) 13:55 Is acne conglobata in the spectrum of HS? Joana Cabete (Lisbon, Portugal) 14:15 Different phenotypes Jorge Romaní De Gabriel (Sabadell, Spain) 14:35 Discussion, Q&A D1T04.4 D1T04.4A D1T04.4B D1T04.4C D1T04.4D D1T04.4E 15:00-16:30 Hidradenitis suppurativa Chairs: Lukasz Matusiak (Wroclaw, Poland) Errol Prens (Rotterdam, Netherlands) 15:00 Multidisciplinary appoach of HS Aude Nassif (Paris, France) 15:20 Surgical treatment David Moreno-Ramirez (Sevilla, Spain) 15:40 Between efficacy and bacterial resistance, what is the good place of systemic antibiotics? Lukasz Matusiak (Wroclaw, Poland) 16:00 Biologics and HS: Where are we? Errol Prens (Rotterdam, Netherlands) 16:20 Discussion, Q&A 45

48 THURSDAY, 10 OCTOBER Review and Updates Hall 9 Sorolla D1T05.1 D1T05.1A D1T05.1B D1T05.1C D1T05.1D D1T05.1E 08:30-10:00 STIs Chairs: Henry John Christiaan De Vries (Amsterdam, Netherlands) Raj Patel (Winchester, United Kingdom) 08:30 How prevention is changing the spectrum of STIs Pablo Hernandez (Valencia, Spain) 08:50 How to interpret laboratory tests Henry John Christiaan De Vries (Amsterdam, Netherlands) 09:10 Genital ulcers: New diagnostic tools Peter Karl Kohl (Berlin, Germany) 09:30 Genital ulcers: When it is not an STI Raj Patel (Winchester, United Kingdom) 09:50 Discussion, Q&A D1T :15-11:45 STIs Chairs: Jackie Sherrard (High Wycombe, United Kingdom) Nicolas Dupin (Paris, France) D1T05.2A D1T05.2B 10:15 STIs in the immunossuppressed host Jackie Sherrard (High Wycombe, United Kingdom) 10:35 Prevention and management of genital herpes during pregnancy and delivery Emese Gellen (Debrecen, Hungary) D1T05.2C 10:55 Diagnosing and managing syphilis in 2019 Nicolas Dupin (Paris, France) D1T05.2D D1T05.2E 11:15 A status on HPV related ano-genital diseases Helle Kiellberg Larsen (Copenhagen, Denmark) 11:35 Discussion, Q&A D1T05.3 D1T05.3A D1T05.3B D1T05.3C D1T05.3D D1T05.3E 13:15-14:45 HIV Chairs: Georg Stary (Vienna, Austria) Vincent Piguet (Toronto, Canada) 13:15 Epidemiology of HIV: Where are we today? Cornelus Sanders (Utrecht, Netherlands) 13:35 Skin diseases associated with HIV Helmut Schöfer (Neu-Isenburg, Germany) 13:55 How effective is HIV preventive and post-exposure therapy? Georg Stary (Vienna, Austria) 14:15 How far are we from curing HIV infection? Vincent Piguet (Toronto, Canada) 14:35 Discussion, Q&A D1T05.4 D1T05.4A D1T05.4B D1T05.4C D1T05.4D D1T05.4E 15:00-16:30 HPV Chairs: George Sorin Tiplica (Bucharest, Romania) Milos Pavlovic (Dubai, United Arab Emirates) 15:00 HPV transmission and pathophysiology of infection George Sorin Tiplica (Bucharest, Romania) 15:20 Management of HPV-positive patients with biologics Raquel Rivera-Díaz (Madrid, Spain) 15:40 Therapy of HPV infection Milos Pavlovic (Dubai, United Arab Emirates) 16:00 HPV vaccination: Benefits and risks Claudia Heller-Vitouch (Vienna, Austria) 16:20 Discussion, Q&A 46

49 Review and Updates N103 D1T :30-10:00 Pregnancy and skin diseases: How to manage Chairs: Selim Aractingi (Paris, France) Dedee Murrell (Sydney, Australia) D1T06.1A D1T06.1B D1T06.1C D1T06.1D D1T06.1E D1T :30 Physiological modifications of the skin during pregnancy Selim Aractingi (Paris, France) 08:50 Bullous diseases Dedee Murrell (Sydney, Australia) 09:10 Papular pruritic diseases Maria-Magdalena Roth (Palma de Mallorca, Spain) 09:30 Exanthema Robert Muellegger (Vienna, Austria) 09:50 Discussion, Q&A 10:15-11:45 Pregnancy and skin diseases: How to manage Chairs: Mark Koh (Singapore) Samantha Vaughan-Jones (Surrey, United Kingdom) Thursday, 10 October D1T06.2A D1T06.2B D1T06.2C D1T06.2D D1T06.2E 10:15 Acne and rosacea Patricia Troielli (Martinez, Argentina) 10:35 Infections and infestations Mark Koh (Singapore) 10:55 Psoriasis and Inflammatory skin diseases in pregnancy: How to manage? Samantha Vaughan-Jones (Surrey, United Kingdom) 11:15 Atopic dermatitis Carsten Hamann (Lebanon, United States) 11:35 Discussion, Q&A D1T06.3 D1T06.3A D1T06.3B D1T06.3C D1T06.3D D1T06.3E 13:15-14:45 Pregnancy and skin diseases: How to manage Chairs: Marie-Aleth Richard (Marseille, France) Giovanna Zambruno (Rome, Italy) 13:15 Atypical naevi and stage I to III melanoma Marie-Aleth Richard (Marseille, France) 13:35 LE and autoimmune diseases Adam Reich (Rzeszow, Poland) 13:55 Prenatal diagnosis referrals: When and where Giovanna Zambruno (Rome, Italy) 14:15 Systemic treatment: What is safe? Jenny Murase (San Francisco, United States) 14:35 Discussion, Q&A D1T :00-16:30 Red face: Other diagnoses Chairs: Melinda Gooderham (Peterborough, Canada) Patricia Troielli (Martinez, Argentina) D1T06.4A D1T06.4B D1T06.4C D1T06.4D D1T06.4E 15:00 Papulopustular rosacea and rosacea-like demodicosis: Two phenotypes of the same disease? Fabienne Forton (Brussels, Belgium) 15:20 Red face: Not always rosacea Melinda Gooderham (Peterborough, Canada) 15:40 Red face revisited: Flushing Guliz Ikizoglu (Mersin, Turkey) 16:00 Papulopustular rosacea: Is there any place for prevention and maintenance treatment? Patricia Troielli (Martinez, Argentina) 16:20 Discussion, Q&A 47

50 THURSDAY, 10 OCTOBER Review and Updates N104 D1T07.1 D1T07.1A D1T07.1B D1T07.1C D1T07.1D D1T07.1E 08:30-10:00 Acute life-threatening diseases in dermatology: The skin as a sentinel Chairs: Angelika Stary (Vienna, Austria) Pablo Fernandez Peñas (Castle Hill, Australia) 08:30 Acute life threatening situations in venereology Angelika Stary (Vienna, Austria) 08:50 Early recognition of necrotising fasciitis Constanza Martinez-Mera (Madrid, Spain) 09:10 Skin markers of severe autoimune diseases (LES, dermatomyositis) Jan Dutz (Vancouver, Canada) 09:30 Graft versus host diseases Pablo Fernandez Peñas (Castle Hill, Australia) 09:50 Discussion, Q&A D1T07.2 D1T07.2A D1T07.2B D1T07.2C D1T07.2D D1T07.2E 10:15-11:45 Acute life-threatening diseases in dermatology: Red flags and emergencies in dermatology Chairs: Roderick James Hay (London, United Kingdom) Branka Marinovic (Zagreb, Croatia) 10:15 Recognising life-threatening facial edema Ronni Wolf (Herzeliya, Israel) 10:35 Recognising life-threatening exanthemas Margarida Gonçalo (Coimbra, Portugal) 10:55 Recognising life-threatening purpura Roderick James Hay (Shipton under Wychwood, United Kingdom) 11:15 Recognising life-threatening bullous diseases Branka Marinovic (Zagreb, Croatia) 11:35 Discussion, Q&A D1T07.3 D1T07.3A D1T07.3B D1T07.3C D1T07.4D D1T07.3E 13:15-14:45 Diseases in migrating populations Chairs: Marco Cusini (Milan, Italy) Colette Van Hees (Rotterdam, Netherlands) 13:15 Skin lesions in migrating populations Marco Cusini (Milan, Italy) 13:35 Initiatives to manage migrating populations Lucinda Claire Fuller (Deal, United Kingdom) 13:55 Deep mycosis Jorge Ocampo-Candiani (Monterrey, Mexico) 14:15 Recognising leprosy Colette Van Hees (Rotterdam, Netherlands) 14:35 Discussion, Q&A D1T07.4 D1T07.4A D1T07.4B D1T07.4C D1T07.4D D1T07.4E 15:00-16:30 Diseases in travellers Chairs: Omar Lupi (Rio de Janeiro, Brazil) Menno Gaastra (Alkmaar, Netherlands) 15:00 Haemorrhagic fevers Omar Lupi (Rio de Janeiro, Brazil) 15:20 Travelling with bed bugs Olivier Chosidow (Creteil, France) 15:40 Skin injuries from marine animals Menno Gaastra (Alkmaar, Netherlands) 16:00 Travelers Dermatoses: Europe and Beyond Kenneth Tomecki (Cleveland, United States) 16:20 Discussion, Q&A 48

51 Review and Updates N D1T :30-10:00 Scars and keloids Chairs: Franz Trautinger (St. Poelten, Austria) Merete Haedersdal (Copenhagen, Denmark) D1T08.1A D1T08.1B D1T08.1C D1T08.1D D1T08.1E D1T :30 Updates in wound healing: Mechanisms and translation Franz Trautinger (St. Poelten, Austria) 08:50 Scar and keloid prevention Aleksejs Zavorins (Riga, Latvia) 09:10 Future of medical scar treatment Gabriella Fabbrocini (Naples, Italy) 09:30 Lasers and energy-based approaches to different types of scars Merete Haedersdal (Copenhagen, Denmark) 09:50 Discussion, Q&A 10:15-11:45 Ulcers Chairs: Jürg Hafner (Zurich, Switzerland) Catherine van Montfrans (Rotterdam, Netherlands) Thursday, 10 October D1T08.2A D1T08.2B D1T08.2C D1T08.2D D1T08.2E 10:15 Approach to atypical ulcers Kirsi Isoherranen (Veikkola, Finland) 10:35 Non healing ulcers Catherine van Montfrans (Rotterdam, Netherlands) 10:55 A new concept on calciphylaxis and Martorell hypertensive ischemic leg ulcer Jürg Hafner (Zurich, Switzerland) 11:15 Non-surgical management of chronic wounds Ionela Manole (Bucharest, Romania) 11:35 Discussion, Q&A D1T08.3 D1T08.3A D1T08.3B D1T08.3C D1T08.3D D1T08.3E 13:15-14:45 Vasculitis and vasculopathies Chairs: Maria del Mar Llamas Velasco (Madrid, Spain) Warren Piette (Chicago, United States) 13:15 The vasculitis classification and its clinical impact Cord Sunderkötter (Munster, Germany) 13:35 Histopathology of vasculitis and vasculopathies: What is important for the clinician Maria del Mar Llamas Velasco (Madrid, Spain) 13:55 Workup and management of Raynaud s phenomenon Anna Lis-Swiety (Katowice, Poland) 14:15 Workup and management of patients with livedo vasculopathy Warren Piette (Chicago, United States) 14:35 Discussion, Q&A D1T08.4 D1T08.4A D1T08.4B D1T08.4C D1T08.4D D1T08.4E 15:00-16:30 Vasculitis and vasculopathies Chairs: Vilija Oke (Stockholm, Sweden) Angelo Valerio Marzano (Milan, Italy) 15:00 How to approach purpura Vilija Oke (Stockholm, Sweden) 15:20 Leukocytoclastic vasculitis: Diagnosis and management Angelo Valerio Marzano (Milan, Italy) 15:40 Eosinophilic vasculitis Jan Christoph Simon (Leipzig, Germany) 16:00 Approach to diagnosis of vasculitis Cord Sunderkötter (Munster, Germany) 16:20 Discussion, Q&A 49

52 THURSDAY, 10 OCTOBER Controversies N D1T09.1 D1T09.1A D1T09.1B D1T09.1C D1T09.1D D1T09.1E 08:30-10:00 Topical corticosteroids Chairs: Peter Van de Kerkhof (Nijmegen, Netherlands) Andreas Wollenberg (Munich, Germany) 08:30 In psoriasis - yes Rolland Gyulai (Pecs, Hungary) 08:50 In psoriasis - no Peter Van de Kerkhof (Nijmegen, Netherlands) 09:10 In atopic dermatitis - yes Andreas Wollenberg (Munich, Germany) 09:30 In atopic dermatitis - no Michael Cork (Sheffield, United Kingdom) 09:50 Discussion, Q&A D1T09.2 D1T09.2A D1T09.2B D1T09.2C D1T09.2D D1T09.2E 10:15-11:45 Biologics in skin disease Chairs: Christopher E.M. Griffiths (Manchester, United Kingdom) Luís Puig (Barcelona, Spain) 10:15 Pemphigoid bullous and topical corticosteroids - yes Pascal Joly (Rouen, France) 10:35 Pemphigoid bullous and topical corticosteroids - no Michael Hertl (Marburg, Germany) 10:55 Biologics in psoriasis as first line therapy in moderate psoriasis - yes Luís Puig (Barcelona, Spain) 11:15 Biologics in psoriasis as first line therapy in moderate psoriasis - no Christopher Griffiths (Manchester, United Kingdom) 11:35 Discussion, Q&A D1T09.3 D1T09.3A D1T09.3B D1T09.3C D1T09.3D D1T09.3E 13:15-14:45 Drugs in acne Chairs: Lajos Kemény (Szeged, Hungary) Vincenzo Bettoli (Ferrara, Italy) 13:15 Topical antibiotics should be forbidden in acne - yes Falk Ochsendorf (Frankfurt, Germany) 13:35 Topical antibiotics should be forbidden in acne - no Alison Layton (Harrogate, United Kingdom) 13:55 Low dose isotretinoin for severe acne - yes Vincenzo Bettoli (Ferrara, Italy) 14:15 Low dose isotretinoin for severe acne - no Lajos Kemény (Szeged, Hungary) 14:35 Discussion, Q&A D1T09.4 D1T09.4A D1T09.4B D1T09.4C D1T09.4D D1T09.4E 15:00-16:30 Hidradenitis suppurativa Chairs: Christos Zouboulis (Dessau, Germany) Hessel van der Zee (Rotterdam, Netherlands) 15:00 Antibiotics in Hidradenitis suppurativa: Advantages Christos Zouboulis (Dessau, Germany) 15:20 Antibiotics in Hidradenitis suppurativa: Disadvantages Hessel van der Zee (Rotterdam, Netherlands) 15:40 Biologics in Hidradenitis suppurativa: Advantages Emilie SBIDIAN (Creteil, France) 16:00 Biologics in Hidradenitis suppurativa: Disadvantages Jose Carlos Pascual Ramírez (Alicante, Spain) 16:20 Discussion, Q&A 50

53 Training and education forum N D1T :30-10:00 Non-melanoma skin cancer Chairs: Matilda Bylaite-Bucinskiene (Vilnius, Lithuania) Paola Pasquali (Cambrils, Spain) D1T10.1A D1T10.1B D1T10.1C D1T10.1D D1T10.1E D1T :30 Clinical and pathological spectrum: Basal cell carcinoma Matilda Bylaite-Bucinskiene (Vilnius, Lithuania) 08:50 Clinical and pathological spectrum: Squamous cell carcinoma Paola Pasquali (Cambrils, Spain) 09:10 Basal cell and squamous cell carcinoma: Molecular pathogenesis Carla Ferrandiz-Pulido (Barcelona, Spain) 09:30 Clinical and histological spectrum of Merkel cell carcinoma Marek Jankowski (Bydgoszcz, Poland) 09:50 Discussion, Q&A 10:15-11:45 Non-melanoma skin cancer Chairs: Henrik Frank Lorentzen (Aarhus C, Denmark) Marie Beylot-Barry (Bordeaux, France) Thursday, 10 October D1T10.2A D1T10.2B D1T10.2C D1T10.2D D1T10.2E 10:15 Topical drugs for BCC and SCC Klara Mosterd (Maastricht, Netherlands) 10:35 Systemic drugs for advanced BCC and SCC Henrik Frank Lorentzen (Aarhus C, Denmark) 10:55 Changing spectrum of NMSC in the immunosuppressed patient Ulrike Leiter (Tubingen, Germany) 11:15 Overview on new therapies in cutaneous lymphomas Marie Beylot-Barry (Bordeaux, France) 11:35 Discussion, Q&A D1T10.3 D1T10.3A D1T10.3B D1T10.3C D1T10.3D D1T10.3E 13:15-14:45 Melanoma Chairs: Luis Miguel Soares de Almeida (Lisboa, Portugal) Rana Anadolu (Ankara, Turkey) 13:15 Clinical spectrum and histopathology Luis Miguel Soares de Almeida (Lisboa, Portugal) 13:35 Genetic pathway of melanoma development Thomas Wiesner (Vienna, Austria) 13:55 Dermoscopy of pigmented lesions Rana Anadolu (Ankara, Turkey) 14:15 The diagnostic biopsy: Why, where and when? Maximilian Gassenmaier (Tubingen, Germany) 14:35 Discussion, Q&A D1T10.4 D1T10.4A D1T10.4B D1T10.4C D1T10.4D D1T10.4E 15:00-16:30 Melanoma Chairs: Veronique Bataille (Hemel Hempstead, United Kingdom) Thomas Eigentler (Tubingen, Germany) 15:00 Neo adjuvant or adjuvant: What is the best for melanoma? Simone Ribero (Turin, Italy) 15:20 Metastatic melanoma: When to do what type of genetic testing Veronique Bataille (Hemel Hempstead, United Kingdom) 15:40 Systemic targeted treatment of metastatic melanoma Maria Inês Coutinho (Coimbra, Portugal) 16:00 Systemic immunotherapy of metastatic melanoma Thomas Eigentler (Tubingen, Germany) 16:20 Discussion, Q&A 51

54 THURSDAY, 10 OCTOBER Training and education forum N D1T11.1 D1T11.1A D1T11.1B D1T11.1C D1T11.1D D1T11.1E 08:30-10:00 Eczemas: Atopic dermatitis Chairs: Nicholas Reynolds (Newcastle upon Tyne, United Kingdom) Matthias Schmuth (Innsbruck, Austria) 08:30 Pathophysiology Nicholas Reynolds (Newcastle upon Tyne, United Kingdom) 08:50 Clinical features and differential diagnosis Matthias Schmuth (Innsbruck, Austria) 09:10 Topical and combination therapies Jan Gutermuth (Brussels, Belgium) 09:30 Systemic immunomodulators Christian Vestergaard (Skoedstrup, Denmark) 09:50 Discussion, Q&A D1T11.2 D1T11.2A D1T11.2B D1T11.2C D1T11.2D D1T11.2E 10:15-11:45 Eczemas Chairs: Cecilia Svedman (Malmo, Sweden) Marie-Noëlle Crepy (Paris, France) 10:15 Allergic contact dermatitis Cecilia Svedman (Malmo, Sweden) 10:35 Diagnostic testing in eczema Ann Goossens (Leuven, Belgium) 10:55 Differential diagnosis and pitfalls Jonathan White (Brussel, Belgium) 11:15 Occupational dermatitis Marie-Noëlle Crepy (Paris, France) 11:35 Discussion, Q&A D1T11.3 D1T11.3A D1T11.3B D1T11.3C D1T11.3D D1T11.3E 13:15-14:45 Drug reactions Chairs: Dieter Metze (Munster, Germany) Heike Rockmann (Utrecht, Netherlands) 13:15 Clinical spectrum and classification of drug reactions Heike Rockmann (Utrecht, Netherlands) 13:35 Histology and differential diagnosis Dieter Metze (Munster, Germany) 13:55 Treatment of drug reactions Nikhil Yawalkar (Bern, Switzerland) 14:15 When, where and how to test Neil Shear (Toronto, Canada) 14:35 Discussion, Q&A D1T11.4 D1T11.4A D1T11.4B D1T11.4C D1T11.4D D1T11.4E 15:00-16:30 Urticaria Chairs: Clive Grattan (London, United Kingdom) Martijn van Doorn (Amsterdam, Netherlands) 15:00 Type I allergy: Clinical manifestations Torsten Zuberbier (Berlin, Germany) 15:20 Angioedema: Clinical spectrum Clive Grattan (London, United Kingdom) 15:40 Physical urticaria: Diagnosis and management Emek Kocatürk Göncü (Istanbul, Turkey) 16:00 Treatment of chronic spontaneous urticaria Martijn van Doorn (Amsterdam, Netherlands) 16:20 Discussion, Q&A 52

55 Special Interest Meetings N D1T Media session - How to give a good presentation Chairs: TBC Speakers TBC D1T :15-14:55 Practical pearls from private office Chairs: Monika Gniadecka (Herlev, Denmark) Rolf Ostendorf (Monchengladbach, Germany) D1T13.3A D1T13.3B D1T13.3C D1T13.3D D1T13.3E 13:15 Photodynamic therapy with different light sources Jürgen Funk (Moss, Norway) 13:35 Vulva clinic in Private office Menno Gaastra (Alkmaar, Netherlands) 13:55 Dermatoscopy of nail pathologies Georges Reuter (Strasbourg, France) 14:15 What not to do in private practice: Learning from mistakes Christopher Rowland Payne (London, United Kingdom) 14:35 Discussion, Q&A Thursday, 10 October D1T :00-16:30 History of dermatology Chairs: Michael Lukas Geiges (Bassersdorf, Switzerland) Nick Levell (Norwich, United Kingdom) D1T13.4A D1T13.4B D1T13.4C 15:00 A history of accidental self-immolation aggravated by oil-based skin and hair products Nick Levell (Norwich, United Kingdom) 15:20 Abrahao Rotberg: Should we continue his fight? Patricia Deps (Brazil) 15:40 Patches ( mouches ): Medical and anthropological uses Carlo Gelmetti (Milan, Italy) D1T13.4D 16:00 From archfiend to partner: The changing role of the microbiome and the skin, Part 1 Michael Lukas Geiges (Bassersdorf, Switzerland) D1T13.4E 16:10 From archfiend to partner: The changing role of the microbiome and the skin, Part 2 Lawrence Chukwudi Nwabudike (Bucharest, Romania) D1T13.4F 16:20 Discussion 53

56 THURSDAY, 10 OCTOBER Free Communications N FC01 FC01.01 FC01.02 FC01.03 FC01.04 FC01.05 FC01.06 FC01.07 FC01.08 FC :30-10:00 Free communications in Psoriasis Chairs: Pille Konno (Tallin, Estonia) Robert Emil Hunger (Bern, Switzerland) 08:30 Long-term efficacy and safety of continuous Q12W risankizumab: Results from the openlabel extension LIMMitless Kim Papp (Ontario, Canada) 08:40 Long-term real-world safety and effectiveness of adalimumab for moderate to severe psoriasis: 10-Year interim results from the ESPRIT registry Diamant Thaçi (Lubeck, Germany) 08:50 Global, regional and country-specific prevalence of psoriasis: A Bayesian meta-regression of population-based studies. Rosa Parisi (Manchester, United Kingdom) 09:00 Consistent response to guselkumab by disease region at week 48 in the treatment of moderate to severe psoriasis: Results from the ECLIPSE trial Richard Langley (Nova Scotia, Canada) 09:10 Netakimab: A novel IL17-inhibitor for treatment of moderate-to-severe plaque psoriasis Vladislav Khairutdinov (Saint-Petersburg, Russian Federation) 09:20 Real-world experience with apremilast: Influence of number of prior conventional systemic therapies on physician- and patient-reported outcomes in patients with plaque psoriasis during routine dermatology care in Germany Kristian Reich (Hamburg, Germany) 09:30 Exploring the psoriatic transcriptome during secukinumab treatment. Trine Bertelsen (Aabyhoej, Denmark) 09:40 Rates of malignancies through 4 Years of tildrakizumab exposure in resurface 1 and resurface 2 Stephen Rozzo (Princeton, United States) 09:50 The value of indirect comparison and network meta-analysis methodologies in psoriasis for treatment decisions in clinical practice Matthias Augustin (Hamburg, Germany) FC02 FC02.01 FC02.02 FC02.03 FC02.04 FC :15-11:45 Free communications in Psoriasis Chairs: Aleksandra Lesiak (Lodz, Poland) Daiva Jasaitiene (Kaunas, Lithuania) 10:15 Long-term safety of guselkumab in patients with moderate-to-severe plaque psoriasis: Integrated data through week 156 of the phase 3 VOYAGE 1 and VOYAGE 2 trials Kristian Reich (Hamburg, Germany) 10:25 Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate-to-severe plaque psoriasis: 60-week results from a randomised, double-blinded, Phase 2b extension study Kim Papp (Onterio, Canada) 10:35 C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis Yi Zheng (Beijing, China) 10:45 Study on the perception of therapeutic inertia by patients in France Bruno Halioua (Paris, France) 10:55 Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: Pooled analyses of 4 phase 3 clinical trials Alice Gottlieb (New York, United States) 54

57 FC02.06 FC :05 Adalimumab monotherapy vs. adalimumab and methotrexate combination therapy in psoriasis: First-year results on drug survival, effectiveness and safety Gayle van der Kraaij (Amsterdam, Netherlands) 11:15 Response to IL17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding region of the IL17A gene: Results from a multicentre study of four European psoriasis cohorts. Lieke van Vugt (Nijmegen, Netherlands) FC :25 Pharmacovigilance of systemic antipsoriatic treatment: Results from more than 13,000 patient years in the German Psoriasis Registry PsoBest Christina Sorbe (Hamburg, Germany) FC :35 Certolizumab pegol for treatment of plaque psoriasis: Pooled three-year efficacy outcomes from the Intent-to-Treat population of two phase 3 trials (CIMPASI-1 and CIMPASI-2) Kristian Reich (Hamburg, Germany) FC03 13:15-14:45 Free communications in Therapy Chairs: Oscar Zaar (Goteborg, Sweden) Can Baykal (Istanbul, Turkey) Thursday, 10 October FC :15 Efficacy and safety of risankizumab in patients with active psoriatic arthritis over 24 weeks: Clinical and biomarker results from a phase 2 trial Frank Behrens (Frankfurt am Main, Germany) FC03.02 FC03.03 FC03.04 FC03.05 FC03.06 FC03.07 FC03.08 FC :25 24-week results from a multi-centre, randomised study evaluating ixekizumab versus adalimumab in psoriatic arthritis patients with psoriasis of >=10% or <10% body surface area involvement at baseline 13:35 TBC Saxon Smith (Sydney, Australia) 13:45 Use of chlormethine (CL) gel in treatment of mycosis fungoide (MF) from the French Early Access Program 13:55 TBC Martine Bagot (Paris, France) 14:05 Omalizumab as therapy for chronic spontaneous urticaria in patients with neoplasms 14:15 TBC Luca Schneller-Pavelescu (Alicante, Spain) 14:25 Real world audit data on biologic therapy for psoriasis from a district general hospital setting Geraldine Haebich (Bridgend, United Kingdom) 14:35 Ixekizumab and pregnancy outcomes in patients with psoriasis or psoriatic arthritis Alexander Egeberg (Hellerup, Denmark) 55

58 THURSDAY, 10 OCTOBER FC04 FC :00-16:30 Free communications in Therapy Chairs: Asja Prohic (Sarajevo, Bosnia and Herzegovina) Antonio Massa (Porto, Portugal) 15:00 Multistate modelling of time to response in patients with moderate to severe psoriasis treated with brodalumab or ustekinumab in the AMAGINE-2 and -3 studies Paulo Filipe (Lisbon, Portugal) FC :10 Serlopitant improves psoriatic pruritus in a range of patient subtypes: Results of a phase 2 randomized, double-blind, placebo-controlled clinical trial Mary Clare Spellman (Redwood City, United States) FC04.03 FC04.04 FC04.05 FC04.06 FC04.07 FC04.08 FC :20 Increased risk of serious infection in older adults with psoriasis but not through its immuno-modulatory treatment: A propensity-score matched population-based study Mia Schneeweiss (Boston, United States) 15:30 Treatment switching among biologic-naive psoriasis patients initiating apremilast, tumor necrosis factor inhibitors, or interleukin inhibitors David Kaplan (Overland Park, United States) 15:40 Real world data of SB4 (Etanercept biosimilar) in patients with psoriasis from the British Association of Dermatologists Biologic Interventions Register (BADBIR) Alexander Egeberg (Hellerup, Denmark) 15:50 Body Mass Index and systemic corticosteroid use as indicators of disease burden and their influence on the safety profile of certolizumab pegol across indications Andrew Blauvelt (Portland, United States) 16:00 A phase II clinical trial of safety and efficacy of rva576(coversin) in adult mild to moderate bullous pemphigoid patients: First results of the pilot study Christian Sadik (Lubeck, Germany) 16:10 A randomized, double-blind, placebo and active controlled, global multicenter trial to evaluate the efficacy and safety of oral BTK inhibitor PRN1008 in moderate to severe pemphigus Dedee Murrell (Sydney, Australia) 16:20 Dapsone as steroid-sparing agent for the management of infantile and childhood bullous pemphigoid associated with Hyper IgE: Report of four cases and review of literature Eyleny Meisyah Fitri (Jakarta, Indonesia) 56

59 Practical Workshops (Fully Booked) The below courses required pre-registration and are no longer open to new participants Track 14 N D1T :30-11:45 Advanced allergology workshop Chairs: Ana Gimenez-Arnau (Barcelona, Spain) Sabine Altrichter (Berlin, Germany) Mette Sommerlund (Aarhus, Denmark) The workshop focuses on practical aspects about how to diagnose etiologically, type I and type IV hypersensitivity in cutaneous inmunoallergic diseases including also the differential diagnosis of inducible chronic urticaria and environmental induced dermatitis exacerbations in atopic patients. D1T :15-16:30 Wound healing workshop Chairs: Elena Conde (Madrid, Spain) Kirsi Isoherranen (Veikkola, Finland) Miriam Loots (Rotterdam, Netherlands) Cathelijne den Hartog (Rotterdam, Netherlands) Thursday, 10 October The workshop introduces the main principles of diagnosis and treatment of leg ulcers and teaches how to perform an accurate wound assessment, measure ankle-brachial index, make systematic and efficient differential diagnosis, approach compression therapy and get to know different local strategies to promote wound healing, from wound dressings to skin grafting. Track 15 N D1T :30-11:45 Basic surgery workshop (morning) Chairs: Marcus Muche (Hoorn, Netherlands) Victoria Marmgren (Molndal, Sweden) D1T :15-16:30 Basic surgery workshop (afternoon) Chairs: Marcus Muche (Hoorn, Netherlands) Victoria Marmgren (Molndal, Sweden) The basic surgery workshop is repeated twice: once in the morning, once in the afternoon. Description Review preparation of surgical procedures of the skin, (facial) anatomy, anesthesia, instruments and suturing. Hands-on training of suturing, ellipse excision, flaps and grafts. Discussion and illustration of different techniques. Live videos will be used to visualize anesthetic procedures, use of instruments, suturing and different reconstructions. These courses use materials provided by selected sponsors. Participants should be aware that there are a variety of different, similar products that they can use beyond the ones provided during the workshop. 57

60 FRIDAY 11 OCTOBER Room Name Hall 10 Dalí Hall 10 Coello Hall 10 Velázquez Hall 9 Picasso Hall 9 Sorolla N103 N104 Capacity Session type Hot topics Review and updates Review and updates Review and updates Review and updates Review and updates Review and updates Track D2T02.1 Interactive dermatopathology D2T03.1 Mohs surgery D2T04.1 Paediatric dermatology D2T05.1 Hair and scalp disorders D2T06.1 Topographic dermatology: Face D2T07.1 Skin imaging: Confocal microscopy D2T1.1 Spotlights 2 D2T02.2 Interactive dermatopathology D2T03.2 Urticaria D2T04.2 Paediatric dermatology D2T05.2 Hair and scalp disorders D2T06.2 Topographic dermatology: Genital D2T07.2 Skin imaging: Sonography in dermatology D2T01.2 Melanoma D2T02.3 Dermatosurgery (Part 1) D2T03.3 Photodermatology D2T04.3 Geriatric dermatology D2T05.3 Nail disorders D2T06.3 Topographic dermatology: Hands and feet D2T07.3 Skin imaging: Optical coherence tomography D2T01.3 Melanoma D2T02.4 Dermatosurgery (Part 2) D2T03.4 Photodermatology D2T04.4 Geriatric dermatology D2T05.4 Acral skin tumours D2T06.4 Interventional phlebology D2T07.4 Skin imaging: Computer vision (machine and deep learning) Industry sessions Industry sessions 58

61 Reviews and updates Expert Forum Training and education forum Special interest meetings Practical workshops Hot topics Free communications N N N N N N N N Review and updates Expert Forum Review and updates Training and education forum Training and education forum Special interest meetings Practical workshops Practical workshops D2T08.1 Pruritus D2T09.1 Systemic treatment in dermatology: Old and new D2T09.2 Medical devices D2T10.1 Pain D2T10.2 Joint EADV/ AAD session D2T11.1 Psoriasis D2T11.2 Acne and rosacea D2T12.1 Surgical therapy D2T12.2 Non-surgical therapy D2T13.1 Building the doctor-patient relationship through effective communication D2T14.1 Laser therapy workshop fully booked D2T15.1 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (morning) Friday, 11 October fully booked AGM Annual General Meeting (EADV members only) D2T08.2 Skin infections (bacterial) D2T08.3 Skin infections (viral, parasitic and fungal) D2T09.3 e-dermatology D2T09.4 Artificial intelligence and big data D2T10.3 ESDR session D2T10.4 Pharmacoeconomics and patient access to innovative drugs D2T11.3 Autoimmune disorders D2T11.4 Autoimmune disorders D2T12.3 Dermatopathology D2T12.4 Dermatopathology D2T13.3 Hot European research topics supported by the EADV (PPRC) D2T13.4 Editors pick of the year: A global comparison D2T14.2 Ultrasound: Practical hands-on dermatology workshop fully booked D2T15.2 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (afternoon) fully booked Industry sessions 59

62 FRIDAY 11 OCTOBER Review and Updates Hall 10 Dalí D2T :30-11:45 Spotlights 2 Chairs: Margarida Gonçalo (Coimbra, Portugal) Monika Arenbergerova (Prague, Czech Republic) D2T01.1A D2T01.1B D2T01.1C D2T01.1D D2T01.1E D2T01.1F D2T01.1G D2T01.1H D2T01.1I 08:30 Immunotherapy for advanced non-melanoma skin cancer Eve Maubec (Bobigny, France) 08:50 Pearls and pitfalls for linear closures and flaps Ricardo Vieira (Coimbra, Portugal) 09:10 Upcoming treatment in chronic urticaria Ana Gimenez-Arnau (Barcelona, Spain) 09:30 Systemic lupus erythematosus Branka Marinovic (Zagreb, Croatia) 09:50 Combined strategies for hidradenitis suppurativa? Antonio Martorell Calatayud (Valencia, Spain) 10:10 Lice, scabies and fleas Thomas Herzinger (Kingston, Canada) 10:30 Contact dermatitis: New allergens Margarida Gonçalo (Coimbra, Portugal) 10:50 New procedures in melasma: Benefits and risks Zoe Apalla (Thessaloniki, Greece) 11:10 Discussion, Q&A D2T01.2 D2T01.2A D2T01.2B D2T01.2C D2T01.2D D2T01.2E 13:15-14:45 Melanoma Chairs: Tamar Nijsten (Rotterdam, Netherlands) Jean Jacques Grob (Marseille, France) 13:15 Epidemiology of melanoma in Europe Tamar Nijsten (Rotterdam, Netherlands) 13:35 Genetic testing in daily practice Maria Concetta Fargnoli (Rieti, Italy) 13:55 How to deal with new staging system Monika Arenbergerova (Prague, Czech Republic) 14:15 Is there still a place for sentinel lymph node biopsy? Jean Jacques Grob (Marseille, France) 14:35 Discussion, Q&A D2T01.3 D2T01.3A D2T01.3B D2T01.3C D2T01.3D D2T01.3E 15:00-16:30 Melanoma Chairs: Rodica Maria Cosgarea (Cluj Napoca, Romania) Petr Arenberger (Prague, Czech Republic) 15:00 Killing me softly with lentigo maligna Rodica Maria Cosgarea (Cluj Napoca, Romania) 15:20 Adjuvant therapy: An update Petr Arenberger (Prague, Czech Republic) 15:40 How to manage BRAF-positive metastatic patients Thomas Eigentler (Tubingen, Germany) 16:00 Update on immunotherapy in metastatic melanoma Judit Olah (Szeged, Hungary) 16:20 Discussion, Q&A 60

63 Review and Updates Hall 10 Coello D2T02.1 D2T02.1A D2T02.1B D2T02.1C D2T02.1D D2T02.1E 08:30-10:00 Interactive dermatopathology Chairs: Luis Requena (Spain) Franco Rongioletti (Cagliari, Italy) 08:30 Panniculitis Luis Requena (Madrid, Spain) 08:50 Cutaneous lymphomas Lorenzo Cerroni (Graz, Austria) 09:10 Endocrine and metabolic diseases under microscope Franco Rongioletti (Cagliari, Italy) 09:30 Pruritus under the microscope Dieter Metze (Munster, Germany) 09:50 Discussion, Q&A D2T :15-11:45 Interactive dermatopathology Chairs: Bernard Cribier (Strasbourg, France) Bernhard Zelger (Innsbruck, Austria) D2T02.2A D2T02.2B D2T02.2C D2T02.2D D2T02.2E 10:15 Alopecias in systemic diseases Maria Miteva (Miami, United States) 10:35 Granulomatous diseases Bernard Cribier (Strasbourg, France) 10:55 Histopathology of the main autoinflammatory diseases Athanassios Kolivras (Brussels, Belgium) 11:15 Vasculitis Bernhard Zelger (Innsbruck, Austria) 11:35 Discussion, Q&A Friday, 11 October D2T :15-14:45 Dermatosurgery (Part 1) Chairs: Judith Ulla Ostertag (Maastricht, Netherlands) John Paoli (Gothenburg, Sweden) D2T02.3A D2T02.3B D2T02.3C D2T02.3D D2T02.3E D2T02.3F 13:15 Elliptical excisions and its variations Jean-Michel Amici (Bordeaux, France) 13:30 How to perform nail matrix biopsies Eckart Haneke (Freiburg, Germany) 13:45 Practical tips for excisions on the lower legs and feet Aleksandar Krunic (Chicago, United States) 14:00 Mohs surgery: The first stage and lab technique Judith Ulla Ostertag (Maastricht, Netherlands) 14:15 Mohs surgery: Beyond the first stage John Paoli (Gothenburg, Sweden) 14:30 The Tübinger Torte technique step-by-step Matthias Möhrle (Tubingen, Germany) 61

64 FRIDAY 11 OCTOBER D2T :00-16:30 Dermatosurgery (Part 2) Chairs: Jean-Michel Amici (Bordeaux, France) Severin Läuchli (Zurich, Switzerland) D2T02.4A D2T02.4B D2T02.4C D2T02.4D D2T02.4E 15:00 Cheek and neck reconstruction Joseph Alcalay (Tel Aviv, Israel) Jean-Michel Amici (Bordeaux, France) 15:20 Nasal reconstruction Chrysalyne Schmults (Boston, United States) Falk Bechara (Bochum, Germany) 15:40 Lip reconstruction Olivier Cogrel (Bordeaux, France) Antoni Bennassar Vicens (Palma de Mallorca, Spain) 16:00 Auricular reconstruction Severin Läuchli (Zurich, Switzerland) Aleksandar Krunic (Chicago, United States) 16:20 Discussion, Q&A 62

65 Review and Updates Hall 10 Velázquez D2T03.1 D2T03.1A D2T03.1B D2T03.1C D2T03.1D D2T03.1E 08:30-10:00 Mohs surgery Chairs: Renate Ruth van den Bos (Rotterdam, Netherlands) Eduardo Nagore (Valencia, Spain) 08:30 Setting up Mohs surgery in an office Renate Ruth van den Bos (Rotterdam, Netherlands) 08:50 Dermatofibrosarcoma protuberans Jean Francois Sei (St. Germain en Laye, France) 09:10 Lentigo maligna Eduardo Nagore (Valencia, Spain) 09:30 Non-melanoma skin cancer Robert Gniadecki (Copenhagen, Denmark) 09:50 Discussion, Q&A D2T :15-11:45 Urticaria Chairs: Ana Gimenez-Arnau (Barcelona, Spain) Marcus Maurer (Berlin, Germany) D2T03.2A D2T03.2B D2T03.2C D2T03.2D D2T03.2E 10:15 Taking the best of antihistamine therapy Martin Church (Berlin, Germany) 10:35 Autoimmunity in chronic spontaneous urticaria Aurelie Du Thanh (Montpellier, France) 10:55 Biomarkers in chronic spontaneous urticaria Ana Gimenez-Arnau (Barcelona, Spain) 11:15 New therapies in chronic urticaria Marcus Maurer (Berlin, Germany) 11:35 Discussion, Q&A Friday, 11 October D2T03.3 D2T03.3A D2T03.3B D2T03.3C D2T03.3D D2T03.3E 13:15-14:45 Photodermatology Chairs: Percy Mario Lehmann (Wuppertal, Germany) Sally Helen Ibbotson (Dundee, United Kingdom) 13:15 Pathogenesis of lupus photosensitivity Peter Wolf (Graz, Austria) 13:35 Pathogenesis of PLE Maria Teresa Rossi (Brescia, Italy) 13:55 Towards a standard for phototesting? Percy Mario Lehmann (Wuppertal, Germany) 14:15 Towards a standard for photopatch testing? Sally Helen Ibbotson (Dundee, United Kingdom) 14:35 Discussion, Q&A D2T03.4 D2T03.4A D2T03.4B D2T03.4C D2T03.4D D2T03.4E 15:00-16:30 Photodermatology Chairs: Karel Ettler (Hradec Kralove, Czech Republic) Serena Lembo (Naples, Italy) 15:00 Photoprotection - UV filters: Properties, use and safety in sun products Karel Ettler (Hradec Kralove, Czech Republic) 15:20 Effects of visible light Serena Lembo (Naples, Italy) 15:40 Photoageing: What can be done to prevent it Antony Young (London, United Kingdom) 16:00 Systemic photoprotection: Antioxidants and vitamins Salvador González Rodriguez (Madrid, Spain) 16:20 Discussion, Q&A 63

66 FRIDAY 11 OCTOBER Review and Updates Hall 9 Picasso D2T04.1 D2T04.1A D2T04.1B D2T04.1C D2T04.1D D2T04.1E 08:30-10:00 Paediatric dermatology Chairs: Daniel Hohl (Lausanne, Switzerland) Irene Stefanaki (Athens, Greece) 08:30 Common genetic diseases in childhood Daniel Hohl (Lausanne, Switzerland) 08:50 RASopathies Angela Hernandez-Martin (Madrid, Spain) 09:10 Giant melanocytic naevi Irene Stefanaki (Athens, Greece) 09:30 Blistering diseases Johann Bauer (Salzburg, Austria) 09:50 Discussion, Q&A D2T04.2 D2T04.2A D2T04.2B D2T04.2C D2T04.2D D2T04.2E 10:15-11:45 Paediatric dermatology Chairs: Carolina Gouveia (Bern, Switzerland) Zsanett Renáta Csoma (Szeged, Hungary) 10:15 Hair disorders in children Carolina Gouveia (Bern, Switzerland) 10:35 Novel therapeutic approaches in psoriasis Marina Papoutsaki (Athens, Greece) 10:55 New and emerging therapies in atopic dermatitis Stephanie Christen-Zäch (Lausanne, Switzerland) 11:15 Emergencies in paediatric dermatology Zsanett Renáta Csoma (Szeged, Hungary) 11:35 Discussion, Q&A D2T04.3 D2T04.3A D2T04.3B D2T04.3C D2T04.3D D2T04.3E 13:15-14:45 Geriatric dermatology Chairs: Hassan Galadari (Dubai, United Arab Emirates) Antonella Tosti (Miami, United States) 13:15 Update on ageing of the skin Hassan Galadari (Dubai, United Arab Emirates) 13:35 Checklist before prescribing systemic treatment Zrinka Bukvic Mokos (Zagreb, Croatia) 13:55 Hair and nail disorders in the mature patient Antonella Tosti (Miami, United States) 14:15 Pruritus in the elderly Manuel Pereira (Munster, Germany) 14:35 Discussion, Q&A D2T04.4 D2T04.4A D2T04.4B D2T04.4C D2T04.4D D2T04.4E 15:00-16:30 Geriatric dermatology Chairs: Ulrike Blume-Peytavi (Berlin, Germany) Rick Waalboer-Spuij (Rotterdam, Netherlands) 15:00 Bullous disorders and comorbidities in the elderly Jose Manuel Mascaro (Barcelona, Spain) 15:00 Dermatological emergencies in the elderly Ulrike Blume-Peytavi (Berlin, Germany) 15:40 How to manage skin tumours in the elderly Rick Waalboer-Spuij (Rotterdam, Netherlands) 15:40 Chronic ulcers in elderly: How to manage? Paola Monari (Brescia, Italy) 16:00 Discussion, Q&A 64

67 Review and Updates Hall 9 Sorolla D2T05.1 D2T05.1A D2T05.1B D2T05.1C D2T05.1D D2T05.1E 08:30-10:00 Hair and scalp disorders Chairs: Jose Carlos Cardoso (Coimbra, Portugal) Jerry Shapiro (New York, United States) 08:30 Management of extensive actinic keratosis of the scalp Colin Morton (Perthshire, United Kingdom) 08:50 Differential diagnoses of isolated nodules of the scalp Jose Carlos Cardoso (Coimbra, Portugal) 09:10 Non-scarring folliculitis of the scalp Asja Prohic (Sarajevo, Bosnia and Herzegovina) 09:30 Diagnosis and management of scarring alopecia Jerry Shapiro (New York, United States) 09:50 Discussion, Q&A D2T :15-11:45 Hair and scalp disorders Chairs: Ramon Grimalt (Terrassa, Spain) Spyridon Gkalpakiotis (Prague, Czech Republic) D2T05.2A D2T05.2B D2T05.2C D2T05.2D D2T05.2E 10:15 Congenital hair abnormalities Nieves Puente De Pablo (Madrid, Spain) 10:35 Androgenetic alopecia and mimicks Ramon Grimalt (Terrassa, Spain) 10:55 New drugs for alopecia areata Spyridon Gkalpakiotis (Prague, Czech Republic) 11:15 Hair transplantation Conradus Ghosal Gho (Maastricht, Netherlands) 11:35 Discussion, Q&A Friday, 11 October D2T05.3 D2T05.3A D2T05.3B D2T05.3C D2T05.3D D2T05.3E 13:15-14:45 Nail disorders Chairs: Uwe Paasch (Leipzig, Germany) Dimitrios Rigopoulos (Athens, Greece) 13:15 Psoriasis of the nails Uwe Paasch (Leipzig, Germany) 13:35 Is there a place for biologics in nail disorders other than psoriasis? Dimitrios Rigopoulos (Athens, Greece) 13:55 Update on onychomycosis treatment Neil Shear (Toronto, Canada) 14:15 How to deal with melanonychia Sedef Sahin (Istanbul, Turkey) 14:35 Discussion, Q&A D2T05.4 D2T05.4A D2T05.4B D2T05.4C D2T05.4D D2T05.4E 15:00-16:30 Acral skin tumours Chairs: Giulio Gualdi (Brescia, Italy) Roland Kaufmann (Frankfurt, Germany) 15:00 Tumour of the nail: Differential diagnosis Anita Takwale (Cheltenham, United Kingdom) 15:20 Management of acral Bowen s disease and SCC Giulio Gualdi (Brescia, Italy) 15:40 Acral pigmented lesions Cristina Carrera (Barcelona, Spain) 16:00 Management of acral melanoma Roland Kaufmann (Frankfurt, Germany) 16:20 Discussion, Q&A 65

68 FRIDAY 11 OCTOBER Review and Updates N103 D2T06.1 D2T06.1A D2T06.1B D2T06.1C D2T06.1D D2T06.1E 08:30-10:00 Topographic dermatology: Face Chairs: Agustín Alomar (Barcelona, Spain) TBC 08:30 Papulopustular rosacea and rosacea-like demodicosis: Two phenotypes of the same disease? TBC 08:50 Red face: Not always rosacea Eszter Baltas (Szeged, Hungary) 09:10 Red face revisited: Flushing TBC 09:30 Isotretinoin in rosacea: First or second line? Agustín Alomar (Barcelona, Spain) 09:50 Discussion, Q&A D2T06.2 D2T06.2A D2T06.2B D2T06.2C D2T06.2D D2T06.2E 10:15-11:45 Topographic dermatology: Genital Chairs: Werner Aberer (Graz, Austria) Maria Teresa Fernández-Figueras (Barcelona, Spain) 10:15 Lichen sclerosus: Diagnostic and therapeutic challenge Werner Aberer (Graz, Austria) 10:35 Condyloma acuminata: Update Martina Part (Bratislava, Slovakia) 10:55 Bowen and bowenoid papulosis: Diagnostic and therapeutic challenge Maria Teresa Fernández-Figueras (Barcelona, Spain) 11:15 Paget s disease Andre Lencastre (Lisboa, Portugal) 11:35 Discussion, Q&A D2T06.3 D2T06.3A D2T06.3B D2T06.3C D2T06.3D D2T06.3E 13:15-14:45 Topographic dermatology: Hands and feet Chairs: Dagmar Simon (Bern, Switzerland) Aikaterini Patsatsi (Thessaloniki, Greece) 13:15 Hyperhidrosis: Is it treatable? Alba Catala Gonzalo (Barcelona, Spain) 13:35 Palmoplantar pustulosis: An update Jana Kazandjieva (Sofia, Bulgaria) 13:55 Chronic hand eczema versus psoriasis Dagmar Simon (Bern, Switzerland) 14:15 Bullous diseases Aikaterini Patsatsi (Thessaloniki, Greece) 14:35 Discussion, Q&A D2T06.4 D2T06.4A D2T06.4B D2T06.4C D2T06.4D D2T06.4E 15:00-16:30 Interventional phlebology Chairs: Felizitas Pannier (Bonn, Germany) Michael Kockaert (Zurich, Switzerland) 15:00 Skin changes on the leg - What may be the cause? Elena Conde (Madrid, Spain) 15:20 Duplex sonography: Why is it also important for dermatologist? Michael Kockaert (Zurich, Switzerland) 15:40 What you did not know about compression stockings: Hot topics Catharina van der Wegen-Franken (Bergen op Zoom, Netherlands) 16:00 Basic treatments in phlebology: Sclerotherapy and beyond Felizitas Pannier (Bonn, Germany) 16:20 Discussion, Q&A 66

69 Review and Updates N104 D2T07.1 D2T07.1A D2T07.1B D2T07.1C D2T07.01D D2T07.1E 08:30-10:00 Skin imaging: Confocal microscopy Chairs: Martina Ulrich (Berlin, Germany) Philippe Bahadoran (Nice, France) 08:30 When do I need confocal microscopy Philippe Bahadoran (Nice, France) 08:50 Confocal reflectance microscopy: Evidence and cost - efficacy in skin cancer Martina Ulrich (Berlin, Germany) 09:10 Confocal microscopy in inflammatory diseases Marco Ardigo (Rome, Italy) 09:30 Multimodal ex-vivo confocal microscopy in Mohs surgery Javiera Perez-Anker (Barcelona, Spain) 09:50 Discussion, Q&A D2T :15-11:45 Skin imaging: Sonography in dermatology Chairs: Fernando Alfageme (Madrid, Spain) Priscila Giavedoni (Barcelona, Spain) D2T07.2A D2T07.2B D2T07.2C D2T07.2D D2T07.2E 10:15 State-of-the-art and future of ultrasound in dermatology Fernando Alfageme (Madrid, Spain) 10:35 Sonography in inflammatory diseases Priscila Giavedoni (Barcelona, Spain) 10:55 Sonography in malignant melanoma and skin cancer Marina Venturini (Brescia, Italy) 11:15 Sonography in the evaluation of neurofibromatosis Laurent Machet (Tours, France) 11:35 Discussion, Q&A Friday, 11 October D2T07.3 D2T07.3A D2T07.3B D2T07.3C D2T07.3D D2T07.3E 13:15-14:45 Skin imaging: Optical coherence tomography Chairs: Julia Welzel (Augsburg, Germany) Giovanni Pellacani (Modena, Italy) 13:15 OCT in dermatology: Principles and new technologies Oriol Yelamos Pena (Barcelona, Spain) 13:35 OCT and RCM in the assessment of in vivo skin cancer margins Nathalie de Carvalho (Modena, Italy) 13:55 Dynamic optical coherence tomography Julia Welzel (Augsburg, Germany) 14:15 Optical coherence tomography in the evaluation of actinic keratosis and squamous cell carcinoma Giovanni Pellacani (Modena, Italy) 14:35 Discussion, Q&A D2T :00-16:30 Skin imaging: Computer vision (machine and deep learning) Chairs: Josep Malvehy (Barcelona, Spain) Harald Kittler (Vienna, Austria) D2T07.4A D2T07.4B D2T07.4C D2T07.4D D2T07.4E 15:00 Challenges and opportunities of computer vision in dermatology Josep Malvehy (Barcelona, Spain) 15:20 Are computers better than dermatologists in melanoma diagnosis? Harald Kittler (Vienna, Austria) 15:40 Machine learning in total body photography of high-risk melanoma patients Hans Peter Soyer (Brisbane, Australia) 16:00 Digital pathology and augmented reality in dermatology and dermatopathology Laszlo Igali (United Kingdom) 16:20 Discussion, Q&A 67

70 FRIDAY 11 OCTOBER Review and Updates N D2T08.1 D2T08.1A D2T08.1B D2T08.1C D2T08.1D D2T08.1E 08:30-10:00 Pruritus Chairs: Sonja Ständer (Munster, Germany) Jacek Szepietowski (Wroclaw, Poland) 08:30 Pruritus and prurigo: New definitions Sonja Ständer (Munster, Germany) 08:50 Diagnosing and treating pruritus from systemic diseases Nagihan Sahillioglu (Istambul, Turkey) 09:10 Drug-induced pruritus Anna Chiara Fostini (Verona, Italy) 09:30 New treatments for chronic pruritus Jacek Szepietowski (Wroclaw, Poland) 09:50 Discussion, Q&A D2T08.2 D2T08.2A D2T08.2B D2T08.2C D2T08.2D D2T08.2E 13:15-14:45 Skin infections (bacterial) Chairs: Nikolai Tsankov (Sofia, Bulgaria) Carmen Maria Salavastru (Bucharest, Romania) 13:15 The importantce of MRSA in skin infections Nikolai Tsankov (Sofia, Bulgaria) 13:35 Erysipelas and their treatment Carmen Maria Salavastru (Bucharest, Romania) 13:55 Severe and life-threatening bacterial skin infections André De Castro Pinho (Coimbra, Portugal) 14:15 Mycobacterial skin infections: What s new Mateja Dolenc Voljc (Ljubljana, Slovenia) 14:35 Discussion, Q&A D2T08.3 D2T08.3A D2T08.3B D2T08.3C D2T08.3D D2T08.3E 15:00-16:30 Skin infections (viral, parasitic and fungal) Chairs: Arjen Fokko Nikkels (Malmedy, Belgium) TBC 15:00 Acute viral exanthemas: Anything new? Vincent Descamps (Paris, France) 15:20 Viral infections in atopic dermatitis patients: Risk factors for eczema herpeticum, vaccinatum, Cocsakie, etc. Miguel Pinto Gouveia (Coimbra, Portugal) 15:40 Recurrent HSV infections: Manifestations and the resistance question Arjen Fokko Nikkels (Malmedy, Belgium) 16:00 Relapsing scabies and lice: How to manage Clarissa Vergunst (Amsterdam, Netherlands) 16:20 Discussion, Q&A 68

71 Expert Forum N D2T09.1 D2T09.1A D2T09.1B D2T09.1C D2T09.1D D2T09.1E 08:30-10:00 Systemic treatment in dermatology: Old and new Chairs: Giovanni Leone (Rome, Italy) Ulrike Just (Wien, Austria) 08:30 Ivermectin Charlotte Bernigaud (Creteil, France) 08:50 Metformin Raj Kubba (New Delhi, India) 09:10 Photopheresis Ulrike Just (Wien, Austria) 09:30 Afamelanotide (analogue of MSH) Giovanni Leone (Rome, Italy) 09:50 Discussion, Q&A D2T :15-11:45 Medical devices Chairs: Christine Dierickx (Luxembourg, Luxembourg) Peter Bjerring (Risskov, Denmark) D2T09.2A D2T09.2B D2T09.2C D2T09.2D D2T09.2E 10:15 Light-based, home-use devices for hair removal: Why do they work and how effective they are Christine Dierickx (Luxembourg, Luxembourg) 10:35 Critical appraisal of home-use for therapeutic indications Peter Bjerring (Risskov, Denmark) 10:55 Update on home-use device standards and regulations Godfrey Town (Swansea, United Kingdom) 11:15 Home-use devices: The consumer perspective Lawrence Newman (Cheadle Hulme, United Kingdom) 11:35 Discussion, Q&A Friday, 11 October D2T09.3 D2T09.3A D2T09.3B D2T09.3C D2T09.3D D2T09.3E 13:15-14:45 e-dermatology Chairs: Günter Burg (Zurich, Switzerland) Suzanne Pasmans (Rotterdam, Netherlands) 13:15 e-learning: e-teaching, a European model Günter Burg (Zurich, Switzerland) 13:35 The role of e-dermatology: The Canadian experience Harvey Lui (Vancouver, Canada) 13:55 Inflammatory skin diseases: e-dermatology in daily practice Suzanne Pasmans (Rotterdam, Netherlands) 14:15 The role of e-dermatology in developing countries Jules Lipoff (Philadelphia, United States) 14:35 Discussion, Q&A D2T09.4 D2T09.4A D2T09.4B D2T09.4C D2T09.4D D2T09.4E 15:00-16:30 Artificial intelligence and big data Chairs: Anna Wozniacka (Lodz, Poland) Helmut Beltraminelli (Bern, Switzerland) 15:00 AI for melanoma diagnosis Hans Peter Soyer (Brisbane, Australia) 15:20 Risks and benefits of smartphone diagnosis Anna Wozniacka (Lodz, Poland) 15:40 The role of AI in inflammatory skin diseases Natalie Garzorz-Stark (Munich, Germany) 16:00 AI: Potential risks and benefits Helmut Beltraminelli (Bern, Switzerland) 16:20 Discussion, Q&A 69

72 FRIDAY 11 OCTOBER Review and Updates N D2T10.1 D2T10.1A D2T10.1B D2T10.1C D2T10.1D D2T10.1E 08:30-10:00 Pain Chairs: Anna Zalewska (Lodz, Poland) Robert Artur Dahmen (Praha, Czech Republic) 08:30 How to manage pain before and after skin surgery Robert Artur Dahmen (Praha, Czech Republic) 08:50 Acute pain in dermatology: How to manage Laurent Misery (Brest, France) 09:10 Pain in chronic skin diseases: How to manage Anna Zalewska (Lodz, Poland) 09:30 Controlling pain: Appropriate techniques for procedures in daily practice Ana Brinca (Coimbra, Portugal) 09:50 Discussion, Q&A D2T10.2 D2T10.2A D2T10.2B D2T10.2C 10:15-11:45 Joint EADV/AAD session Chairs: Kenneth Tomecki (Cleveland, United States) TBC 10:15 Tales from a rash whisperer: Untangling the mystery of adult recalcitrant eczematous dermatitis Jenny Murase (San Francisco, United States) 10:45 New discoveries in vitiligo Amit Pandya (Dallas, United States) 11:15 New concepts on skin mosaicism Antonio Torrelo (Madrid, Spain) D2T10.3 D2T10.3A D2T10.3B D2T10.3C D2T10.3D D2T10.3E 13:15-14:45 ESDR session Chairs: Christopher Griffiths (Manchester, United Kingdom) Hervé Bachelez (Paris, France) 13:15 Ageing of skin of colour Rachel Watson (Manchester, United Kingdom) 13:35 Connecting inflammation to depigmenting disorders Katia Boniface (Bordeaux, France) 13:55 Novel T helper cell subsets in inflammatory skin disease Christoph Schlapbach (Bern, Switzerland) 14:15 MicroRNAs as therapeutic targets or biomarkers in psoriasis Eniko Sonkoly (Stockholm, Sweden) 14:35 Discussion, Q&A D2T10.4 D2T10.4A D2T10.4B D2T10.4C D2T10.4D D2T10.4E 15:00-16:30 Pharmacoeconomics and patient access to innovative drugs Chairs: Lidija Kandolf-Sekulovic (Belgrade, Serbia) Adriana Garcia Castro (Barcelona, Spain) 15:00 Differences among European countries in patient access to innovative drugs Lidija Kandolf-Sekulovic (Belgrade, Serbia) 15:20 The role of patient associations in the access to innovative drugs Adriana Garcia Castro (Barcelona, Spain) 15:40 Clinical trial as a way to access to innovative drugs. Pros and cons Ludovic Martin (Angers Cedex, France) 16:00 The economic impact of biosimilars in dermatology Pere Ventayol (Palma, Spain) 16:20 Discussion, Q&A 70

73 Training and education forum N D2T11.1 D2T11.1A D2T11.1B D2T11.1C D2T11.1D D2T11.1E 08:30-10:00 Psoriasis Chairs: Jörg Prinz (Munich, Germany) Paolo Gisondi (Verona, Italy) 08:30 Spectrum and pathophysiology Jörg Prinz (Munich, Germany) 08:50 Differential diagnosis and pitfalls Paolo Gisondi (Verona, Italy) 09:10 Topical therapy and phototherapy Wolf-Henning Boehncke (Geneva, Switzerland) 09:30 Biologics in psoriasis James Krueger (New York, United States) 09:50 Discussion, Q&A D2T :15-11:45 Acne and rosacea Chairs: Elena Araviiskaia (St. Petersburg, Russian Federation) Hans Bredsted Lomholt (Aalborg, Denmark) D2T11.2A D2T11.2B D2T11.2C D2T11.2D D2T11.2E 10:15 Management of mild to moderate acne Elena Araviiskaia (St. Petersburg, Russian Federation) 10:35 Management of severe acne Eva Remenyik (Debrecen, Hungary) 10:55 Diagnosis and management of rosacea Hans Bredsted Lomholt (Aalborg, Denmark) 11:15 Differential diagnosis of facial folliculitis Rick Hoekzema (Amsterdam, Netherlands) 11:35 Discussion, Q&A Friday, 11 October D2T11.3 D2T11.3A D2T11.3B D2T11.3C D2T11.3D D2T11.3E 13:15-14:45 Autoimmune disorders Chairs: Stefan Beissert (Dresden, Germany) Mirjana Gajic-Veljic (Belgrade, Serbia) 13:15 Histopathology and its pitfalls Sofie De Schepper (Laarne, Belgium) 13:35 Spectrum of autoimmune diseases Stefan Beissert (Dresden, Germany) 13:55 Spectrum of systemic lupus erythematosus Mirjana Gajic-Veljic (Belgrade, Serbia) 14:15 Dermatomyositis Carlo Mainetti (Bellinzona, Switzerland) 14:35 Discussion, Q&A D2T11.4 D2T11.4A D2T11.4B D2T11.4C D2T11.4D D2T11.4E 15:00-16:30 Autoimmune disorders Chairs: Barbara Horvath (Groningen, Netherlands) Ruediger Eming (Marburg, Germany) 15:00 Spectrum of bullous diseases Sarolta Kárpáti (Budapest, Hungary) 15:20 Group of pemphigoid diseases Barbara Horvath (Groningen, Netherlands) 15:40 Group of pemphigus diseases Ruediger Eming (Marburg, Germany) 16:00 Vasculitis Erkan Alpsoy (Antalya, Turkey) 16:20 Discussion, Q&A 71

74 FRIDAY 11 OCTOBER Training and education forum N D2T12.1 D2T12.1A D2T12.1B D2T12.1C D2T12.1D D2T12.1E 08:30-10:00 Surgical therapy Chairs: Luis Ríos Buceta (Madrid, Spain) Daniela Cunha (Lisbon, Portugal) 08:30 Preoperative assessment Myrto-Georgia Trakatelli (Brussels, Belgium) 08:50 What you should know about Mohs surgery Luis Ríos Buceta (Madrid, Spain) 09:10 Reconstruction techniques of choice for the facial cosmetic units Daniela Cunha (Lisbon, Portugal) 09:30 Surgery of the nail Marta Sar-Pomian (Warsaw, Poland) 09:50 Discussion, Q&A D2T12.2 D2T12.2A D2T12.2B D2T12.2C D2T12.2D D2T12.2E 10:15-11:45 Non-surgical therapy Chairs: Agustín Toll (Barcelona, Spain) Miguel Correia (Lisboa, Portugal) 10:15 Radiotherapy in dermatology: What the dermatologist should know Agustín Toll (Barcelona, Spain) 10:35 Compounding for daily practice Petra Staubach Renz (Mainz, Germany) 10:55 Cryosurgery Nuno Menezes (Portugal) 11:15 What the dermatologist should know about lasers Miguel Correia (Lisboa, Portugal) 11:35 Discussion, Q&A D2T12.3 D2T12.3A D2T12.3B D2T12.3C D2T12.3D D2T12.3E 13:15-14:45 Dermatopathology Chairs: Josette André (Brussels, Belgium) Maria del Mar Llamas Velasco (Madrid, Spain) 13:15 What you should know about epidermal carcinomas Carlo Francesco Tomasini (Pavia, Italy) 13:35 What you should know about nail diseases Josette André (Brussels, Belgium) 13:55 What you should know about vascular tumours Maria del Mar Llamas Velasco (Madrid, Spain) 14:15 What you should know about the histopathology of alopecia Catherine M. Stefanato (London, United Kingdom) 14:35 Discussion, Q&A D2T12.4 D2T12.4A D2T12.4B D2T12.4C D2T12.4D D2T12.4E 15:00-16:30 Dermatopathology Chairs: Gürkan Kaya (Geneva, Switzerland) TBC 15:00 What you should know about locally agressive adnexal carcinomas Gürkan Kaya (Geneva, Switzerland) 15:20 What you should know about B-cell lymphomas Rein Willemze (Leiden, Netherlands) 15:40 What you should know about pseudolymphomas TBC 16:00 What you should know about paediatric life-threatening diseases Sylvie Fraitag (Paris, France) 16:20 Discussion, Q&A 72

75 Special Interest Meetings N D2T :30-11:45 Building the doctor-patient relationship through effective communication Chairs: Catherine van Montfrans (Rotterdam, Netherlands) Francoise Poot (Brussels, Belgium) Jean Marie Meurant (Ottawa, Canada) D2T13.1A D2T13.1B D2T13.1C D2T13.1D D2T13.1E D2T13.1F D2T13.1G D2T13.1H 08:30 Introduction Catherine van Montfrans (Rotterdam, Netherlands) 08:35 My journey in dermatology: What was good what was bad in communicating with the dermatologist Snežana Šundić-Vardić (Belgrade, Serbia) 08:50 The consequences of inadequate patient communications Francesca Sampogna (Rome, Italy) 09:05 Supporting the mental health of patients Stella Amesz (Epe, Netherlands) 09:20 Best practices in communication for an optimal doctor-patient relationship Lucia Tomas Aragones (Muniesa, Spain) 09:35 Effective interviewing for patient engagement Christine Bundy (Cardiff, United Kingdom) 09:50 Collaboratively setting objectives for improved patient outcomes Jasmin Barman (Zurich, Switzerland) 10:05 BREAK Friday, 11 October D2T13.1I D2T13.1L D2T13.1M 10:20 Creating a curriculum on optimal communication in dermatology Francoise Poot (Brussels, Belgium) 10:35 Panel Discussion: How to support physicians in improving their patient communications Patrick Kemperman (Amsterdam, Netherlands) Christine Bundy (Cardiff, United Kingdom) Stella Amesz (Epe, Netherlands) Antoine Gliksohn (Fontenay-sous-Bois, France) 11:15 Q&A - discussion Catherine van Montfrans (Rotterdam, Netherlands) D2T13.3 D2T13.3A D2T13.3B D2T13.3C D2T13.3D D2T13.3E D2T13.3F 13:15-14:55 Hot European research topics supported by the EADV (PPRC) Chairs: Jacek Szepietowski (Wroclaw, Poland) Philippe Bahadoran (Nice, France) 13:15 How to Apply Philippe Bahadoran (Nice, France) 13:25 European prurigo project Manuel Pereira (Munster, Germany) 13:45 Partner bereavement and skin disease Sinead Langan (London, United Kingdom) 14:05 European guidelines on the management of patients with psychodermatological diseases Anthony Bewley (London, United Kingdom) 14:25 Identifying novel pharmacologic targets in bullous pemphigoid: Unraveling the mechanisms of eosinophils Arianna Fay Agnoletti (Los Angeles, United States) 14:45 Atypical Spitz tumors and Spitzoid melanoma: A large-scale study of molecular aberrations, histopathologic features and clinical outcomes Sandra Peternel (Rijeka, Croatia) 73

76 FRIDAY 11 OCTOBER D2T13.4 D2T13.4A D2T13.4B D2T13.4C D2T13.4D D2T13.4E D2T13.4F 15:00-16:30 Editors pick of the year: A global comparison Chairs: Johannes Ring (Munich, Germany) Jane Grant-Kells (Chicago, United States) 15:00 Welcome and introduction Johannes Ring (Munich, Germany) 15:05 Best papers of the year from JAAD Jane Grant-Kells (Chicago, United States) 15:25 Best papers of the year from JDS Riichiro Abe (Niigata, Japan) 15:45 Best papers of the year from BJD John Ingram (Cardiff, United Kingdom) 16:05 Best papers of the year from JEADV Johannes Ring (Munich, Germany) 16:25 General discussion 74

77 Practical Workshops (Fully Booked) The below courses required pre-registration and are no longer open to new participants Track 14 N D2T :30-11:45 Laser therapy workshop Chairs: Albert Wolkerstorfer (Vleuten, Netherlands) Pablo Boixeda (Madrid, Spain) Keyvan Nouri (Miami, United States) The workshop focuses on vascular lesions, pigmented lesions, laser endpoints, how to avoid complications, laser asisted drug delivery and ablative and fractional lasers. Each of these topics will be systematically approached with a short introduction, an overview of available devices, a review of indications and an interactive panel discussion with tips, tricks and pitfalls. The main goal of the workshop is to gain insight into the essentials of laser dermatology and improve outcomes in laser therapy. D2T :15-16:30 Ultrasound: Practical hands-on dermatology workshop Chairs: Fernando Alfageme (Madrid, Spain) Esther Roe (Barcelona, Spain) Orlando Catalano (Naples, Italy) The workshop focuses on the implementation of dermatologic ultrasound as a diagnosthic method in the clinical practice. The goals of this course are training in practical basic ultrasound equipment knobology, learning by doing scanning protocols of skin, hair and nails and performing systematic exploration of axilla and groin in patients with melanoma. Friday, 11 October Track 15 N D2T15.1 D2T :30-11:45 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (morning) Chairs: Peter Velthuis (Rotterdam, Netherlands) Samira Baharlou (Brussels, Belgium) Sanjay Rajpara (Aberdeen, United Kingdom) 13:15-16:30 Workshop on the use of botulinum toxin in cosmetic and medical dermatology (afternoon) Chairs: Peter Velthuis (Rotterdam, Netherlands) Samira Baharlou (Brussels, Belgium) Sanjay Rajpara (Aberdeen, United Kingdom) The botulinum toxin workshop is repeated twice: once in the morning, once in the afternoon. This workshop gives both theory behind the use of botulinum toxin for aesthetic and medical dermatological indications and a hands-on training on the use of toxins and to learn where to place the injections points for successful treatment outcomes. These courses use materials provided by selected sponsors. Participants should be aware that there are a variety of different, similar products that they can use beyond the ones provided during the workshop. 75

78 SATURDAY, 12 OCTOBER Room Name Hall 10 Dalí Hall 10 Coello Hall 10 Velázquez Hall 9 Picasso Hall 9 Sorolla N103 N104 Capacity Session type Hot topics Review and updates Review and updates Review and updates Review and updates Review and updates Review and updates Track D3T02.1 Skin ageing D3T03.1 Autoinflammatory diseases D3T04.1 Psychodermatology D3T05.1 Mucosal inflammatory diseases D3T06.1 NMSC: Basal cell carcinoma D3T07.1 Management of adverse drug reactions D3T01.1 Late breaking news D3T02.2 Skin ageing D3T03.2 Connective tissue diseases D3T04.2 Psychodermatology D3T05.2 Mucosal neoplasia D3T06.2 NMSC: Actinic keratosis D3T07.2 Microbiote and skin: A new therapeutic area PL-B Plenary Lectures D3T01.2 Psoriasis treatment D3T02.3 Basic scientific cosmetology D3T03.3 Autoimmune bullous diseases D3T04.3 Contact eczemas D3T05.3 Skin diseases in transplant patients D3T06.3 NMSC: Squamous cell carcinoma D3T07.3 Holistic approach in dermatology D3T01.3 Psoriasis treatment D3T02.4 Basic scientific cosmetology D3T03.4 Autoimmune bullous diseases: Neutrophilic and pustular dermatoses D3T04.4 Occupational dermatoses D3T05.4 Vascular malformations and tumours D3T06.4 Other skin cancers D3T07.4 Body art 76

79 Reviews and updates Controversies Expert Forum Training and education forum Free communications Special interest meetings Practical workshops Hot topics N N N N N N N N Review and updates Controversies and Expert forum Training and education forum Training and education forum Free communications Special interest meetings Practical workshops Practical workshops D3T08.1 Rising stars session D3T08.2 EADV President s symposium D3T09.1 Inflammatory diseases D3T09.2 Inflammatory diseases D3T10.1 Infectious diseases D3T10.2 STIs D3T11.1 Nail disorders D3T11.2 Hair disorders FC05 Free communications in miscellaneous FC06 Free communications in miscellaneous D3T13.1 Nurse Day - Part 1 D3T13.2 Nurse Day - Part 2 D3T14.1 Phlebology workshop (beginners) fully booked D3T15.1 Advanced surgery workshop (morning) fully booked Saturday, 12 October D3T08.3 Lessons from registries D3T08.4 Quality assurance in daily practice D3T09.3 Advantage of a multidisciplinary approach D3T09.4 Advantage of a multidisciplinary approach D3T10.3 Topical and systemic therapies of skin diseases D3T10.4 Topical and systemic therapies of skin diseases D3T11.3 Paediatric dermatology D3T11.4 Paediatric dermatology FC07 Free communications in atopic dermatitis and urticaria FC08 Free communications in acne and related disorders D3T13.3 Nurse Day - Interactive Sessions D3T14.2 Phlebology workshop (advanced) fully booked D3T15.2 Advanced surgery workshop (afternoon) fully booked 77

80 SATURDAY, 12 OCTOBER Plenary Lectures Hall 10 Dalí PL-B PL-B01 12:00-12:50 Plenary Lectures B Chairs: Luca Borradori (Bern, Switzerland) Pedro Jaen (Madrid, Spain) 12:00 Rosacea: From the new spectrum to the new therapies Bernard Cribier - Strasbourg, France Bernard Cribier is the Head of Department of Dermatology & Dermatopathology at the Strasbourg University Hospital, France. He is a certified Dermatologist since 1989 and has a PhD in Virology. His main fields of interest are dermatopathology, rosacea and history of dermatology. He is the Editor-in-Chief of the Annales de Dermatologie et de Vénéréologie since He is the author of 438 indexed articles (H index: 59) and 72 book chapters, including a book dedicated to clinicopathological correlation: Dermatologie, de la Microscopie à la Clinique. In the field of dermatopathology, he is the coordinator of the French network for adnexal carcinomas (CARADERM). All his academic efforts are dedicated to teaching dermatopathology to both dermatologists and pathologists and to emphasize the critical role of dermatopathology in dermatology. Bernard Cribier is also a member of the international ROSCO group which contributed significantly to the recent classification of rosacea. Session Description There has been a dramatic increase in the number of scientific articles dedicated to rosacea in the past 15 years. We have access almost every month to new data on epidemiology, physiopathology, evaluation, comorbidities, and medical or instrumental treatment of this complex disease. The main mechanisms involved in rosacea are multiple, i.e. environment, genetics, vascular changes and vascular lesions, innate immunity, pro-inflammatory mechanisms, neurovascular troubles, increased colonisation by Demodex folliculorum, altered microbiome including Demodex own microbiome, sebaceous glands, etc. Prevention is based on sun protection, eye care when necessary and avoiding certain enhancing factors like alcohol, heat or spicy food. The treatment of rosacea relies first on instrumental methods (lasers, intense pulsed light and surgery) and cosmetics, which are important in a disease associated with a major impact on quality of life and psychiatrics comorbidities. Medical approach is based on vasoconstrictors, beta-blockers (vascular targets), antibiotics (targets: microbiome; inflammation; oxidation), anti-parasitic drugs (target: Demodex) and retinoids (target: inflammation, sebaceous glands). Eye involvement requires specialised management. Dermatologists should therefore offer a global and personalised approach to their rosacea patients. Learning Objectives: - To understand the basic mechanisms involved in the pathophysiology of rosacea - To learn the main therapeutic targets according to the known mechanisms of the disease - To optimise existing therapies to the needs of each patient, i.e. developing a personalised approach of patient care 78

81 PL-B02 12:20 Comeback of the great imitator Stephan Lautenschlager - Zürich, Switzerland Dr. Stephan Lautenschlager is a Professor of Dermatology at the University of Zurich, Switzerland. In addition, he is the Chairman of the Outpatient Clinic of Dermatology and Venereology, Triemli Hospital, also in Zurich. He has held this elected position since Dr. Lautenschlager earned his MD at the University of Basel, Switzerland. He did his internship in Internal Medicine and Surgery at the Hospital of Davos, Switzerland, and his residency in Dermatology with the Department of Dermatology at the University Hospital of Basel. He then completed a research and clinical fellowship in Infectious Disease at the F. Hoffmann- LaRoche & Co in Switzerland, and with the Division of Infectious Disease, the University of Wisconsin Hospital in Madison, USA, respectively. Additionally, he completed a clinical medical Dermatology fellowship at the Department of Dermatology, Mayo Clinic in Rochester, USA. Dr. Lautenschlager is a Fellow of the European Academy of Dermatology and Venereology, American Academy of Dermatology, and a member of many international societies. He is the President Elect of the Swiss Foundation against Sexually Transmitted Infections, and the Representative for Switzerland in the International Union against STIs in Europe, a position he has held since His main clinical and research interest are clinical and epidemiological research in STIs, especially Herpes Simplex Viral infection and Syphilis. He has demonstrated leadership in the field of STI control and prevention and has widely published on these subjects in many top academic journals, as well as in the mainstream media. The results of his work have translated into practice guidelines for the treatment of people who are at risk or are affected by STIs. For the IUSTI meeting 2017 held in Helsinki, Finland, he served as the chair of the scientific committee. Session Description Since centuries syphilis diagnoses have fluctuated, reflecting social, economic and technological trends. After a marked decline in the context of AIDS prevention campaigns, a significant increase has been observed in the Western World since The current estimated global prevalence remains high, with around 0.5% for men and women, but varies importantly among risk groups, largely involving men who have sex with men, many of whom are infected with HIV. Clinicians should be aware of the different manifestations of syphilis and the difficulties in the diagnosis and management of the disease. There is a need for increased awareness of the symptoms and signs of acute infections, together with a willingness to consider the diagnosis of syphilis in patients with vague symptoms. Regular screening of risk groups, followed by prompt treatment, remains essential to interrupt syphilis transmission in a context where HIV prevention has expanded towards biomedical prophylaxis. Saturday, 12 October Learning Objectives - Update knowledge in epidemiology of syphilis - Recognise atypical primary and secondary forms - Increase awareness of possible infections with Treponema pallidum 79

82 SATURDAY, 12 OCTOBER Review and Updates Hall 10 Dalí D3T :30-11:45 Late breaking news Chairs: Brigitte Dréno (Nantes, France) Erwin Tschachler (Vienna, Austria) Session programme TBC D3T01.2 D3T01.2A D3T01.2B D3T01.2C D3T01.2D D3T01.2E 13:15-14:45 Psoriasis treatment Chairs: Hervé Bachelez (Paris, France) Richard Warren (Manchester, United Kingdom) 13:15 Update on pathogenesis Curdin Conrad (Lausanne, Switzerland) 13:35 Pustular and erythrodermic psoriasis: Phenotypic variants? Hervé Bachelez (Paris, France) 13:55 Classical systemic treatment / phototherapy Lars Iversen (Aarhus N, Denmark) 14:15 Choosing the right new therapeutics Richard Warren (Manchester, United Kingdom) 14:35 Discussion, Q&A D3T01.3 D3T01.3A D3T01.3B D3T01.3C D3T01.3D D3T01.3E 15:00-16:30 Psoriasis treatment Chairs: Tiago Torres (Porto, Portugal) Antonio Costanzo (Milan, Italy) 15:00 Treating psoriasis in patients with chronic infection and neoplasia Brian Kirby (Dublin, Ireland) 15:20 Treating psoriasis in patients with metabolic comorbidities Tiago Torres (Porto, Portugal) 15:40 Adverse events from biologic therapy Kim Papp (Ontario, Canada) 16:00 Therapeutic pipeline Antonio Costanzo (Milan, Italy) 16:20 Discussion, Q&A 80

83 Review and Updates Hall 10 Coello D3T02.1 D3T02.1A D3T02.1B D3T02.1C D3T02.1D D3T02.1E 08:30-10:00 Skin ageing Chairs: Henry Lim (Grosse Pointe, United States) Yolanda Gilaberte Calzada (Zaragoza, Spain) 08:30 Clinical and histological manifestations of photoageing Henry Lim (Grosse Pointe, United States) 08:50 Pathophysiology of photoageing Amaya Viros (Manchester, United Kingdom) 09:10 Skin barrier in ageing Leonie Jacobs (Rotterdam, Netherlands) 09:30 Colour-related skin ageing Yolanda Gilaberte Calzada (Zaragoza, Spain) 09:50 Discussion, Q&A D3T :15-11:45 Skin ageing Chairs: Mauro Picardo (Rome, Italy) Alain Taieb (Bordeaux, France) D3T02.2A D3T02.2B D3T02.2C D3T02.2D D3T02.2E 10:15 Can we delay skin ageing? Zahir Nizar (Riyadh, Saudi Arabia) 10:35 Are sunscreens able to prevent photoageing? Thomas Schwarz (Kiel, Germany) 10:55 Are antioxidants able to prevent photoageing? Mauro Picardo (Rome, Italy) 11:15 Ageing melanocytes Alain Taieb (Bordeaux, France) 11:35 Discussion, Q&A Saturday, 12 October D3T02.3 D3T02.3A D3T02.3B D3T02.3C D3T02.3D D3T02.3E 13:15-14:45 Basic scientific cosmetology Chairs: Ester Serra-Baldrich (Barcelona, Spain) Klaus Ejner Andersen (Odense, Denmark) 13:15 Rationale on anti-ageing cosmetic ingredients Enzo Berardesca (Rome, Italy) 13:35 Do cleansers and moisturers affect the microbiome? Ester Serra-Baldrich (Barcelona, Spain) 13:55 Biology of nanoparticles Klaus Ejner Andersen (Odense, Denmark) 14:15 Biology of topical vitamin A treatment TBC 14:35 Discussion, Q&A D3T02.4 D3T02.4A D3T02.4B D3T02.4C D3T02.4D D3T02.4E 15:00-16:30 Basic scientific cosmetology Chairs: Jean Krutmann (Dusseldorf, Germany) Anne Le Pillouer-Prost (Marseille, France) 15:00 Effects of photodynamic therapy on aged skin Anne Le Pillouer-Prost (Marseille, France) 15:20 Effects of peels on aged skin Oliver Kreyden (Basel, Switzerland) 15:40 Probiotics and prebiotics Dae Hun Suh (Seoul, Korea, Rep. of South) 16:00 Air pollution and ageing Jean Krutmann (Dusseldorf, Germany) 16:20 Discussion, Q&A 81

84 SATURDAY, 12 OCTOBER Review and Updates Hall 10 Velázquez D3T03.1 D3T03.1A D3T03.1B D3T03.1C D3T03.1D D3T03.1E 08:30-10:00 Autoinflammatory diseases Chairs: Antonio Torrelo (Madrid, Spain) Amir Yazdi (Aachen, Germany) 08:30 Clinical spectrum of autoinflammatory diseases in children Antonio Torrelo (Madrid, Spain) 08:50 Symptoms of autoinflammatory diseases Karoline Krause (Berlin, Germany) 09:10 Pathophysiology and treatment Amir Yazdi (Aachen, Germany) 09:30 From autoinflammation to autoimmune diseases Dennis McGonagle (Leeds, United Kingdom) 09:50 Discussion, Q&A D3T03.2 D3T03.2A D3T03.2B D3T03.2C D3T03.2D D3T03.2E 10:15-11:45 Connective tissue diseases Chairs: Hugo Schönenberger de Oliveria (Coimbra, Portugal) Mirjana Milinkovic (Belgrade, Serbia) 10:15 Clinical and biological approach to suspected systemic lupus Marzia Caproni (Florence, Italy) 10:35 Update on lupus erythematosus treatment Ana Brasileiro (Lisbon, Portugal) 10:55 Morphea and linear scleroderma Hugo Schönenberger de Oliveria (Coimbra, Portugal) 11:15 Early diagnosis and treatment of dermatomyositis Mirjana Milinkovic (Belgrade, Serbia) 11:35 Discussion, Q&A D3T03.3 D3T03.3A D3T03.3B D3T03.3C D3T03.3D D3T03.3E 13:15-14:45 Autoimmune bullous diseases Chairs: Luca Borradori (Bern, Switzerland) Enno Schmidt (Lubeck, Germany) 13:15 Early diagnosis and treatment of bullous pemphigoid Luca Borradori (Bern, Switzerland) 13:35 The spectrum of pemphigoid diseases Detlef Zillikens (Lubeck, Germany) 13:55 Atypical presentation of vulgaris and paraneoplastic pemphigus Katarzyna Wozniak (Warsaw, Poland) 14:15 Treatment of pemphigus vulgaris: Update Enno Schmidt (Lubeck, Germany) 14:35 Discussion, Q&A D3T03.4 D3T03.4A D3T03.4B D3T03.4C D3T03.4D D3T03.4E 15:00-16:30 Autoimmune bullous diseases: Neutrophilic and pustular dermatoses Chairs: Miklos Sardy (Budapest, Hungary) Alexander Navarini (Zurich, Switzerland) 15:00 Linear IgA bullous dermatosis Emiliano Antiga (Florence, Italy) 15:20 Dermatitis herpetiformis Miklos Sardy (Budapest, Hungary) 15:40 Sweet syndrome Alexander Navarini (Zurich, Switzerland) 16:00 Acute generalised exanthematous pustulosis Philippe Musette (Rouen, France) 16:20 Discussion, Q&A 82

85 Review and Updates Hall 9 Picasso D3T04.1 D3T04.1A D3T04.1B D3T04.1C D3T04.1D D3T04.1E 08:30-10:00 Psychodermatology Chairs: Lucia Tomas Aragones (Muniesa, Spain) Adam Reich (Rzeszow, Poland) 08:30 Skin-picking syndromes Bárbara Roque Ferreira (Coimbra, Portugal) 08:50 Delusion of parasitosis Adam Reich (Rzeszow, Poland) 09:10 Munchausen syndrome and the skin Uwe Gieler (Giessen, Germany) 09:30 Handling of mental health problems and psychotropic drugs by the dermatologist Lucia Tomas Aragones (Muniesa, Spain) 09:50 Discussion, Q&A D3T :15-11:45 Psychodermatology Chairs: Francoise Poot (Brussels, Belgium) Martin Steinhoff (Doha, Qatar) D3T04.2A D3T04.2B D3T04.2C D3T04.2D D3T04.2E 10:15 Brain-skin connections in atopic dermatitis Martin Steinhoff (Doha, Qatar) 10:35 The psychologic burden of chronic urticaria Karsten Weller (Berlin, Germany) 10:55 Acne excoria and its treatment Francoise Poot (Brussels, Belgium) 11:15 Communicating bad news Patrick Maurice Jean Henri Kemperman (Amsterdam, Netherlands) 11:35 Discussion, Q&A Saturday, 12 October D3T04.3 D3T04.3A D3T04.3B D3T04.3C D3T04.3D D3T04.3E 13:15-14:45 Contact eczemas Chairs: Olivier Aerts (Antwerp, Belgium) Paolo Pigatto (Milan, Italy) 13:15 From irritant to allergic contact dermatitis Stefan Martin (Freiburg, Germany) 13:35 Allergic contact dermatitis is more than eczema Olivier Aerts (Antwerp, Belgium) 13:55 New allergens in daily life Thomas Rustemeyer (Amsterdam, Netherlands) 14:15 Contact allergy in the mucosa Paolo Pigatto (Milan, Italy) 14:35 Discussion, Q&A D3T04.4 D3T04.4A D3T04.4B D3T04.4C D3T04.4D D3T04.4E 15:00-16:30 Occupational dermatoses Chairs: Swen Malte John (Osnabruck, Germany) Andrea Bauer (Dresden, Germany) 15:00 The spectrum of occupational skin diseases Marie-Noëlle Crepy (Paris, France) 15:20 Prevention of occupational hand eczema Tove Agner (Copenhagen, Denmark) 15:40 New occupational allergens Swen Malte John (Osnabruck, Germany) 16:00 Occupational skin cancer Andrea Bauer (Dresden, Germany) 16:20 Discussion, Q&A 83

86 SATURDAY, 12 OCTOBER Review and Updates Hall 9 Sorolla D3T05.1 D3T05.1A D3T05.1B D3T05.1C D3T05.1D D3T05.1E 08:30-10:00 Mucosal inflammatory diseases Chairs: Loic Vaillant (Tours Cedex, France) Carmen Lisboa Silva (Santa Cristina Couto, Portugal) 08:30 Immunity at mucosal surfaces Peter Schmid-Grendelmeier (Zurich, Switzerland) 08:50 Differential diagnosis and management of oral erosions Malgorzata Olszewska (Warsaw, Poland) 09:10 Mucosal lichen planus: Update on diagnosis and treatment Loic Vaillant (Tours, France) 09:30 Differential diagnosis of genital ulcers Carmen Lisboa Silva (Santa Cristina Couto, Portugal) 09:50 Discussion, Q&A D3T05.2 D3T05.2A D3T05.2B D3T05.2C D3T05.2D D3T05.2E 10:15-11:45 Mucosal neoplasia Chairs: Christian Posch (Munich, Germany) Sebastien Fouéré (Paris, France) 10:15 How to treat vulvar in situ carcinoma Iris Hendriks (Rotterdam, Netherlands) 10:35 HPV-associated mucosal neoplasia Sebastien Fouéré (Paris, France) 10:55 How to manage actinic cheilitis Juraj Hegyi (Bratislava, Slovakia) 11:15 Staging and management of mucosal melanomas Christian Posch (Munich, Germany) 11:35 Discussion, Q&A D3T05.3 D3T05.3A D3T05.3B D3T05.3C D3T05.3D D3T05.3E 13:15-14:45 Skin diseases in transplant patients Chairs: Klemens Rappersberger (Vienna, Austria) Stefano Piaserico (Padua, Italy) 13:15 How to manage multiple relapsing warts Raimonds Karls (Daugmale, Latvia) 13:35 m-tor inhibitors in the management of viral infections Wolfram Hoetzenecker (Linz, Austria) 13:55 Kaposi sarcoma in organ transplant recipients Klemens Rappersberger (Vienna, Austria) 14:15 Immuno-suppressed protocols and risk of skin cancer Stefano Piaserico (Padua, Italy) 14:35 Discussion, Q&A D3T05.4 D3T05.4A D3T05.4B D3T05.4C D3T05.4D D3T05.4E 15:00-16:30 Vascular malformations and tumours Chairs: Laurence Boon (Brussels, Belgium) Eulalia Baselga (Barcelona, Spain) 15:00 New insights in genetic of vascular anomalies and translation to possible therapeutics Julie Powell (Montreal, Canada) 15:20 Update on surgery of slow-flow vascular malformations Laurence Boon (Brussels, Belgium) 15:40 Better delineation of capillary malformation of the limbs Anne Dompmartin-Blanchere (Caen, France) 16:00 Infantile haemangioma sequelae Eulalia Baselga (Barcelona, Spain) 16:20 Discussion, Q&A 84

87 Review and Updates N103 D3T06.1 D3T06.1A D3T06.1B D3T06.1C D3T06.1D D3T06.1E 08:30-10:00 NMSC: Basal cell carcinoma Chairs: Tamara Gracia-Cazaña (Barbastro, Spain) Jonathan Slater (Redhill, United Kingdom) 08:30 Resistance mechanisms in BCC and treatment combinations Tamara Gracia-Cazaña (Barbastro, Spain) 08:50 Consequences of rising incidence of BCC Tamar Nijsten (Rotterdam, Netherlands) 09:10 Management of challenging BCC cases Ervin Epstein (Oakland, United States) 09:30 Treatment of advanced BCC: Vismodegib and beyond Jonathan Slater (Redhill, United Kingdom) 09:50 Discussion, Q&A D3T :15-11:45 NMSC: Actinic keratosis Chairs: Francesca Farnetani (Modena, Italy) TBC D3T06.2A D3T06.2B D3T06.2C D3T06.2D D3T06.2E 10:15 Classification of AKs Alexander Stratigos (Athens, Greece) 10:35 New biomarkers for the transition from AK to SCC Thomas Dirschka (Wuppertal, Germany) 10:55 Non-invasive techniques in the evaluation of field cancerisation Francesca Farnetani (Modena, Italy) 11:15 Comparing treatment guidelines Lutz Schmitz (Bochum, Germany) 11:35 Discussion, Q&A Saturday, 12 October D3T06.3 D3T06.3A D3T06.3B D3T06.3C D3T06.3D D3T06.3E 13:15-14:45 NMSC: Squamous cell carcinoma Chairs: Claas Ulrich (Berlin, Germany) Nicole Basset-Seguin (Paris, France) 13:15 New insights in the pathogenesis of SCC Ievgenia Pastushenko (Brussels, Belgium) 13:35 Prevention of SCC in OTR. Is it possible? Claas Ulrich (Berlin, Germany) 13:55 Occupational ultraviolet light exposure and the risk for the development of basal and cutaneous squamous cell carcinoma Anita Gunaric (Medjugorje, Bosnia and Herzegovina) 14:15 High-risk SCC: Evidence-based case management Nicole Basset-Seguin (Paris, France) 14:35 Discussion, Q&A D3T :00-16:30 Other skin cancers Chairs: Lukas Kofler (Tubingen, Germany) Philippe Saiag (Boulogne, France) D3T06.4A D3T06.4B D3T06.4C D3T06.4D D3T06.4E 15:00 Adnexal carcinomas Claudia Bernardez-Guerra (Madrid, Spain) 15:20 Merkel cell carcinoma Mahtab Samimi (Tours, France) 15:40 Angiosarcoma Lukas Kofler (Tubingen, Germany) 16:00 DFSP Philippe Saiag (Boulogne, France) 16:20 Discussion, Q&A 85

88 SATURDAY, 12 OCTOBER Review and Updates N104 D3T07.1 D3T07.1A D3T07.1B D3T07.1C D3T07.1D D3T07.1E 08:30-10:00 Management of adverse drug reactions Chairs: Alena Fialova (Prague, Czech Republic) Virginia Velasco-Tamariz (Madrid, Spain) 08:30 EGFR inhibitors Danijela Dobrosavljevic (Belgrade, Serbia) 08:50 Checkpoint inhibitors Alena Fialova (Prague, Czech Republic) 09:10 Vaccine-induced drug reactions Virginia Velasco-Tamariz (Madrid, Spain) 09:30 Reactions to biologics Rolland Gyulai (Pecs, Hungary) 09:50 Discussion, Q&A D3T07.2 D3T07.2A D3T07.2B D3T07.2C D3T07.2D D3T07.2E 10:15-11:45 Microbiote and skin: A new therapeutic area Chairs: Thomas Volz (Munich, Germany) Hok Bing Thio (Rotterdam, Netherlands) 10:15 Skin microbiome: Control on skin inflammation Thomas Volz (Munich, Germany) 10:35 How to train the immune system in newborn and infants Tilo Biedermann (Munich, Germany) 10:55 Improving the course of psoriasis using the microbiome Hok Bing Thio (Rotterdam, Netherlands) 11:15 The influence of the gut microbiome on anti-cancer therapy Veronique Bataille (Hemel Hempstead, United Kingdom) 11:35 Discussion, Q&A D3T07.3 D3T07.3A D3T07.3B D3T07.3C D3T07.3 D3T07.3E 13:15-14:45 Holistic approach in dermatology Chairs: Julien Lambert (Antwerp, Belgium) Anette Bygum (Odense, Denmark) 13:15 Psychodermatology in Vietnam Hau Khang-Tran (Hanoi, Vietnam) 13:35 Oral supplements in addressing common dermatologic problems Julien Lambert (Antwerp, Belgium) 13:55 Passion for Dermatology Compassion for Patients? Anette Bygum (Odense, Denmark) 14:15 Mindfulness in dermatology Cornelis Kennedy (Leiden, Netherlands) 14:35 Discussion, Q&A D3T07.4 D3T07.4A D3T07.4B D3T07.4C D3T04.4D D3T07.4E 15:00-16:30 Body art Chairs: Nicolas Kluger (Helsinki, Finland) Christa de Cuyper (Bruges, Belgium) 15:00 Epidemiology from small tattoos to body art Nicolas Kluger (Helsinki, Finland) 15:20 Tattoo regret: treatment options Kristine Heidemeyer (Bern, Switzerland) 15:40 Tattoo removal in patients with tattoo allergy Sebastiaan Alain Servé van der Bent (Amsterdam, Netherlands) 16:00 Complications with body art Christa de Cuyper (Bruges, Belgium) 16:20 Discussion, Q&A 86

89 Review and Updates N D3T08.1 D3T08.1A D3T08.1B D3T08.1C D3T08.1D D3T08.1E D3T08.1F D3T08.1G D3T08.1H D3T08.1I 08:30-10:00 Rising stars session Chairs: Michael John Boffa (Floriana, Malta) Catherine van Montfrans (Rotterdam, Netherlands) 08:30 Successful treatment of bullous pemphigoid with omalizumab Galina Balakirski (Bonn, Germany) 08:40 Leishmaniasis Khadija Sellami (Sfax, Tunisia) 08:50 Bullous diseases Cathy Zhao (Sydney, Australia) 09:00 Syphilis in the past and present Maria Isabela Sarbu (Bucharest, Romania) 09:10 Pemphigus vulgaris and foliaceus Bela Tamasi (Budapest, Hungary) 09:20 Hidradenitis suppurativa syndromes Allard Vossen (Rotterdam, Netherlands) 09:30 Phototherapy for cutaneous disorders in children TBC 09:40 Surgical site infections (SSIs) in dermatologic surgery: Preventative guidelines and challenges Karim Saleh (Lund, Sweden) 09:50 Discussion, Q&A D3T :15-11:45 EADV President s Symposium «Skin and brain: Unraveled connections» Chairs: Carle Paul (Toulouse, France) Luca Borradori (Bern, Switzerland) Alexander Stratigos (Athens, Greece) Saturday, 12 October D3T08.2A D3T08.2B 10:15 Cross-talk between immune cells and nerve fibers in skin Nicolas Gaudenzio (Toulouse, France) 10:40 The skin-brain axis in inflammatory skin disease Christopher Griffiths (Manchester, United Kingdom) D3T08.2C 11:05 Pharmacological relief of itch: What is relevant in 2019? Sonja Ständer (Munster, Germany) D3T08.2D 11:30 Discussion, Q&A D3T08.3 D3T08.3A D3T08.3B D3T08.3C D3T08.3D D3T08.3E 13:15-14:45 Lessons from registries Chairs: Piergiacomo Calzavara-Pinton (Brescia, Italy) Thrasyvoulos Tzellos (Harstad, Norway) 13:15 Tips and tricks for a new registry: Why, when and how Matthias Augustin (Hamburg, Germany) 13:35 Differences of rates of psoriatic patients receiving biologics Piergiacomo Calzavara-Pinton (Brescia, Italy) 13:55 Do we need a European melanoma register? Michael Weichenthal (Kiel, Germany) 14:15 Hidradenitis suppurativa: Starting a European register Thrasyvoulos Tzellos (Harstad, Norway) 14:35 Discussion, Q&A 87

90 SATURDAY, 12 OCTOBER D3T08.4 D3T08.4A D3T08.4B D3T08.4C D3T08.4D D3T08.4E 15:00-16:30 Quality assurance in daily practice Chairs: Kees-Peter de Roos (Uden, Netherlands) Jean-Luc Bernabo (Palamos, Spain) 15:00 Quality management in a private office TBC 15:20 Safety procedures in interventional dermatology Jean-Luc Bernabo (Palamos, Spain) 15:40 Experience with safety management systems Kees-Peter de Roos (Uden, Netherlands) 16:00 How social media can work for and against you Rosa Taberner (Palma, Spain) 16:20 Discussion, Q&A Controversies N D3T09.1 D3T09.1A D3T09.1B D3T09.1C D3T09.1D D3T09.1E 08:30-10:00 Inflammatory diseases Chairs: Valeria Aoki (São Paulo, Brazil) Ulrich Mrowietz (Kiel, Germany) 08:30 Rituximab in pemphigus - First line therapy Vinay Keshava Murthy (Bangalore, India) 08:50 Rituximab in pemphigus - Second line therapy Valeria Aoki (São Paulo, Brazil) 09:10 Therapy of psoriasis - Phototherapy is still a therapeutic option Vigfus Sigurdsson (Utrecht, Netherlands) 09:30 Therapy of psoriasis - No place for photherapy anymore Ulrich Mrowietz (Kiel, Germany) 09:50 Discussion, Q&A D3T09.2 D3T09.2A D3T09.2B D3T09.2C D3T09.2D D3T09.2E 10:15-11:45 Inflammatory diseases Chairs: Gregor Jemec (Copenhagen, Denmark) TBC 10:15 Dermatomyositis: Antibody profile is important for diagnosis and management Emmanuel Laffitte (Geneva, Switzerland) 10:35 Dermatomyositis: Antibody profile is not important for diagnosis and management Petra De Haes (Leuven, Belgium) 10:55 Hidradenitis suppurativa: Systemic therapy is the best approach Gregor Jemec (Copenhagen, Denmark) 11:15 Hidradenitis suppurativa: Surgical therapy is the best approach Eva Vilarrasa (Barcelona, Spain) 11:35 Discussion, Q&A 88

91 Expert Forum N D3T09.3 D3T09.3A D3T09.3B D3T09.3C D3T09.3D D3T09.3E 13:15-14:45 Advantages of a multidisciplinary approach Chairs: Milos Nikolic (Belgrade, Serbia) Onofre Sanmartin (Quart de Poblet, Spain) 13:15 Dermatology and oncology in the management of metastatic melanoma Claus Garbe (Tubingen, Germany) 13:35 Dermatology and rheumatology in the managment of lupus erythematosus Milos Nikolic (Belgrade, Serbia) 13:55 Dermatology and paediatrics in the managment of childhood exanthema Christine Bodemer (Paris, France) 14:15 Dermatologists and critical care in side effects of growth factors inhibitors Onofre Sanmartin (Quart de Poblet, Spain) 14:35 Discussion, Q&A D3T :00-16:30 Advantage of a multidisciplinary approach Chairs: Alison Layton (Harrogate, United Kingdom) Matthias Goebeler (Wurzburg, Germany) D3T09.4A D3T09.4B D3T09.4C D3T09.4D D3T09.4E 15:00 Obesity: When to think of endocrinopathy Marie-Charlotte Brueggen (Zurich, Switzerland) 15:20 Surgical dermato-oncology: Where are the limits Alessandro Testori (Milan, Italy) 15:40 Acne: When to think of endocrinopathy Alison Layton (Harrogate, United Kingdom) 16:00 Sarcoidosis: When and how to check for internal involvement Matthias Goebeler (Wurzburg, Germany) 16:20 Discussion, Q&A Saturday, 12 October 89

92 SATURDAY, 12 OCTOBER Training and education forum N D3T10.1 D3T10.1A D3T10.1B D3T10.1C D3T10.1D D3T10.1E 08:30-10:00 Infectious diseases Chairs: Filip Rob (Prague, Czech Republic) Mario Fabri (Koln, Germany) 08:30 Erysipelas and cellulitis Filip Rob (Prague, Czech Republic) 08:50 Staphylococcal cellulitis Mario Fabri (Koln, Germany) 09:10 Dermoscopy of Tinea Capitis Dimitrios Ioannides (Thessaloniki, Greece) 09:30 Important viral diseases Mihael Skerlev (Zagreb, Croatia) 09:50 Discussion, Q&A D3T10.2 D3T10.2A D3T10.2B D3T10.2C D3T10.2D D3T10.2E 10:15-11:45 STIs Chairs: Suzana Ljubojevic (Zagreb, Croatia) TBC 10:15 HPV infections and their treatment Alexander Kreuter (Oberhausen, Germany) 10:35 Syphilis: From the clinics to serology Suzana Ljubojevic (Zagreb, Croatia) 10:55 Gonorrhea and urethritis Alba Catala Gonzalo (Barcelona, Spain) 11:15 Clinics of HIV infections Michel Janier (Paris, France) 11:35 Discussion, Q&A D3T10.3 D3T10.3A D3T10.3B D3T10.3C D3T10.3D D3T10.3E 13:15-14:45 Topical and systemic therapies of skin diseases Chairs: Zsuzsanna Bata-Csorgo (Szeged, Hungary) Menno Alexander de Rie (Breukelen, Netherlands) 13:15 Choosing the right vehicle Tabi Anika Leslie (London, United Kingdom) 13:35 The correct therapeutical approach with glucocorticosteroids Zsuzsanna Bata-Csorgo (Szeged, Hungary) 13:55 Calcineurin inhibitors: Fears, facts and possibilities Uffe Nygaard (Brabrand, Denmark) 14:15 Topical immune-activation Menno Alexander de Rie (Breukelen, Netherlands) 14:35 Discussion, Q&A D3T10.4 D3T10.4A D3T10.4B D3T10.4C D3T10.4D D3T10.4E 15:00-16:30 Topical and systemic therapies of skin diseases Chairs: Elke de Jong (Nijmegen, Netherlands) Georgios Chaidemenos (Thessaloniki, Greece) 15:00 Topical treatment in acne and rosacea Esteban Dauden (Madrid, Spain) 15:20 How to treat eczema and psoriasis of the scalp Elke de Jong (Nijmegen, Netherlands) 15:40 Topical treatment of psoriasis in difficult to treat areas: Genital, folds and palmoplantar Peter Van de Kerkhof (Nijmegen, Netherlands) 16:00 Spectrum of systemic therapies in psoriasis Georgios Chaidemenos (Thessaloniki, Greece) 16:20 Discussion, Q&A 90

93 Training and education forum N D3T11.1 D3T11.1A D3T11.1B D3T11.1C D3T11.1D D3T11.1E 08:30-10:00 Nail disorders Chairs: Dimitrios Rigopoulos (Athens, Greece) TBC 08:30 Performing nail biopsy for beginners Roman Minano-Medrano (Alcorcon, Spain) 08:50 Onychoscopy of inflammatory nail disorders Aurora Maria Alessandrini (Bologna, Italy) 09:10 How to use prognostic factors to improve cure rates in the treatment of onychomycosis Bardur Sigurgeirsson (Kopavogur, Iceland) 09:30 Biologic therapy in inflammatory nail disorders Dimitrios Rigopoulos (Athens, Greece) 09:50 Discussion, Q&A D3T :15-11:45 Hair disorders Chairs: Petra Dikrama (Utrecht, Netherlands) Sergio Vaño-Galván (Madrid, Spain) D3T11.2A D3T11.2B D3T11.2C D3T11.2D D3T11.2E 10:15 Tips for diagnosis of non-scarring hair loss Petra Dikrama (Utrecht, Netherlands) 10:35 Management of scarring alopecia Anna Waskiel (Warsaw, Poland) 10:55 New treatments for alopecia (low light laser, PRP injection, JAKi, Prostaglandine D2i) Nawaf Al-Mutairi (Farwaniya, Kuwait) 11:15 Hair transplantation: Clinical experience and future plans Sergio Vaño-Galván (Madrid, Spain) 11:35 Discussion, Q&A Saturday, 12 October D3T11.3 D3T11.3A D3T11.3B D3T11.3C D3T11.3D D3T11.3E 13:15-14:45 Paediatric dermatology Chairs: Miikka Vikkula (Brussels, Belgium) Regina Fölster-Holst (Kiel, Germany) 13:15 A «checklist» approach to diagnosing and managing birthmarks Satyamaanasa Polubothu (London, United Kingdom) 13:35 Vascular anomalies: Classification, clinical challenges and management Miikka Vikkula (Brussels, Belgium) 13:55 Neonatal emergencies Regina Fölster-Holst (Kiel, Germany) 14:15 Neurocutaneous syndromes Pierre Vabres (Dijon, France) 14:35 Discussion, Q&A D3T11.4 D3T11.4A D3T11.4B D3T11.4C D3T11.4D D3T11.4E 15:00-16:30 Paediatric dermatology Chairs: Daniel Sossau (Tubingen, Germany) TBC 15:00 Viral and bacterial infections Daniel Sossau (Tubingen, Germany) 15:20 Systemic therapy of paediatric psoriasis Selma Poparic (Sarajevo, Bosnia and Herzegovina) 15:40 Paediatric vitiligo: How to manage Alain Taieb (Bordeaux, France) 16:00 Management of ichtyosis in children Marie-Anne Morren (Lausanne, Switzerland) 16:20 Discussion, Q&A 91

94 SATURDAY, 12 OCTOBER Special Interest Meetings N D3T :30-10:00 Nurse Day (Part 1) Chairs: Christa de Cuyper (Bruges, Belgium) Swen Malte John (Osnabruck, Germany) D3T13.1A D3T13.1B D3T13.1C 08:30 Hand dermatitis: Clinical aspect and differential diagnosis Ester Serra-Baldrich (Barcelona, Spain) 09:00 Occupational hand dermatitis in health-care workers Swen Malte John (Osnabruck, Germany) 09:30 Occupational hand dermatitis in industrial setting. Diagnostic patch testing: How to select the test series according to the profession? Thomas Rustemeyer (Amsterdam, Netherlands) D3T :15-12:15 Nurse Day (Part 2) Chairs: Marco Romanelli (Pisa, Italy) Corinne Scicluna Ward (St. Julians, Malta) D3T13.2A D3T13.2B D3T13.2C D3T13.2D 10:15 The role of the nurse specialist in wound healing Corinne Scicluna Ward (St. Julians, Malta) 10:45 Atypical wounds and pyoderma: A diagnostic and therapeutic challenge Valentina Dini (Pisa, Italy) 11:15 Incontinence associated dermatitis and moisture associated skin damage Dimitri Beeckman (Ghent, Belgium) 11:45 Biologics in a nutshell (what nurses should know about biologics in dermatology) Dagmar Simon (Bern, Switzerland) D3T :00-16:30 Nurse Day - Afternoon interactive sessions Two rotating sessions will take place in the afternoon so that participants can assist to both of them. Chairs: Hand Dermatitis part Yolanda Gilaberte Calzada (Zaragoza, Spain) Kathrin Thormann (Bern, Switzerland) Chairs: Wound healing part Hilde Beele (Ghent, Belgium) Valentina Dini (Pisa, Italy) 3T13.3A Hand dermatitis: prevention and management. and The teaching role of nurse specialist Kathrin Thormann (Bern, Switzerland) Skin protection for health professionals: Glove choice and usage Anna Buse (Osnabruck, Germany) 3T13.3B Wound care: and How to choose an adequate wound dressing: Take (your) TIME for it! Hilde Beele (Ghent, Belgium) Steven Smet (Ghent, Belgium) 92

95 Free Communications N FC05 08:30-10:00 Free communications in Miscellaneous Chairs: Mateja Dolenc Voljc (Ljubljana, Slovenia) Paschalis Konstantinou (Limassol, Cyprus) FC05.01 FC05.02 FC05.03 FC05.04 FC05.05 FC05.06 FC05.07 FC05.08 FC :30 Prevalence of hidradenitis suppurativa: Population based study in employees Natalie Kirsten (Hamburg, Germany) 08:40 Combination of chemical peel are more effective than singe on peel in treatment of mild to moderate acne vulgaris Khaled Gharib (Zagazig, Egypt) 08: nm non-ablative fractional laser combined with isotretinoic acid and traditional Chinese pricking blood therapy for the treatment of acne Lin Gao (Xi an, China) 09:00 The risk of pulmonary embolism in patients with pemphigus: A population-based largescale longitudinal study Khalaf Kridin (Tamra, Israel) 09:10 Epidemiyology and evaluation of clinical and/or serological flares of 65 patients with pemphigus foliaceus: Focusing on personal and enviromental factors Sila Kılıç Sayar (Istanbul, Turkey) 09:20 KX2-391 ointment 1%, a novel Src phosphorylation and tubulin polymerisation inhibitor, for the treatment of actinic keratosis: Results from two pivotal Phase III studies Andrew Blauvelt (Portland, United States) 09:30 External validation of a prognostic model to predict survival of sentinel node-negative melanoma patients Norbertus Anton Ipenburg (Leiden, Netherlands) 09:40 Thick melanomas without lymph node metastases: A forgotten group with poor prognosis Mary-Ann El Sharouni (Utrecht, Netherlands) 09:50 Correlation between the histological type of the incident and the subsequently diagnosed non-melanoma skin cancer Pedro Miguel Garrido (Lisboa, Portugal) Saturday, 12 October FC06 FC06.01 FC06.02 FC06.03 FC06.04 FC06.05 FC06.06 FC06.07 FC06.08 FC :15-11:45 Free communications in Miscellaneous Chairs: Erjona Shehu (Tirana, Albania) Jean-Luc Bernabo (Palamos, Spain) 10:15 Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): A case series Constanza Riquelme (Barcelona, Spain) 10:25 Variability in the diagnosis of surgical site infections after full-thickness skin grafting: An international survey Karim Saleh (Lund, Sweden) 10:35 Retrospective study of the efficacy of superficial radiation therapy following surgical excision for treating Keloid scars Brian Berman (Miami Beach, United States) 10:45 Perioperative management of anti-thrombotic drugs in dermatological surgery Piru Pathmarajah (London, United Kingdom) 10:55 Explainable deep learning diagnosis system for clinical dermatology Ludovic Amruthalingam (Allschwil, Switzerland) 11:05 TBC 11:15 A case series of topical timolol 0.5% in secondary intention wound healing Corniche Khan (Dublin, Ireland) 11:25 Impact of probiotics on pathogen survival in an huma plasma biofilm model (hpbiom) Ewa Klara Stuermer (Witten, Germany) 11:35 Effectiveness of etanercept in the treatment of toxic epidermal necrolysis Dario Didona (Marburg, Germany) 93

96 SATURDAY, 12 OCTOBER FC07 FC07.01 FC07.02 FC07.03 FC07.04 FC07.05 FC07.06 FC07.07 FC07.08 FC :15-14:45 Free communications in Atopic dermatitis and Urticaria Chairs: Vladimir Vasku (Brno, Czech Republic) Remi Maghia (Brest, France) 13:15 Atopic dermatitis disease biomarkers strongly correlate with IL-13 levels, are regulated by IL-13, and are modulated by tralokinumab in vitro Katharina Drerup (Kiel, Germany) 13:25 TBC 13:35 Onset of effect on symptoms reported in daily diaries in patients with atopic dermatitis treated with baricitinib: Results from two phase 3 trials Andreas Wollenberg (Munich, Germany) 13:45 Serological biomarkers of disease severity and phenotype in atopic dermatitis Jesper Grønlund Holm (Copenhagen, Denmark) 13:55 Dupilumab with concomitant topical corticosteroid treatment results in a lower requirement for rescue medication in patients with moderate-to-severe atopic dermatitis Marjolein De Bruin-Weller (Utrecht, Netherlands) 14:05 Time to Upadacitinib treatment response over 16 weeks for patients with atopic dermatitis from a phase 2b, randomized, placebo-controlled trial Kristian Reich (Hamburg, Germany) 14:15 Results from the phase 2b study demonstrate that ligelizumab achieves sustained control of CSU symptoms during treatment-free follow-up Sinisa Savic (Leeds, United Kingdom) 14:25 Identifying specific patient needs and treatment goals in chronic spontaneous urticaria for a patient-centered clinical decision-making process Rachel Sommer (Hamburg, Germany) 14:35 TBC FC08 FC08.01 FC08.02 FC08.03 FC08.04 FC08.05 FC08.06 FC08.07 FC08.08 FC :00-16:30 Free communications in Acne and related disorders Chairs: Vigfus Sigurdsson (Utrecht, Netherlands) Grisha Mateev (Sofia, Bulgaria) 15:00 The impact of acne treatment on quality of life and self-esteem: A prospective cohort Jerome Kaikati (Beirut, Lebanon) 15:10 Role of the rs polymorphism of VEGF gene in the formation of rosacea Said Kasim Arifov (Tashkent, Uzbekistan) 15:20 Correlation of patient demographic and clinical characteristics with hidradenitis suppurativa (HS) symptom assessment (HSSA) and hidradenitis suppurativa impact assessment (HSIA): Results from the UNITE hidradenitis suppurativa disease registry Afsaneh Alavi (Richmond Hill, Canada) 15:30 QoL-HS - disease specific instrument to assess quality of life in patients with hidradenitis suppurativa Natalie Kirsten (Hamburg, Germany) 15:40 An assessment of the natural history of hidradenitis suppurativa: Results from the 2-Year interim analysis of an international, prospective, disease-based registry (UNITE) Alexa B. Kimball (Boston, United States) 15:50 Long-term patient reported outcomes following laser treatment for hidradenitis suppurativa: A retrospective multicenter study Dewi Rijnenberg (Amsterdam, Netherlands) 16:00 Prevalence of non-alcoholic fatty liver disease in a large cohort of patients with hidradenitis suppurativa Giovanni Damiani (Milan, Italy) 16:10 Elevated serum IL-36 Levels in patients with hidradenitis suppurativa: A case-control study Yildiz Hayran (Ankara, Turkey) 16:20 Paradoxical hidradenitis suppurativa to biologic agents: A case series and literature review José Neves (Lisboa, Portugal) 94

97 Practical Workshops (Fully Booked) The below courses required pre-registration and are no longer open to new participants Track 14 N D3T :30-11:45 Phlebology workshop for beginners Chairs: Felizitas Pannier (Bonn, Germany) George Sorin Tiplica (Bucharest, Romania) Liselot Vink (Amstelveen, Netherlands) This workshop introduces the main principles of phlebology. An explanation on anatomy and physiology of the vascular system of the lower limbs as well as therapy for varicose veins according to the newest guidelines will lead the participants to make a positive and differential diagnosis of vascular diseases of the lower limbs and perform several therapeutic procedures used in phlebology (e.g. sclerotherapy). Three rotating stations will show production of sclerosing foam, injection of spider veins and duplex guided injection techniques. D3T :15-16:30 Advanced Phlebology workshop Chairs: Felizitas Pannier (Bonn, Germany) George Sorin Tiplica (Bucharest, Romania) Eberhard Rabe (Bonn, Germany) This workshop introduces the advanced signs of chronic venous disease. The pathophysiology and clinical picture of chronic venous disease, post-thrombotic syndrome and venous leg ulcers will be explained. The skin changes in in venous disease of the lower leg will show and are discussed. The sclerotherapy of varicose veins according to the newest guidelines will be explained. Three rotating stations will demonstrate the production of sclerosing foam, injection of spider veins and duplex guided injection techniques and then performed by the participants themselves. Saturday, 12 October Differential diagnosis of skin changes in venous disease and of leg ulcers is learned by discussing pictures of clinical cases. In addition there will be some time to discuss questions around indications, techniques, side effects and results of sclerotherapy and other venous techniques. N D3T :30-11:45 Advanced surgery workshop (morning) Chairs: Robert Gniadecki (Copenhagen, Denmark) Annik Van Rengen (Dordrecht, Netherlands) Ehud Miller (Tel Aviv, Israel) D3T :15-16:30 Advanced surgery workshop (afternoon) Chairs: Robert Gniadecki (Copenhagen, Denmark) Annik Van Rengen (Dordrecht, Netherlands) Ehud Miller (Tel Aviv, Israel) The advanced surgery workshop is repeated twice: once in the morning, once in the afternoon. Excisions and closures of of surgical wounds is challenging for many dermatologists. The aim of this interactive session is to close this gap and review different types of facial closures, both primary closures and flaps. There will be focus on the methods achievable for the participants with basic surgery training and experience with the advanced reconstruction in different regions of the face. These courses use materials provided by selected sponsors. Participants should be aware that there are a variety of different, similar products that they can use beyond the ones provided during the workshop. 95

98 EADV SCHOOL Upcoming courses Training courses for residents Course Date Place Chair Lymphomas January 2020 Bordeaux Prof. M. Beylot-Barry Genodermatoses January 2020 Innsbruck Prof. J. Bauer, Prof. M. Schmuth Hidradenitis Suppurativa (*) 3-4 February 2020 Athens Prof. C.C. Zouboulis Bacteriology February 2020 Paris Prof. R.J. Hay, Prof. O. Chosidow Cutaneous Allergy March 2020 Brussels Dr. J. White (*) course also open to specialists Training courses for specialists Course Date Place Chair Sex Workers - STI problems 8-9 November 2019 Bucharest Prof. S. Tiplica, Prof. M. Waugh Non Melanoma Skin Cancer November 2019 Thessaloniki Prof. E. Lazaridou, Prof. D. Ioannides Trichoscopy November 2019 Warsaw Prof. L. Rudnicka Cryosurgery December 2019 Barcelona Dr. P. Pasquali Tropical Dermatology December 2019 Lisbon Dr. P. Cunha And many more to come... Resident courses are free of charge and EADV junior members receive an educational grant. Specialist courses guarantee CME-CPD credits. The registration fee is usually 400 EUR for EADV members and 650 EUR for non-eadv members (some specific courses have different fees). For further information and to apply, visit our website or contact courses@eadv.org Follow us on social networks and discover our newest courses: facebook twitter linkedin PLEASE NOTE: DATES MIGHT BE SUBJECT TO MODIFICATIONS

99 Reviews and updates SUNDAY 13 OCTOBER Room name N103 N104 N N Capacity Session type Aesthetic Sunday Aesthetic Sunday Aesthetic Sunday Aesthetic Sunday Track no D4T01.1 Non-invasive body contouring D4T02.1 Fillers I D4T03.1 Peels D4T04.1 Aesthetic dermatology for medical indications D4T01.2 Energy based devices I, including lasers D4T02.2 Fillers II D4T03.2 Botulinum toxin I D4T04.2 Practice management, including psychology D4T01.3 Energy based devices II, including lasers D4T02.3 Scars D4T03.3 Botulinum toxin II, including complications D4T04.3 Hot topics: Interactive strategies Sunday, 13 October 97

100 SUNDAY 13 OCTOBER Review and Updates D4T :30-10:00 Non-invasive body contouring Chair: Klaus Fritz (Landau, Germany) N103 D4T01.1A D4T01.1B D4T01.1C D4T01.1D D4T01.1E 08:30 Cold versus hot - Cryolipolysis vs Thermolipolysis Christine Dierickx (Luxembourg, Luxembourg) 08:50 Non-invasive body shaping with lasers and EBD: Bipolar and field RF, vacuum, AWT Maurice Adatto (Geneva, Switzerland) 09:10 Non invasive body contouring with HIFU, injection lipolysis, electromagnetic muscle stimulatiation, simultaneous RF and shock waves and combinations Klaus Fritz (Landau, Germany) 09:30 Body contouring with injectables Sonja Sattler (Darmstadt, Germany) 09:50 Discussion, Q&A D4T01.2 D4T01.2A D4T01.2B D4T01.2C D4T01.2D 10:15-11:45 Energy based devices I, including lasers Chair: Keyvan Nouri (Miami, United States) 10:15 Practical aspects of laser tissue interaction Ashraf Badawi (Oakville, Canada) 10:35 Lasers for vascular lesions including IPL Agneta Troilius Rubin (Malmo, Sweden) 10:55 Lasers for pigmented lesions, tattoos and hair removal Keyvan Nouri (Miami, United States) 11:15 Fractional ablative/non-ablative resurfacing including drug delivery Merete Haedersdal (Copenhagen, Denmark) D4T01.3 D4T01.3A D4T01.3B D4T01.3C D4T01.3D D4T01.3E 12:00-13:30 Energy based devices II, including lasers Chair: Leonardo Marini (Trieste, Italy) 12:00 Resistant tattoos: What is the best treatment strategy? Leonardo Marini (Trieste, Italy) 12:20 Resistant Port Wine Stain: What is the best treatment strategy? Agneta Troilius Rubin (Malmo, Sweden) 12:40 New standards in scar treatment Klaus Hoffmann (Bochum, Germany) 13:00 Post-treatment scars and PIH: What should we do? Peter Velthuis (Rotterdam, Netherlands) 13:20 Discussion, Q&A 98

101 Review and Updates N104 D4T02.1 D4T02.1A D4T02.1B D4T02.1C D4T02.1D D4T02.1E 08:30-10:00 Fillers I Chair: Pierre Andre (Paris, France) 08:30 Basic anatomy of the face Herve Raspaldo (Geneva, Switzerland) 08:50 How to start an injector practice? Pierre Andre (Paris, France) 09:10 My technique for newcomers to filler injections Ines Verner Rashkovsky (Savyon, Israel) 09:30 The 1 ml Face-lift» Christopher Rowland Payne (London, United Kingdom) 09:50 Discussion, Q&A D4T02.2 D4T02.2A D4T02.2B D4T02.2C D4T02.2D D4T02.2E 10:15-11:45 Fillers II Chair: Ines Verner Rashkovsky (Savyon, Israel) 10:15 Anatomy of the forehead, nose, lips and chin Benjamin Ascher (Paris, France) 10:35 Injection of the forehead Hugues Cartier (Arras, France) 10:55 Injection of the nose Davi De Lacerda (Sao Paolo, Brazil) 11:15 Injection of the lips and chin Ines Verner Rashkovsky (Savyon, Israel) 11:35 Discussion, Q&A D4T02.3 D4T02.3A D4T02.3B 12:00-13:30 Scars Chair: Hans Laubach (Geneva, Switzerland) 12:00 Lasers and EBD for treatment of scars Keyvan Nouri (Miami, United States) 12:20 Scar treatments with injectables - logical but underused? Louai Salah (Jeddah, Saudi Arabia) Sunday, 13 October D4T02.3C D4T02.3D D4T02.3E 12:40 Treatment of burn scars - how to help people with a debilitating disease Rasha Genedy (Alexandria, Egypt) 13:00 Improving aesthetically unpleasing scars - a how to treatment approach for Hans Laubach (Geneva, Switzerland) 13:20 Discussion, Q&A D4T03.1 D4T03.1A D4T03.1B D4T03.1C D4T03.1D D4T03.1E 08:30-10:00 Peels Chair: Oliver Kreyden (Basel, Switzerland) 08:30 Chemical peeling from antiquity to today Claudia Borelli (Tubingen, Germany) 08:50 My personal approaches Uliana Gout (London, United Kingdom) 09:10 TCA and Phenol - How to make patients happy Oliver Kreyden (Basel, Switzerland) 09:30 Do s and don ts when peeling dark skin Sahar Ghannam (Maidan Hawally, Kuwait) 09:50 Discussion, Q&A 99

102 SUNDAY 13 OCTOBER D4T03.2 D4T03.2A D4T03.2B D4T03.2C D4T03.2D D4T03.2E 10:15-11:45 Botulinum toxin I Chair: Andreas Katsambas (Athens, Greece) 10:15 The magic of BoNT-A Anthony Benedetto (Philadelphia, United States) 10:35 BTX: Upper Face Oliver Kreyden (Basel, Switzerland) 10:55 BTX: Lower face Andreas Katsambas (Athens, Greece) 11:15 How to achieve a natural facial improvement with BTX Leonardo Marini (Trieste, Italy) 11:35 Discussion, Q&A D4T03.3 D4T03.3A D4T03.3B D4T03.3C D4T03.3D D4T03.3E 12:00-13:30 Botulinum toxin II, including complications Chair: Berthold Rzany (Berlin, Germany) 12:00 Different aesthetic concepts and ethnicity Uliana Gout (London, United Kingdom) 12:20 Asian indications for non Asians: An overview Po-Han Huang (Kaohsiung, Taiwan) 12:40 Medical indications from migraine to hypersalivation Oliver Kreyden (Basel, Switzerland) 13:00 Switching toxins: What you should know Berthold Rzany (Berlin, Germany) 13:20 Discussion, Q&A D4T04.1 D4T04.1A D4T04.1B D4T04.1C D4T04.1D D4T04.1E 08:30-10:00 Aesthetic dermatology for medical indications Chairs: Amr Abdel-Hakim Rateb (Cairo, Egypt) Ashraf Badawi (Oakville, Canada) 08:30 Laser treatment of psoriasis Ashraf Badawi (Oakville, Canada) 08:50 Light based treatment of rosacea Pablo Boixeda (Madrid, Spain) 09:10 Medical indications for neuromodulators Amr Abdel-Hakim Rateb (Cairo, Egypt) 09:30 Medical indications for fillers Peter Velthuis (Rotterdam, Netherlands) 09:50 Discussion, Q&A 100

103 D4T04.2 D4T04.2A D4T04.2B D4T04.2C D4T04.2D D4T04.2E 10:15-11:45 Practice management, including psychology Chairs: Maurice Adatto (Geneva, Switzerland) Moshe Lapidoth (Ramat-Gan, Israel) 10:15 Five strategies for growing a successful aesthetic dermatology practice Wendy Lewis (New York, United States) 10:35 Setting realistic expectations for the aesthetic patient Didac Barco (Barcelona, Spain) 10:55 Marketing aspects in aesthetic dermatology Moshe Lapidoth (Ramat-Gan, Israel) 11:15 A review of recent scientific literature on aesthetic patient psychology Maurice Adatto (Geneva, Switzerland) 11:35 Discussion, Q&A D4T04.3 D4T04.3A D4T04.3B D4T04.3C D4T04.3D D4T04.3E 12:00-13:30 Hot topics: Interactive strategies Chair: Christopher Rowland Payne (London, United Kingdom) 12:00 What s new in the last 12 months in the cosmetic literature Claudia Borelli (Tubingen, Germany) 12:20 Intradermal injection of botulinum toxin Ljiljana Medenica (Belgrade, Serbia) 12:40 Techniques to improve skin quality Liliana Sytnyk (Kiev, Ukraine) 13:00 The placebo in cosmetic dermatology Patrizia D Alessio (Villejuif, France) 13:20 Discussion, Q&A Sunday, 13 October 101

104 GENERAL INFORMATION 102

105 CONGRESS GENERAL INFORMATION Address and contact Congress Venue IFEMA - Feria de Madrid Avda. del Partenón, Madrid, Spain Website: Destination Management Company Bco Congresos Plaza de Europa, L Hospitalet de Llobregat Barcelona, Spain Phone: Website: eadv2019officialhotels.com eadv2019@bcocongresos.com Abstract USB Stick The Abstract USB stick is available for Healthcare Professionals to collect from the Novartis booths in the Exhibition Area (Booth D28 and E28, Hall 8) and for Non-Healthcare Professionals at the EADV Resource Centre - EADV App & Social Media booth which you will find in Hall 10. The official EADV Abstract USB Stick contains all of the abstracts that were accepted by the Scientific Reviewers, as well as those submitted by speakers and for industry sessions. Companies and participants may use the material for their personal use; however further copy or reproduction for sale or any other commercial purpose is strictly prohibited without prior permission from the EADV. The Abstract USB Stick has an ISBN (International Standard Book Number) and is therefore a document with clear identification and citable repository. Certificates and accreditation All registered participants will be able to download their certificates online based on their level of engagement: A Certificate of Attendance is available for all registered participants who have a valid registration badge A CME-CPD Certificate is available for all participants who actively attended scientific sessions, have their badge scanned and complete the online evaluation forms An e-poster Certificate is available for all leading e-poster authors A Workshop Certificate is available for all Workshop participants Certificate of Attendance The Certificate of Attendance is available both online and onsite. You can find it for online downloading directly on the EADV website at scientific/cme/download-cme-credits. Simply enter the and password used during the registration process OR the EADV member login details (if a member). Otherwise, it may also be printed directly onsite from the self-printing machines located in the Registration Area starting from Saturday morning until the end of the Congress. CME-CPD Certificate CME-CPD credits are important to keep track of your participation in accredited educational activities, keep you up-to-date on the latest research, and will enhance your professional level. Attending lectures will qualify you for CME- CPD credits: what you need to do is ensure your badge is scanned at the entrance of each session hall and then complete the speaker/ session evaluation forms, which are available on the website or on the Event App. Afterwards, CME-CPD certificates will be ready for downloading directly from eadv.org/scientific/cme/download-cme-credits. Access is enabled with the and password used during the registration process OR with the EADV member log-in details (if a member). Evaluation Forms Evaluation data is essential to our statistics and for the development of the scientific programme. The assessment of sessions and speakers is mandatory for participation in the CME-CPD programme. Evaluation process will be available until 10 November. After this date, certificates will remain available for download but no additional session evaluations are accepted. Please access the module either General Information 103

106 GENERAL INFORMATION 104

107 from the EADV website or from the CME-CPD Evaluation section on the EADV Events App. Code of Conduct The EADV events provide an ideal opportunity for clinicians and researchers to come together to learn about and discuss the latest advances in treatment and care. We expect all attendees to help us ensure a safe and positive conference experience for everyone and a high standard of professional conduct. Delegates are requested to uphold the policies and procedures set forth during the meetings. When an attendee, individually or collectively, purposefully and/or fraudulently circumvents the Academy s rules and ethical standards, the Academy views such conduct as serious violation that could eventually jeopardise attendance at the on-going and future meetings. The EADV is committed to maintaining an environment that encourages respect and dignity for each individual and prohibits harassment by a client, vendor, EADV member, non-member, or any other who may interact with the staff during their course of business. e-posters Abstracts selected for e-posters will be published as electronic posters during the Congress and will be available for viewing in the Interactive e-poster area which is located in Hall 9. In this area there will be space for reading, presenting and discussing e-posters. Oral e-poster sessions timetable: Friday, 11 October , , and Saturday, 12 October and Exhibition Area The Congress will host an Exhibition Area of sqm, located in Hall 8 of the Congress Centre. The Exhibition Area can be accessed from the Avenida (ground floor) and from Hall 10 through 2 connecting nuclei. Products, techniques and equipment will be displayed for exchange between industry partners and dermatology professionals participating in the event. Please note that the Exhibition Area is open to Healthcare Professionals (HCPs) and Industry Participants only, as prescription medical products will be advertised. Article 86 in the EU directive 2001/83/EC has introduced the prohibition of advertising and promoting prescription-only medicines to the general public. The following National Spanish laws, codes and regulations will be in full force and effect during the 28 th EADV Congress in Madrid. Therefore, access to the Exhibition Area, Satellite Symposia and Industry HUB sessions dealing with development, research or other related to prescription medicine will be restricted to Healthcare Professionals and Industry Participants only. Viewing Area 40 big screens are provided and configured exclusively to display the e-posters. The e-posters can be viewed sequentially by number, submission topic or searched individually by title, key word or author. The Exhibition Area will be open during the following hours: Thursday, 10 October Friday, 11 October Saturday, 12 October General Information e-poster area opening hours Wednesday, 9 October 09:00 17:30 Thursday, 10 October 08:30 16:30 Friday, 11 October 08:30 16:30 Saturday, 12 October 08:30 16:30 Presenting Area On the 3 full days during the Congress, 36 presenting authors will present their e-poster research in short pre-scheduled sessions. Please find more details about the Oral e-poster sessions online in the Scientific Programme under the following link: eadvmadrid2019.org/scientific/programme/ Help Desks and Onsite Facilities Accommodation Desk The accommodation desk to get details on accommodation is located in the lobby of the North Convention Centre, on the ground floor. Information Desk The information desk to get details on taxi transfers and the city of Madrid is located in the lobby of the North Convention Centre, on the ground floor. 105

108 GENERAL INFORMATION Lost & Found Please hand in all found items and ask for lost items at the IFEMA Exhibition Office/Exhibitor Care, which is located in the Avenida, on the ground floor, between Hall 6 and Hall 8. Catering Facilities Lunches and coffee breaks are NOT included in the registration fees. Meals and snacks can be purchased within the Congress venue during the opening hours in various catering areas. Interaction on Social Media You are invited to follow the EADV on the following social networks for updated news, to share experiences and practices. Join us to actively connect and interact with other professionals in the field. If you need help with the social media interactions, please visit the App and Social Media at the Resource Centre in Hall 10. Join the conversation using #EADV2019 Cloakroom The Cloakroom is located in the North Convention Centre on floor -1 and will be open during the following hours: Wednesday, 9 October Thursday, 10 October Friday, 11 October Saturday, 12 October Sunday, 13 October EADV.org com/company/ eadveurope com/eadv_/ Charge per garment: 1,65 EUR Charge per luggage item: 3,00 EUR First Aid Room and Emergency Numbers In case of need please visit the Medical Centre, located on the first floor between Halls 7 and 9. Access through the Avenida. Further emergency numbers are: (+34) Any emergency at IFEMA Universal European Emergency Service Number EADV Resource Centre The EADV Resource Centre is located in Hall 10 and is the information point for next events, membership queries, EADV courses, JEADV, CME credits and assistance for download and use of the App...and social interaction. You will also find an e-learning station to stay engaged with JEADV articles-based questionnaires and gain extra credits. EADV Resource Centre opening hours: Wednesday, 9 October 12:00 18:00 Thursday, 10 October 08:00-17:00 Friday, 11 October 08:00-17:00 Saturday, 12 October 08:00-17:00 Internet Access/Wi-Fi Free Wi-Fi access will be available in the common areas of the venue and in the session rooms. Please select the following network name to start your navigation: EADV by Bristol-Myers Squibb Mobile Phone Application (Events App) The EADV Events App will bring the 28 th EADV Congress to your smart phone or tablet. The application offers a tailor-made mobile overview of this scientific event. You will get instant access to the full scientific programme, abstracts, session surveys, industry sessions, exhibition booth locations and the latest news before, during and after the meeting! Interactions will be facilitated by the App, allowing you to send messages to other participants, exchange business cards and make personal appointments. A few days before the event you will receive further information via about how to download the App. For onsite support, please go to the App & Social Media booth at the Resource Centre in Hall

109 EADV App & Social Media booth For assistance with the EADV mobile App or social media, come and visit the EADV App & Social Media booth at the Resource Centre in Hall 10. We will be happy to assist you with the EADV mobile App and social media questions. In addition, Non-HCPs will be able to collect their Abstract USB Stick here. Mobile Phones, Photography, Audio and Video Recording The use of mobile phones as well as audio and video recording devices is strictly prohibited within the scientific session rooms. Please ensure that you have your mobile phone switched off when attending a session. Photography is also not permitted. Press Information for Journalists and Media Representatives Journalists who are working for and representing recognised news organisations are encouraged to attend the meeting as Press. The registration under the Press/ Media Representative category is granted only to journalists or media representatives in possession of: a valid press card or an appropriate letter of assignment two recent published articles (dermatology or venereology-related, or referring to a previous EADV event) a signed copy of the EADV Embargo Policy (downloadable online on the EADV Madrid website) the EADV Registration Form for Press/Media Representatives duly filled Official Language English is the official language of the Congress. No simultaneous translation will be provided. Patient Society Village Don t miss the opportunity to visit the patient organisations area and enjoy an afternoon coffee with them on Thursday 10 October from 15.15, while you exchange useful information on patient needs and common interests. Participating organisations will promote their resources and activities to the professional community of dermatologists and venereologists, stimulate interactions and encourage partnership programme to optimise patient care. The Patient Society Village will take place on Thursday 10 and Friday 11 October in Hall 9. All registered Press members must adhere to the EADV Press & Media Guidelines, Embargo Policy and Filming/Photography/Recording Policy for Professionals. Registered Press can access all scientific sessions, they have full access the Exhibition area, Satellite Symposia and Industry HUB sessions. For further information about registration, the EADV Press and Media Guidelines and the Embargo Policy, please contact Mrs. Kimberley Zimmermann via kimberley.zimmermann@eadv.org. Press Conference The Press Conference will take place in room A9.08 on the first floor above Hall 9. Please check for further announcements regarding the Press Conference. Press Room A fully-equipped Press Room (Room Neptuno) located on the second floor of the North Convention Center, is available for registered journalists and medical writers during the following opening hours: General Information Wednesday, 9 October Thursday, 10 October Friday, 11 October Saturday, 12 October Sunday, 13 October

110 GENERAL INFORMATION 108

111 Registration On-site registration counters are open during the entire congress and within the official registration opening hours. For onsite registration, only payment by credit card (Visa/MasterCard/Maestro) are accepted. A registration is only valid if the full payment of the congress fee has been received. Residents (<35 years old), Students (<35 years old) and Nurses are requested to submit a valid Proof of Status to validate their registration. The Registration Desks are open during the following times: Wednesday, 9 October Thursday, 10 October Friday, 11 October Saturday, 12 October Sunday, 13 October The Badge Exhibitor Desks are open during the following times: Wednesday, 9 October Thursday, 10 October Friday, 11 October Saturday, 12 October The Full Regular Congress Ticket includes: Name badge Transportation pass Admission to the Subspecialty Society Meetings Admission to the EADV Scientific Sessions Admission to the Exhibition Area to Healthcare Professionals (HCPs) and Industry Participants only Admission to Satellite Symposia and Industry Hubs Sessions presenting data or research of prescription medicines to Healthcare Professionals (HCPs) and Industry Participants only Possibility to collect ECMEC credits on participation in the EADV Scientific Sessions Abstract USB Stick Attendance/e-Poster/CME-CPD Certificates Admission to the Networking Symposium (Wednesday, 9 October 2019) Important Notes Participants submitting and paying their registration incorrectly are not entitled to reimbursement. For example, participants registering as Non-Members and (at a later stage) becoming EADV Members will not receive a reimbursement of the difference between the two fees. Nor if, despite being active EADV Members, they create a new profile and register themselves as Non-Members. This will be applied to any registration processed and finalised incorrectly. Refunds and cancellations requests are not accepted or processed on-site. Refund requests can be sent to the EADV Registration Department no later than 2 months after the closure of the event. Requests submitted after this period will not be considered. Refunds, if due, will be issued within 2 months from the receipt of the request. A EUR 50 cancellation fee per ticket cancelled is applicable to all refunds. Any specific requests concerning Group registration will not be discussed on-site during the event for any purpose. Group registrations on-site are not possible. Participant type change requests are not considered on-site. This rule also applies to Third-Party/Group registrations processed incorrectly. Registration Terms and Conditions are available at register/registration-policies/. Registration Name Badge Each participant will receive a name badge on arrival to the Registration Area. The name badge is the official Congress identification document and should be worn at all times in order to gain entry into the conference centre. The name badge is your ticket for booked activities and sessions. Admission to other areas of the conference centre is not permitted without badge identification. For the reprinting of forgotten/lost badges EUR 80 will be charged. A fee of EUR 20 is applicable for every badge re-print due to a change of status from Non-Healthcare Professional to Healthcare Professional (and vice versa). Special Note: The badge includes a QR code containing your full address and . It is the participant s decision to disclose these details to the exhibitors with a scanner. General Information 109

112 GENERAL INFORMATION Participants are asked to check the registration documents for completeness immediately after receiving them at the Registration Desk. Scientific Sessions Sessions of different formats will cover the important fields of dermatology and venereology. Subjects will be treated with different approaches and from different perspectives. The following session types will be scheduled throughout the duration of the Congress and are available to all registered participants: Plenary Lectures, Spotlights, Review and Updates, Expert Forum, Training and Educational Forum, Free Communications, Oral e-poster sessions and much more The scientific programme has been organised on full or half-day tracks; each track has a specific topic and a structured programme. Three separate levels are offered: one junior track for Trainees and Residents, another for Board-Certified Dermatologists and Venereologists and a third one for Expert Specialists. Entry will be made on a first-come, first-served basis. Session Halls All Scientific Session rooms for the 28 th EADV Congress are located within the IFEMA Feria de Madrid. Please refer to the floor plan for orientation. Seating is regulated on a first-come, first-served basis. We recommend you go to the session room well in advance of the session to ensure your place. Due to safety regulations, the organisers will close the access to the session if all seats are occupied. Delegates are not permitted to stand in the aisles of the session rooms. Speaker Preview Room All session rooms are equipped with LCD projection for PowerPoint presentation. Speakers are asked to hand in their presentation at least 3 hours before the lecture if not already uploaded earlier. The Speaker Preview room is located on the first floor of the venue, between Hall 7 and Hall 9. Speakers with a presentation during the first time slot of the morning are kindly asked to hand in their PowerPoint presentation the day before. You will also be asked to fill in a webcasting permission form during this process. Opening hours of the Speaker Preview Room are: Wednesday, 9 October 08:00-17:30 Thursday, 10 October 08:00-17:00 Friday, 11 October 08:00-17:00 Saturday, 12 October 08:00-17:00 Sunday, 13 October 08: All presentations must be in English. Speakers should also verify in the Final Programme that the name of the room and time of session have not changed. Transportation Tickets Attendees with a Full Congress ticket and Exhibitors will be able to collect a Transportation Pass from the Registration Area located on the ground floor of the North Convention Centre, at no additional cost. The Transportation Pass has a validity of 5 days, starting from the first day of use, and will allow delegates to travel within Zone A on the Madrid Metro (including the airport), EMT buses (excluding the Airport Express Line), Renfe Cercaníans trains (zones 0 & A) and on Metro Ligero line (ML1 zone). The IFEMA Congress Centre is only a 10-minute drive from the Madrid Airport and 15 km from the city centre. It can easily be reached by Metro (Line 8), EMT buses (Line 112 & Line 122) and Intercity bus (Line 828). You need to stop at: Feria de Madrid. Use of Private Data The data made available through the Registration Portal for Congresses and Symposia are gathered and treated by the EADV in compliance with the Swiss regulation on data protection and the General Data Protection Regulation. We advise you to read full EADV Privacy Policy on privacy. Transferring the data to the holder of the stand During the EADV Congress you have the right to transfer the data collected by EADV to another controller ( the holder of the stand, Exhibitor ). It might happen through scanning a badge, SpotMe QR code or other means. 110

113 Each participant shall consider that by accepting any scanning of the badge, SpotMe QR code or other means at any stand at the Congress or Symposium, the participant gives authorization to the EADV to transfer the data of the participant to the Exhibitor. The EADV is obliged to make this process possible but does not take any responsibility for what happens with the data after it is being transferred to Exhibitor. We advise to make sure that Exhibitor presents Privacy Policy and read it carefully. It might occur that purposes described by the Exhibitor might include the promotion of pharmaceutical products and similar. Transfer of the data from the EADV to Exhibitor does not mean the removal of original data from EADV. If you wish the data to be removed or have any request or questions, please contact us at any time by writing to Third-party registration The EADV does not officially support or authorize any third-party organization that creates registrations for individuals or groups. We strongly advise to register accordingly to official fees and only on EADV s official websites. Liability Disclaimer The Organisers cannot be held liable for any hindrance or disruption to the Congress arising from political, social or economic events or any other unforeseen incidents beyond their control. The Organisers will accept no liability for any personal injuries sustained or for loss or damage to property belonging to Congress participants, either during or as a result of the Congress or during all tours and events. Registration of a participant entails acceptance of these conditions. General Information 111

114 112

115 NETWORKING SYMPOSIUM DATE: Wednesday, 9 October 2019 START TIME: 17:45 LOCATION: Room Dalí (Hall 10) Please join us in Room Dalí (Hall 10), on Wednesday 9 October, at 17:45 to celebrate the start of the 28 th EADV Congress and participate in the first plenary lecture of this year s edition. The EADV s Opening Plenary Lecture will be accompanied by the welcome speech of the EADV President, Prof. Carle Paul, who will officially inaugurate the congress. Following his words, Dr. Ignacio Hernández Medrano, neurologist at the Ramón y Cajal Hospital, will present an intriguing lecture on Artificial intelligence and medicine: The secrets for a good marriage. The lecture will focus on the meaning of Big Data, machine learning, neural networks and artificial intelligence, as well as on the state of art of artificial intelligence in healthcare and the transition towards algorithmic based healthcare. Afterwards, a cocktail in the foyer outside of Hall 10 will provide the perfect opportunity to network in a friendly and informal atmosphere. Don t miss the opportunity to make new contacts and reconnect with old colleagues in a relaxed but festive atmosphere! General Information 113

116 GENERAL INFORMATION IMPORTANT INFORMATION ON PHARMACEUTICAL ADVERTISING Access to the Exhibition Area, Satellite Symposia and Industry HUB sessions Regulations Related to Industry Activities Article 86 in the EU directive 2001/83/EC lists the prohibition of advertising and promotion of prescription-only medicines to the general public. These legal provisions are included in the country codes of conduct and guidelines for the promotion of medicines and we therefore inform you that local and national Spanish laws, codes and regulations will be in full force and effect during the 28th EADV Congress in Madrid. Association of the Pharmaceutical Industry in Spain (FARMAINDUSTRIA) sarfi/home.html European Federation of Pharmaceutical Industries and Associations (EFPIA) abstract/js22330en/ European Accreditation Council for CME (EACCME) cme-cpd/eaccme International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ifpma-code-of-practice/ These codes prohibit the advertising of prescription-only medicines to the general public, therefore only Healthcare Professionals may be exposed to advertising for prescriptiononly products in Madrid. The Association of the Pharmaceutical Industry in Spain (FARMAINDUSTRIA) defines Healthcare Professionals as: Healthcare Professionals: Any member of the medical, dental, pharmaceutical, nursing or podiatric profession, any other person legally considered as such, or any other person who, in exercising their profession, may perform or participate in the prescription, purchase, supply, dispensation or administration of medicinal products for human use. As a multidisciplinary audience will be attending the Madrid Congress, the EADV will assign different badges to Healthcare Professionals (HCPs) and Non-Healthcare Professionals (NON-HCPs) to ensure compliance with the above regulations. During the registration process, you will be asked to indicate whether you are a Healthcare Professional or not. Depending on the status you have indicated on your registration form, you will receive either a Healthcare Professional (HCP) or Non-Healthcare Professional (NON-HCPs) badge on your arrival to the venue. Access to any industry sessions where data or research of prescription medicines is presented will be limited exclusively to Healthcare Professionals (HCPs) and Industry Participants only. 114

117 115 General Information

118 CONGRESS CENTRE FLOOR PLANS GENERAL FLOOR PLAN North Convention Centre (NCC) North Entrance Registration Area Rooms N Press Room Hall 9 Session Room Picasso Session Room Sorolla e-poster Area & Oral e-poster Presentation Room Patient Society Village Meeting Rooms 9 Meeting Rooms 10 Session Room Dalí Session Room Coello Session Room Velázquez Overflow Area EADV Resource Centre Hall 10 Speaker Preview Room Room Retiro 7 Exhibition Area Hall 8 5 Meeting Rooms 5 Avenida Meeting Rooms Meeting Rooms South Entrance 116

119 ROOMS NORTH CONVENTION CENTRE (NCC) Session Room N Session Room N Session Room N Session Room N Workshops Session Room N Workshops North Convention Centre 1 st floor Session Room N103 Session Room N104 Session Room N Session Room N Session Room N Floor Plans 117

120 FLOORS PLANS HALL 9 Seating Area Skin Vision Oral e-poster Presentation Room e-poster Area Picasso Session Room Industry Lounges & Meeting Rooms Sorolla Session Room Patient Society Village Entrance /Exit Avenida HALL 10 Coello Session Room Overflow Area Dali Session Room Entrance /Exit Avenida Seating Area EADV Resource Centre Velázquez Session Room To Hall 8 Exhibition Area To Hall 8 118

121 119 Floor Plans

122 EXHIBITOR LIST Exhibitor Booth Nr. Exhibitor Booth Nr. 3Gen, Inc. G60 DermapenWorld G50 AbbVie D16 Dermofarm G43 AbbVie E22 DERUNGS LICHT AG - MEDICAL LIGHTING C50 ACROSS CO.,LTD G30 Dr Irena Eris Cosmetic Laboratories B64 A.D.O. Medical Products A66 Dr. Hönle Medizintechnik GmbH A40 Adamo S.r.l.-Horus G37 DUBAI DERMA 2020 G36 Adtec Healthcare A42 Eli Lilly and Company C4 Advalight H41 Eli Lilly and Company E2 Aerolase G17 Euromi SA E57 Aezian G20 Farma Bio Technology B16 Alliance Pharmaceuticals Limited B37 FibroTx B18 Almirall E48 FotoFinder Systems GmbH G56 Alta Care Laboratoires A10 FOTONA C10 Altruist B3 Fresenius Kabi A6 BeautyTECH C24 Galderma E51 Beiersdorf AG B30 German Medical Engineering GmbH B20 Beijing Syntech Laser Co.,Ltd. A37 GTG WELLNESS H29 BIODERMA NAOS D64 H&O Equipments nv F16 bioskin GmbH G10 Hans Biomed, S.L. - Skymedic G27 BODERM S.A. A39 Healux Co., Ltd G34 Boehringer Ingelheim International GmbH B8 HEINE Optotechnik GmbH & Co.KG A44 Brera Medical Technologies C17 Helsinn Healthcare G26 Bristol-Myers Squibb D72 HIRONIC Co., Ltd. G54 Brymill Cryogenic Systems A62 Hurev Co., Ltd G68 BTL INDUSTRIES C11 IDCP MedTech G7 Candela B22 ILLUCO Co., Ltd C2 Canfield Scientific GmbH C38 ILOODA C22 Canon Medical H53 INMODE LTD C16 CANTABRIA LABS D50 INNODERM H54 Caregen G46 International Society of Dermatology A35 CATALYSIS, S. L. H31 IQVIA Biotech G63 Celgene Corporation D39 ISISPHARMA C65 CeraVe E50 Iskra Medical d.o.o. B4 CHUNGWOO G11 Janssen Pharmaceutica NV B44 CLARTEIS B14 Janssen Pharmaceutica NV C26 COCOON MEDICAL A18 Japan Bio Products Co., Ltd. G45 Cortex Technology ApS A21 JETT B68 Cynosure B29 KERNEL MEDICAL EQUIPMENT CO.LTD F18 Daavlin Company C58 KORUST CO., LTD G9 DANA B65 KREUSSLER PHARMA G24 DEKA M.E.L.A. B10 La Roche-Posay E52 Derm101 F59 LABORATOIRE DERMATOLOGIQUE ACM D49 Dermaceutic B73 Laboratoire SVR D58 120

123 Exhibitor Booth Nr. Exhibitor Booth Nr. Laboratoires Bailleul International E64 REFORM Skincare Inc. A34 LABORATOIRES DERMEDEN F56 Regen Lab D10 Laboratoires Pierre Fabre Dermo-Cosmetique A56 Regenera Activa SL H35 LABORATORIO GENOVE E61 RENAISSANCE C15 LASEROPTEK A14 Saalmann medical GmbH & Co. KG F14 LASERVISION GmbH & Co. KG A32 Sanofi Genzyme and Regeneron E9 LC Cell USA G32 Sanofi Genzyme and Regeneron E10 Leo Pharma A/S A48 SESDERMA D59 Leo Pharma A/S A50 SHENB CO., LTD. A30 Leo Pharma A/S A54 Siyemi Learning G44 LETIPharma B59 SKIN TECH PHARMA GROUP SL A51 Lusiné Bruxelles G35 SNJ Co., Ltd B43 MartiDerm C63 Speclipse, Inc. B2 MAVIG GmbH VivaScope Systems C40 Symbio C18 medac GmbH C48 Synteract D9 MEDICI MEDICAL SRL E68 TAVTECH LTD B13 Medicines Evaluation Unit F10 TFS International AB G5 Medscape Education G42 The HydraFacial Company G62 MESOESTETIC PHARMA GROUP G23 TSZEN B7 NeoStrata Company, Inc. G14 UCB Biopharma sprl A28 NEWPONG CO., LTD. G28 Venus Concept E58 NOREVA G61 VICHY LABORATOIRES E49 Novartis Pharma AG D28 Viol Co., Ltd G8 Novartis Pharma AG E28 Wiley A4 NOVAVISION GROUP S.P.A.u.s. B15 Wisepress Ltd A1 Novoxel Ltd G38 WON TECH CO., LTD. F2 OCULO-PLASTIK, INC. A49 ZERO GRAVITY SKIN G31 Omnilux C59 Zimmer MedizinSysteme GmbH C12 PellePharm, Inc G40 Peninsula Medical G6 Pfizer E34 Pfizer E39 PRIME JOURNAL D62 proinnovera GmbH A46 Protect-Laserschutz GmbH B11 PROTEOS BIOTECH H11 Q-Skin Science / AK International G29 QuantifiCare Ra Medical Systems Reference Medical Productos y Servicios, S.L. F5 F12 H7 Exhibitors and Sponsors For the updated Exhibitor list and Exhibition floorplan please consult the EADV Mobile App or the Interactive Exhibition Floorplan available on the Congress website at floorplan/ 121

124 ACKNOWLEDGMENTS The European Academy of Dermatology and Venereology honours its partners who support the profession and specialty of dermatology and venereology. Because of their generosity in supporting 2019 programmes and services, the Academy is able to further its educational goals and mission to serve our members, their patients and the public. SPONSOR OF THE ABSTRACT USB STICK AND LANYARDS SPONSOR OF THE INTERACTIVE EPOSTER AREA AND EADV HEALTHCARE PROVIDER SCHOLARSHIP SPONSOR OF THE POCKET PROGRAMME AND PROGRAMME AT A GLANCE WALL SPONSOR OF THE SPEAKER PREVIEW ROOM AND SEATING AREA HALL 8 SPONSOR OF THE WIFI CONTRIBUTION TO SHIPMENT AND LOGISTICS PROMOTION AND SUPPORT, WELCOME SIGNAGE AND DEDICATED AIRPORT DESK 122

125 SPONSORS OF THE ADVANCED ALLERGOLOGY WORKSHOP SPONSOR OF THE BASIC SURGERY WORKSHOP SPONSOR OF THE PHLEBOLOGY WORKSHOP SPONSORS OF HE WOUND HEALING WORKSHOP Exhibitors and Sponsors SPONSOR OF THE ULTRASOUND WORKSHOP 123

126 Are you considering a clinical trial for your patients? BMS is conducting the POETYK clinical study to investigate a first-of-its-kind, investigational, oral non-biologic medication. Visit booth D72 to learn more about our clinical program or visit Clinicaltrials.gov (NCT , NCT , NCT ) Access to the Exhibition Area is restricted to Healthcare Professionals only EADV Congress WiFi sponsored by: Network name: EADV by Bristol-Myers Squibb No password required 124 IMSEP /19

127 CONTRIBUTOR INDEX Abd Elfattah Afify, Ahmed Abdel Malek, Medhat Abe, Riichiro Aberer, Werner Adatto, Maurice A. Aerts, Olivier Agner, Tove Agnoletti, Arianna Fay Ajaz, Mazhar Alavi, Afsaneh Alcalay, Joseph Alegre Sánchez, Adrián Alessandrini, Aurora Alessandrini, Aurora Maria Alfageme, Fernando Alissa, Ahmed Al-Mutairi, Nawaf Alomar, Agustín Alpsoy, Erkan Amesz, Stella Amici, Jean-Michel Amruthalingam, Ludovic Anadolu, Rana Andersen, Klaus Ejner André, Josette André, Pierre Antiga, Emiliano Aoki, Valeria Apalla, Zoe Aractingi, Selim Araviiskaia, Elena Ardigo, Marco Arenberger, Petr Arenbergerova, Monika Argenziano, Giuseppe Arifov, Said Kasim Armstrong, April Ascher, Benjamin SS14.08 SS11.01 D2T13.4C D2T06.2A D4T01.1B, D4T04.2D D3T04.3B D3T04.4B D2T13.3E D3T06.1D FC08.03, SAT24.05, SS16.06 D2T02.4A SS15.07 SS20.05 D3T11.1B D2T07.2A, SS16.07 SS11.08, SS11.09 D3T11.2C D2T06.1D D2T11.4D D2T13.1D D2T02.3A FC06.05 D1T10.3C D3T02.3C D2T12.3B D4T02.1B D3T03.4A D3T09.1B D2T01.1H, SS21.05 D1T06.1A D2T11.2A D2T07.1C D2T01.3B D2T01.2C D1T02.1A FC08.02 SAT04.01, SAT04.03, SAT04.07 D4T02.2A Audience, Faculty and HUB Augustin, Matthias Bachelez, Hervé Badawi, Ashraf Bagot, Martine Bahadoran, Philippe Bai, Bingxue Balakirski, Galina Baltas, Eszter Baran, Robert Barbarot, Sébastien Barco, Didac Bardhi, Brunilda Barker, Jonathan Barreiro Capurro, Alicia Baselga, Eulalia Basset-Seguin, Nicole Bata-Csorgo, Zsuzsanna Bataille, Veronique Bauer, Andrea Bauer, Johann Bechara, Falk G. Beeckman, Dimitri Beele, Hilde Behrens, Frank Beissert, Stefan Bekkenk, Marcel Bellet, Jane Beltraminelli, Helmut Benedetto, Anthony Berardesca, Enzo Berman, Brian Bernabo, Jean-Luc Bernardez-Guerra, Claudia Bernigaud, Charlotte Bertelsen, Trine Bettoli, Vincenzo D3T08.3A, FC01.09, SAT01.01, SAT01.02, SAT16.01, SAT16.02 D3T01.2B D4T01.2A, D4T04.1A, SS03.15 FC03.04 D2T07.1A, D2T13.3A SS07.19 D3T08.1A D2T06.1B D1T03.4A, SS20.11 SS17.12 D4T04.2B SS19.08 D1T04.3A, SAT23.01, SAT23.05 SS04.01 D3T05.4D D3T06.3D D3T10.3B D1T10.4B, D3T07.2D D3T04.4D D2T04.1D SAT24.04 D3T13.02C D3T13.03C FC03.01 D2T11.3B D1T03.3B, D3T11.4C SS20.14 D2T09.4D D4T03.2A D3T02.3A FC06.03 D3T08.4B D3T06.4A D2T09.1A FC01.07 D1T09.3C Bewley, Anthony Beylot-Barry, Marie Bieber, Thomas D2T13.3D, SS22.15 D1T10.2D D1T01.2A Biedermann, Tilo D1T01.1B, D3T07.2B Bissonnette, Robert Bjerring, Peter Blauvelt, Andrew Blume-Peytavi, Ulrike Bodemer, Christine Boehncke, Wolf-Henning Böhm, Markus Boixeda, Pablo Boniface, Katia Boon, Laurence Boralevi, Franck Borelli, Claudia Borradori, Luca Braathen, Lasse Brancaccio, Gabriella Brasileiro, Ana Brinca, Ana Brouwer, Marijke Bruckner-Tuderman, Leena K. Brueggen, Marie-Charlotte Buchvald, Dusan Bukvic Mokos, Zrinka Bundy, Christine Burden, David Burg, Günter Buse, Anna Bygum, Anette Bylaite-Bucinskiene, Matilda Bylaite-Bucinskiene, Matilda Cabete, Joana Calzavara-Pinton, Piergiacomo Caproni, Marzia Cardoso, Jose Carlos SAT23.04 D2T09.2B FC04.06, FC05.06 D2T04.4B, SAT10.02 D3T09.3C D2T11.1C, SAT03.03 D1T03.3D D4T04.1B, HUB , SS14.06 D2T10.3B D3T05.4B D1T02.2D D4T03.1A, D4T04.3A D3T03.3A SS21.01 SS04.11 D3T03.2B D2T10.1D D2T06.1A D1T01.1G D3T09.4A D1T01.2B D2T04.3B D2T13.1F SAT23.02 D2T09.3A D3T13.03A D3T07.3C D1T10.1A SS18.09 D1T04.3C D3T08.3B D3T03.2A D2T05.1B 125 Contributor Index

128 CONTRIBUTOR INDEX Carrascosa, Jose-Manuel Carrera, Cristina Cartier, Hugues Catala Gonzalo, Alba Cerroni, Lorenzo Chaidemenos, Georgios Chang, Yuan Chen, Ling Chernyshov, Pavel D1T01.3A, HUB , HUB , HUB 2.3.1, HUB , HUB , HUB , SAT 12.01, SAT D2T05.4C D4T02.2B, SS03.10, SS14.07 D2T06.3A, D3T10.2C D2T02.1B D3T10.4D SS07.13 SS07.02 SS17.02, SS22.07 de Berker, David De Bruin-Weller, Marjolein De Carlo, Giuseppe de Carvalho, Nathalie De Castro Pinho, André de Cuyper, Christa De Haes, Petra de Jong, Elke De Lacerda, Davi de Rie, Menno Alexander de Roos, Kees-Peter De Schepper, Sofie De Vries, Henry John Christiaan Deleuran, Mette Sondergaard Deps, Patricia SS20.03 FC07.05, SAT16.04, SS17.04, SS17.06 HUB , HUB D2T07.3B D2T08.2C D3T04.4D D3T09.2B D3T10.4B D4T02.2C D3T10.3D D3T08.4C D2T11.3A D1T05.1B D1T01.3B D1T13.4B El Sayed, Mahira El Sharouni, Mary-Ann Elkasah, Fathi EL-Samahy, May Eming, Ruediger Emmert, Steffen Epstein, Ervin Errichetti, Enzo Ettler, Karel Ezzedine, Khaled Fabbrocini, Gabriella Fabri, Mario Fakih, Nabil Fang, Wei Fargnoli, Maria Concetta Farnetani, Francesca Fassihi, Hiva Fernandez Canga, Paula SS11.12 FC05.08 SS11.04 SS19.01 D2T11.4C SS09.08 D3T06.1C D1T02.4A, SS04.13 D2T03.4A D1T03.3C D1T08.1C, SS19.03 D3T10.1B HUB SS07.10 D2T01.2B D3T06.2C SS09.02, SS09.03 SS15.04 Chosidow, Olivier D1T07.4B Descamps, Vincent D2T08.3A Fernandez Peñas, Pablo D1T07.1D Christen-Zäch, Stephanie Church, Martin Cogrel, Olivier D2T04.2C D2T03.2A D2T02.4C, SS15.09 Dessinioti, Clio Dhaoui, Mohamed Abderraouf Di Cesare, Antonella D1T04.1D SS11.07 SS16.02 Fernández-Figueras, Maria Teresa Ferrandiz-Pulido, Carla Fialova, Alena D2T06.2C D1T10.1C D3T07.1B Conde, Elena D2T06.4A Di Chiacchio, Nilton SS20.10 Fida, Monika SS19.07 Conejo-Mir, Julian SS15.13 Di Chiacchio, Nilton Gioia SS20.08 Filipe, Paulo FC04.01 Conforti, Claudio SS04.08 Didona, Dario FC06.09 Fitri, Eyleny Meisyah FC04.09 Conrad, Curdin Cork, Michael J. D3T01.2A D1T09.1D, HUB Didona, Dario Dierickx, Christine D1T09.2B D2T09.2A, D4T01.1A Flohr, Carsten Fluhr, Joachim W. D1T01.3D, SS17.07 D3T02.3D Corneli, Paola SS04.10 Dikrama, Petra D3T11.2A Fölster-Holst, Regina D3T11.3C Correia, Miguel D2T12.2D Dini, Valentina D3T13.02B Forsea, Ana-Maria D1T02.2A Cosgarea, Rodica Maria Costanzo, Antonio Coutinho, Maria Inês Crepy, Marie-Noëlle Creusot, Muriel Cribier, Bernard Csoma, Zsanett Renáta Cunha, Daniela Cusini, Marco Cybulska, Beata Czarnecka-Operacz, Magdalena Dahmen, Robert Artur D Alessio, Patrizia Damiani, Giovanni D2T01.3A D3T01.3D D1T10.4C D1T11.2D, D3T04.4A SS14.11 D2T02.2B, PLB.01 D2T04.2D D2T12.1C D1T07.3A SS03.19 D1T02.2C D2T10.1A D4T04.3D FC08.07 Dirschka, Thomas Dobrosavljevic, Danijela Dolenc Voljc, Mateja Dompmartin-Blanchere, Anne Dréno, Brigitte Drerup, Katharina Du Thanh, Aurelie Dummer, Reinhard Dupin, Nicolas Dutz, Jan Egeberg, Alexander Eigentler, Thomas D3T06.2B, SS21.06 D3T07.1A D2T08.2D D3T05.4C D1T04.1A FC07.01 D2T03.2B SAT09.01, SAT09.03 D1T05.2C D1T07.1C FC03.09, FC04.05, SAT01.03 D1T10.4D, D2T01.3C Forton, Fabienne Fostini, Anna Chiara Fouéré, Sebastien Fraitag, Sylvie Franca, Katlein Franke, Viola Fransen, Frederike Fritz, Klaus Fuller, Lucinda Claire Funk, Jürgen Gaastra, Menno Gajic-Veljic, Mirjana Galadari, Hassan Gandini, Sara Gao, Lin D1T06.4A D2T08.1C D3T05.2B D2T12.4D SS03.03 D3T08.1G SS14.04 D4T01.1C D1T07.3B D1T13.3A D1T07.4C, D1T13.3B D2T11.3C D2T04.3A SS18.11 FC

129 Garbe, Claus Garcia Castro, Adriana Garcia-Bustinduy, Marta Garcovich, Simone Garrido, Pedro Miguel Garzorz-Stark, Natalie Gassenmaier, Maximilian Gaudenzio, Nicolas Geiges, Michael Lukas Gelfand, Joel M. Gellen, Emese Gelmetti, Carlo Genedy, Rasha Ghannam, Sahar Gharib, Khaled Gho, Conradus Ghosal Giamarellos-Bourboulis, Evangelos Giavedoni, Priscila Gieler, Uwe Gilaberte, Yolanda Gilaberte Calzada, Yolanda Gilliet, Michel Gimenez-Arnau, Ana Gisondi, Paolo Gkalpakiotis, Spyridon Gkini, Maria-Angeliki Glaser, Dee Anna Gniadecki, Robert Goebeler, Matthias Goh, Chee-Leok Gonçalo, Margarida González Rodriguez, Salvador Gooderham, Melinda Goossens, Ann Gordon, Kenneth B. Gottlieb, Alice B. D3T09.3A, SS18.01 D2T10.4B SS22.03 SS16.01 FC05.09 D2T09.4C D1T10.3D D3T08.2A D1T13.4D SAT21.02 D1T05.2B D1T13.4C, SS17.03 D4T02.3C D4T03.1D FC05.02, SS11.03 D2T05.2D SS16.09 D2T07.2B D3T04.1C SS18.10, SS21.07 D3T02.1D, SS12.04 D1T01.1A D2T01.1C, D2T03.2C D2T11.1B D2T05.2C SS22.11 SS08.02, SS08.06, SS08.07, SS08.08, SS08.09, SS08.10, SS08.11 D2T03.1D D3T09.4D D1T03.2B D1T07.2B, D2T01.1G D2T03.4D D1T06.4B, SAT04.04 D1T11.2B SAT04.02, SAT21.01, SAT21.04, SAT21.05 FC02.05 Gout, Uliana Gouveia, Carolina Gracia-Cazaña, Tamara Grant-Kells, Jane Grattan, Clive Griffiths, Christopher Grimalt, Ramon Grimstad, Øystein Grob, Jean Jacques Gualdi, Giulio Gunaric, Anita Gutermuth, Jan Guttman, Emma Gutzmer, Ralf Gyulai, Rolland Hadj-Rabia, Smaïl Haebich, Geraldine Haedersdal, Merete Hafner, Jürg Halioua, Bruno Hamann, Carsten Hamm, Henning Haneke, Eckart Havryliuk, Oleksandra Hay, Roderick James Hayran, Yildiz Hegyi, Juraj Heidemeyer, Kristine Heller-Vitouch, Claudia Hendriks, Iris Heratizadeh, Annice Hernandez, Pablo Hernández Medrano, Ignacio Hernandez-Martin, Angela Herranz, Pedro Herzinger, Thomas Hijnen, Dirk Jan D4T03.1B, D4T03.3A D1T02.4C, D2T04.2A D3T06.1A D2T13.4B D1T11.4B D1T09.2D, D3T08.2B, SAT 12.03, SS12.01 D2T05.2B D1T04.3B D2T01.2D, SAT09.04 D2T05.4B D3T06.3C D1T11.1C SAT19.03 SAT09.02 D1T09.1A, D3T07.1D SS12.02 FC03.08 D1T08.1D, D4T01.2D D1T08.2C FC02.04 D1T06.2D D1T03.1C D2T02.3B SS22.10 D1T07.2C FC08.08 D3T05.2C D3T07.4B D1T05.4D D3T05.2A SS17.15 D1T05.1A PLNS D2T04.1B HUB D2T01.1F SS17.11 Hill, Nicola SAT 18.01, SAT 18.04, SAT Hodak, Emmilia Hoekzema, Rick Hoetzenecker, Wolfram SAT11.04 D2T11.2D D3T05.3B Hohl, Daniel Holm, Jesper Grønlund Horvath, Barbara Hristakieva, Evgenyia Huang, Po-Han Hun Suh, Dae Ibbotson, Sally Helen Igali, Laszlo Ikizoglu, Guliz Ingram, John R. Ioannides, Dimitrios Iorizzo, Matilde Ipenburg, Norbertus Anton Irvine, Alan Isoherranen, Kirsi Iversen, Lars Jacobs, Leonie Jafferany, Mohammad Janier, Michel Jankowski, Marek Jemec, Gregor B.E. Jiang, Xian John, Swen Malte Joly, Pascal Jurakic Toncic, Ruzica Just, Ulrike Kaikati, Jerome Kajaia, Albina Kandolf-Sekulovic, Lidija Kang, XiaoJing Kaplan, David L. Karls, Raimonds Kárpáti, Sarolta Katsambas, Andreas Kaufmann, Roland Kaya, Gürkan Kaya, Gürkan Kazandjieva, Jana Kemény, Lajos D2T04.1A FC07.04 D2T11.4B, HUB SS16.05 D4T03.3B D1T04.1C, D3T02.4C D2T03.3D, SS12.03 D2T07.4D D1T06.4C D2T13.4D D3T10.1C SS20.13 FC05.07 SAT19.02 D1T08.2A D3T01.2C, HUB , HUB , SAT13.02 D3T02.1C SS22.02 D3T10.2D D1T10.1D D3T09.2C, SAT04.05 SS07.08 D3T04.4C, D3T13.01B D1T09.2A, HUB , HUB SS04.04 D2T09.1C FC08.01 SS03.16, SS03.17 D2T10.4A SS07.04 FC04.04 D3T05.3A D2T11.4A D4T03.2C, SS03.01 D2T05.4D D2T12.4A SS13.02, SS13.05 D2T06.3B D1T09.3D 127 Contributor Index

130 CONTRIBUTOR INDEX Kemperman, Patrick Maurice Jean Henri Kennedy, Cornelis Keshava Murthy, Vinay Khairutdinov, Vladislav Khan, Corniche Khang-Tran, Hau Kiellberg Larsen, Helle Kılıç Sayar, Sila King, Kacie Kirby, Brian D2T13.1L, D3T04.2D D3T07.3 D3T09.1A FC01.05 FC06.07 D3T07.3A D1T05.2D FC05.05 D2T13.1B D3T01.3A, SAT02.04 Kircik, Leon HUB , HUB , HUB , HUB , HUB , HUB , HUB , HUB , HUB , HUB , HUB , HUB Kirsten, Natalie Kittler, Harald Kluger, Nicolas Kocatürk Göncü, Emek Kockaert, Michael Kofler, Lukas Koh, Mark Kohl, Peter Karl Kolivras, Athanassios Kovacs, Maximilian Krause, Karoline Krekels, Gertruud Kreuter, Alexander Kreyden, Oliver Kridin, Khalaf Kristensen, Johannes Krueger, James Krunic, Aleksandar Krutmann, Jean Kubba, Raj Kukutsch, Nicole Ariana Kupfer, Jörg Laffitte, Emmanuel FC05.01, FC08.04 D2T07.4B D3T07.4A D1T11.4C D2T06.4B D3T06.4C D1T06.2B D1T05.1C D2T02.2C SS16.10 D3T03.1B SS15.01 D3T10.2A D3T02.4B, D4T03.1C, D4T03.2B, D4T03.3C, SS03.07 FC05.04 SS22.14 D2T11.1D D2T02.3C D3T02.4D D2T09.1B D1T02.1C SS22.05 D3T09.2A Lallas, Aimilios Lambert, Jo Lambert, Julien Langan, Sinead Maire Langley, Richard Lapidoth, Moshe Laubach, Hans-Joachim Läuchli, Severin Laureano Oliveira, André Lautenschlager, Stephan Layton, Alison Lazaridou, Elisavet Le Pillouer-Prost, Anne Lebwohl, Mark Lehmann, Percy Mario Leiter, Ulrike Lembo, Serena Lencastre, Andre Leone, Giovanni Leslie, Tabi Anika Levell, Nick Lewis, Wendy Li, Ping Lim, Henry W. Liopyris, Konstantinos Lipoff, Jules Lisboa Silva, Carmen Lis-Swiety, Anna Liu, Ying Ljubojevic, Suzana Llamas Velasco, Maria del Mar Llombart Cussac, Beatriz Lomholt, Hans Bredsted Longo, Maria López-Bárcenas, Adriana Lopez-Estebaranz, Jose Luis Lorentzen, Henrik Frank Lotti, Torello M. Lui, Harvey D1T02.2B SAT03.05, SAT21.03 D3T07.3B D2T13.3C FC01.04, SAT 18.02, SAT03.01, SAT03.02, SAT03.04, SAT03.06 D4T04.2C D4T02.3D D2T02.4D D1T02.4D PLB.02 D1T09.3B, D3T09.4C SS04.14 D3T02.4A, SS14.01, SS21.08 SAT17.01, SAT17.04 D2T03.3C D1T10.2C D2T03.4B D2T06.2D, SS20.06 D2T09.1D D3T10.3A D1T13.4A D4T04.2A SS07.18 D3T02.1A, HUB SS04.15 D2T09.3D D3T05.1D D1T08.3C SS07.12 D3T10.2B D1T08.3B, D2T12.3C SS15.08 D2T11.2C D1T02.3A SS19.05, SS19.11 D1T04.2D D1T10.2B SS03.05 D2T09.3B Luo, Diqing Lupi, Omar Machet, Laurent Mainetti, Carlo Malvehy, Josep Manole, Ionela Marini, Leonardo Marinovic, Branka Marrón Moya, Servando E. Martin, Ludovic Martin, Stefan Martínez-Herrera, Erick Martinez-Mera, Constanza Martorell Calatayud, Antonio Marzano, Angelo Valerio Mascaro, Jose Manuel Massa, Antonio Augusto Fernandes Mateeva, Vali Matusiak, Lukasz Maubec, Eve Maurer, Marcus Mazer, Jean-Michel McBride, Sandy McGonagle, Dennis Medenica, Ljiljana Mendes-Bastos, Pedro Menezes, Nuno Metz, Martin Metze, Dieter Michenko, Anna Milinkovic, Mirjana Miller, Nicola Minano-Medrano, Roman Misery, Laurent Miteva, Maria Moftah, Nayera Möhrle, Matthias Molina-Leyva, Alejandro Monari, Paola Moreno-Ramirez, David Morren, Marie-Anne SS07.01 D1T07.4A D2T07.2D D2T11.3D D2T07.4A D1T08.2D D3T02.3D, D4T01.3A, D4T03.2D, SS03.09, SS14.05 D1T07.2D, D2T01.1D SS22.09 D2T10.4C D3T04.3A SS19.06 D1T07.1B D2T01.1E D1T08.4B D2T04.4A D1T04.2A SS18.08 D1T04.4C D2T01.1A D2T03.2D D1T03.2D SAT01.04 D3T03.1D D4T04.3B D1T04.2C D2T12.2C SAT05.03 D1T11.3B, D2T02.1D SS22.13 D3T03.2D SS09.09 D3T11.1A D2T10.1B D2T02.2A SS19.09 D2T02.3F SS16.04 D2T04.4D D1T04.4B, SS18.03 D3T11.4D, HUB

131 Morton, Colin Mosterd, Klara Mrowietz, Ulrich SAT Muellegger, Robert Muhlstadt, Michael Munte, Kai Murase, Jenny Murrell, Dedee Musette, Philippe Nagore, Eduardo Nassif, Aude Navarini, Alexander Neves, José Newman, Lawrence D2T05.1A, SS21.02 D1T10.2A D3T09.1D, FC02.08, D1T06.1D SS15.05 SS15.02 D1T06.3D, D2T10.2A D1T06.1B, FC04.08 D3T03.4D D1T01.1D, D2T03.1C D1T04.4A D3T03.4C, SAT23.03 FC08.09 D2T09.2D Nickoloff, Brian HUB Nijsten, Tamar Nikkels, Arjen Fokko Nikolakis, Georgios Nikolic, Milos Nisa Akay, Bengu Nizar, Zahir Nocera, Thérèse Nouri, Keyvan Nwabudike, Lawrence Chukwudi Nygaard, Uffe Ocampo-Candiani, Jorge Ochsendorf, Falk Oke, Vilija Olafsson, Jon Hjaltalin Olah, Judit Olszewska, Malgorzata Ortiz Romero, Pablo Luis Ostertag, Judith Ulla Paasch, Uwe Padovese, Valeska Panduru, Mihaela Pandya, Amit Pannier, Felizitas D2T01.2A, D3T06.1B D2T08.3C SS16.11 D3T09.3B D1T02.1B D3T02.2A SAT10.04 D4T01.2C, D4T02.3A, SS03.11, SS14.03 D1T13.4E D3T10.3C D1T07.3C D1T09.3A D1T08.4A D3T08.4A D2T01.3D D3T05.1B SAT11.01, SAT11.03, SAT11.05 D2T02.3D D2T05.3A D1T01.1C SS19.10 D2T10.2B D2T06.4D Paoli, John Papageorgiou, Cryssoula Papoutsaki, Marina Papp, Kim A. Pariser, David Parisi, Rosa Parsad, Davinder Part, Martina Pascual Ramírez, Jose Carlos Pasmans, Suzanne Pasquali, Paola Passeron, Thierry Pastushenko, Ievgenia Patel, Raj Pathmarajah, Piru Patsatsi, Aikaterini Pavlovic, Milos Pellacani, Giovanni Pendaries, Philippe Pereira, Manuel Pedro Perez-Anker, Javiera Peris, Ketty Peternel, Sandra Piaserico, Stefano Picardo, Mauro Pieretti, Lisa J. Piette, Warren Pigatto, Paolo Piguet, Vincent Pinto Gouveia, Miguel Piraccini, Bianca Maria Pljakoska, Vesna Polubothu, Satyamaanasa Poot, Francoise Poparic, Selma Posch, Christian Powell, Julie D2T02.3E SS04.07, SS15.10 SS04.02 D2T04.2B D3T01.3C, FC01.01, FC02.02, SAT13.03 SS08.03, SS08.04, SS08.05, SS08.12, SS08.13 FC01.03 D1T03.1A D2T06.2B D1T09.4D D2T09.3C D1T10.1B D1T03.2A D3T06.3A D1T05.1D FC06.04 D2T06.3D D1T05.4C D2T07.3D SS18.14 D2T04.3D, D2T13.3B, SAT05.02 D2T07.01D SS18.05 D2T13.3F D3T05.3D, SAT08.02, SS21.04 D3T02.2C SS08.01 D1T08.3D D3T04.3D D1T05.3D D2T08.3B D1T02.3B, D1T03.4D, SS20.01 SS03.18 D2T04.1C, D3T11.3A D2T13.1I, D3T04.2C, SS22.06 D3T11.4B D3T05.2D D3T05.4A Prens, Errol Prignano, Francesca Prinz, Jörg Prohic, Asja Puente De Pablo, Nieves Puig, Luís Puig, Susana Puig, Susana Punchera, Jori Quaglino, Pietro D1T04.4D HUB D2T11.1A D2T05.1C D2T05.2A D1T09.2C, SAT 18.03, SAT08.04 D1T02.2D SS09.07 SS14.12 D2T12.4C, SAT11.02 Queiro, Rubén HUB , HUB , HUB Radtke, Marc Ran, Yu-Ping Rappersberger, Klemens Raspaldo, Herve Rateb, Amr Abdel-Hakim Redondo, Pedro Reich, Adam Reich, Kristian Remenyik, Eva Requena, Luis Reuter, Georges Revol, Olivier Reynolds, Nicholas Ribero, Simone Richard, Marie-Aleth Richert, Bertrand Rigopoulos, Dimitrios Rijnenberg, Dewi Ring, Johannes Ríos Buceta, Luis Riquelme, Constanza Risphon, Ayelet Rivera-Díaz, Raquel Rob, Filip Röcken, Martin SAT13.01 SS07.16 D3T05.3C D4T02.1A D4T04.1C SS15.06 D1T06.3B, D3T04.1B FC01.06, FC02.01, FC02.09, FC07.06, SAT02.01, SAT02.02, SAT19.01, SAT19.04 D2T11.2B D2T02.1A D1T13.3C SS18.13 D1T11.1A D1T10.4A D1T06.3A D1T03.4C, SS20.09 D2T05.3B, D3T11.1D, SS20.07, SS20.15 FC08.06 D2T13.4A, D2T13.4E D2T12.1B FC06.01 SS04.06 D1T05.4B D3T10.1A D1T01.1F 129 Contributor Index

132 CONTRIBUTOR INDEX Rockmann, Heike Rodriguez-Cerdeira, Carmen Romanelli, Marco Romaní De Gabriel, Jorge Romanov, Dmitry Rongioletti, Franco Roque Ferreira, Bárbara Ros, Sandra Rosi, Elia Rossi, Maria Teresa Roth, Maria-Magdalena Rowland Payne, Christopher Rozzo, Stephen Rubin, Adam Rudnicka, Lidia Ruiz Rosas, Aura Ibeth Rustemeyer, Thomas Rzany, Berthold Sadek, Ahmed Sadik, Christian Sahillioglu, Nagihan Sahin, Sedef Saiag, Philippe Salah, Louai Salavastru, Carmen Maria Saleh, Karim Salhi, Aïcha Samimi, Mahtab Sampogna, Francesca Sanders, Cornelus Sanmartin, Onofre Sarbu, Maria Isabela Sardy, Miklos Sarkany, Robert Sar-Pomian, Marta Sattler, Sonja Saunte, Ditte Marie Saurat, Jean-Hilaire Savic, Sinisa Sbidian, Emilie Schelke, Leonie Schlapbach, Christoph Schmid-Grendelmeier, Peter D1T11.3A SS19.02 SS16.03 D1T04.3D SS22.04 D2T02.1C D3T04.1A SS22.12 SS16.08 D2T03.3B D1T06.1C D1T13.3D, D4T02.1D FC01.08 SS20.04 D1T02.4B SS14.10 D3T04.3C, D3T13.01C D4T03.3D SS03.08, SS04.16 FC04.07 D2T08.1B D2T05.3D D3T06.4D D4T02.3B D2T08.2B D3T08.1H, FC06.02 SS11.11 D3T06.4B, SS18.06 D2T13.1C, SS22.08 D1T05.3A D3T09.3D D3T08.1D D3T03.4B SS09.01, SS12.05 D2T12.1D D4T01.1D D1T01.1H SAT10.01, SAT10.03 FC07.07 D1T09.4C SS03.06 D2T10.3C D3T05.1A Schmidt, Enno Schmitz, Lutz Schmults, Chrysalyne Schmuth, Matthias Schneeweiss, Mia Schneller-Pavelescu, Luca Schöfer, Helmut Schönenberger de Oliveria, Hugo Schwarz, Thomas Segura, Sonia Segurado, Gonzalo Sei, Jean Francois Sellami, Khadija Serra-Baldrich, Ester Seyger, Marieke Sgouros, Dimitris Shapiro, Jerry Sharquie, Khalifa Shear, Neil Sheng, Yujun Sherrard, Jackie Sigurdsson, Vigfus Sigurgeirsson, Bardur D3T03.3D D3T06.2D D2T02.4B D1T11.1B FC04.03 FC03.06 D1T05.3B D3T03.2C D3T02.2B SS04.09 D1T03.1D D2T03.1B D3T08.1B D3T02.3B, D3T13.01A D1T01.1E SS04.05 D2T05.1D SS11.05, SS11.06 D1T11.3D, D2T05.3C SS07.05 D1T05.2A D3T09.1C D3T11.1C Simm, Christoph HUB Simon, Dagmar Simon, Jan Christoph Simpson, Eric Sinani, Ardiana Skerlev, Mihael Skov, Lone Smith, Catherine Smith, Saxon Soares de Almeida, Luis Miguel Sobell, Jeffrey M Somani, Ally-Khan Sommer, Rachel Sonkoly, Eniko Sossau, Daniel Soyer, Hans Peter Spellman, Mary Clare Sprecher, Eli D2T06.3C, D3T13.02D D1T08.4C SAT16.03 SS19.04 D3T10.1D SS10.02, SS10.07 SS10.01, SS10.05, SS10.06, SS10.08 FC03.02 D1T10.3A FC08.05 SS15.03 FC07.08 D2T10.3D D3T11.4A D2T07.4C, D2T09.4A FC04.02 PL-A01 Spuls, Phyllis Ständer, Sonja Starace, Michela Starace, Michela Stary, Angelika Stary, Georg Staubach Renz, Petra Stefanato, Catherine M. Steinhoff, Martin SS17.08, SS17.16 D2T08.1A, D3T08.2C, SAT05.01, SAT05.04, SAT05.05 D1T02.3C SS20.02 D1T07.1A D1T05.3C D2T12.2B D2T12.3D D3T04.2A Stingl, Georg HUB , PL-A02 Stojkovic-Filipovic, Jelena Stolz, Wilhelm Stratigos, Alexander Strober, Bruce Strohal, Robert Stuermer, Ewa Klara Su, Huichun Sun, Jianfang Sunderkötter, Cord Sundić-Vardić, Snezana Suppa, Mariano Svedman, Cecilia Sytnyk, Liliana Szegedi, Andrea Szeimies, Rolf-Markus Szepietowski, Jacek Taberner, Rosa Taieb, Alain Takwale, Anita Tamasi, Bela Tams, Spiro TBC, Testori, Alessandro Thaçi, Diamant Thio, Hok Bing Thormann, Kathrin Thyssen, Jacob Tiodorovic, Danica D3T10.4A D1T02.3D D3T06.2A SS10.03, SS10.11 SS10.10 FC06.08 SS07.06 SS07.15 D1T08.3A, D1T08.4D D2T13.1G SS18.12 D1T11.2A D4T04.3C D1T01.3C SS14.13, SS21.03 D2T08.1D D3T08.4D D3T02.2D, SS17.09 D2T05.4A D3T08.1E SS11.10 SAT08.02 D3T09.4B FC01.02, SAT08.01, SAT08.03, SAT08.06 D3T07.2C D3T13.03A D1T04.2B, SS17.05, SS17.14, SS17.18 D1T02.2C, SS

133 Tiplica, George Sorin D1T05.4A Velasco-Tamariz, Virginia D3T07.1C Wozniak, Katarzyna D3T03.3C Toll, Agustín D2T12.2A Velthuis, Peter D4T01.3D Wu, Liangcai SS07.07 Tomas Aragones, Lucia Tomasini, Carlo Francesco Tomecki, Kenneth Torrelo, Antonio Torres, Tiago Torres Lozada, Vicente Tosti, Antonella Town, Godfrey Trakatelli, Myrto-Georgia Trautinger, Franz Troielli, Patricia Troilius Rubin, Agneta Tsankov, Nikolai Tschandl, Philipp Tursen, Belma Tursen, Umit Tzellos, Thrasyvoulos Ulrich, Claas Ulrich, Martina Vabres, Pierre Vaillant, Loic Van de Kerkhof, Peter C.M. van den Bos, Renate Ruth van der Bent, Sebastiaan Alain Servé van der Kraaij, Gayle van der Wegen-Franken, Catharina D2T13.1E, D3T04.1D, SS22.01 D2T12.3A, SS13.02, SS13.04 D1T07.4D D2T10.2C, D3T03.1A D3T01.3B, SS10.04, SS10.09 D1T04.1B D2T04.3C D2T09.2C D1T03.4B, D2T12.1A D1T08.1A D1T06.2A, D1T06.4D D4T01.2B, D4T01.3B, SS14.09 D2T08.2A SS04.03 SS03.13 SS03.14 D3T08.3D, SAT24.01, SAT24.03, SAT24.06 D3T06.3B D2T07.1B D3T11.3D D3T05.1C D1T09.1B, D3T10.4C, HUB D2T03.1A D3T07.4C FC02.06 D2T06.4C Velthuis, Peter Ventayol, Pere Venturini, Marina Vergunst, Clarissa Verner Rashkovsky, Ines Veronique, Del Marmol Vestergaard, Christian Vieira, Ricardo Vikkula, Mikka Vilarrasa, Eva Viros, Amaya Vlahovic, Tracey Vojvodic, Aleksandra Volz, Thomas Vossen, Allard Waalboer-Spuij, Rick Wambier, Carlos Gustavo Wang, Jin Wang, Liuyuan Ward, Corinne Warren, Richard Waskiel, Anna Watson, Rachel Weichenthal, Michael Weidinger, Stephan Weller, Karsten Welzel, Julia White, Jonathan Whittle, Carolina Wiesner, Thomas Willemze, Rein SS03.04 D2T10.4D D2T07.2C D2T08.3D D4T02.1C, D4T02.2D, SS03.02 SS18.07, SS18.15 D1T11.1D, SS17.13, SS17.17 D2T01.1B, SS18.04 D3T11.3B D3T09.2D D3T02.1B SS20.12 SS03.12 D3T07.2A D3T08.1F D2T04.4C D1T03.1B SS07.14 SS07.09 D3T13.02A D3T01.2D, SAT02.03, SAT17.02 D3T11.2B D2T10.3A D3T08.3C SAT17.03 D3T04.2B D2T07.3C D1T11.2C HUB , HUB D1T10.3B D2T12.4B Wu, Rina Yaremkevych, Roman Yawalkar, Nikhil Yazdi, Amir Yelamos Pena, Oriol Young, Antony R. Zalaudek, Iris Zalewska, Anna Zambruno, Giovanna Zargari, Omid Zavorins, Aleksejs Zelger, Bernhard Zhang, Bin Zhao, Cathy Zheng, Yi Zhu, Shen Zillikens, Detlef Zouboulis, Christos Zuberbier, Torsten SS07.17 D2T06.1C D1T11.3C D3T03.1C D2T07.3A D2T03.4C D1T02.1D D2T10.1C D1T06.3C SS11.02 D1T08.1B D2T02.2D SS07.11 D3T08.1C FC02.03 SS07.03 D3T03.3B D1T09.4A, SS16.12 D1T11.4A van der Zee, Hessel D1T09.4B Wolf, Peter D2T03.3A van Doorn, Martijn D1T11.4D Wolf, Ronni D1T07.2A van Geel, Nanja Van Hees, Colette van Montfrans, Catherine van Vugt, Lieke Vaño-Galván, Sergio Vaughan-Jones, Samantha D1T03.3A D1T07.4D D1T08.2B, D2T13.1A, D2T13.1M FC02.07 D3T11.2D D1T06.2C Wolkerstorfer, Albert Wollenberg, Andreas Wollenberg, Andreas Wozniacka, Anna D1T03.2C, SS14.02, SS14.14 D1T09.1C, SS17.01, SS17.10, SS17.19 FC07.03 D2T09.4B 131 Contributor Index

134 BIOLOGICS IN MODERATE TO SEVERE PSORIASIS: DISCOVER THE ROAD TO LONG-TERM CONTROL CONTRIBUTOR INDEX EADV, Thursday 10 October 2019, , Room N , IFEMA Feria de Madrid, Madrid, Spain IL-12/23 IL-17 UNME T NEEDS -23 L ONG-TER M DISEAS E CO NTROL IL SAFETY DISCOVER THE ROAD TO LONG-TERM CONTROL AGENDA Time EACCME ACCREDITED 1 EUROPEAN CME CREDIT Topic Welcome and introductions Professor Diamant Thaçi Mind the gap the benefits of modern biologic treatment Professor Stefano Piaserico En route to long-term control? Professor Diamant Thaçi Targeting safety in treatment decisions Professor Luis Puig Navigating the options which way will you go? All Close Professor Diamant Thaçi Academy This symposium is taking place during the 28th EADV Congress. This symposium is sponsored by Almirall, S.A. and is restricted to Healthcare Professionals only. 132

135 PLATINUM SPONSORS GOLD SPONSORS SILVER SPONSORS BRONZE SPONSORS

136 Join Us! at the 28th Annual EADV Congress for two informative sessions Feria de Madrid, Madrid, Spain October 2019 Refreshments will be provided. BREAKING THE VICIOUS CYCLE Redefining Expectations in the Management of Atopic Dermatitis Thursday, 10 October :00-18:30 Room: N103, North Convention Center, Floor 1 In this symposium, a roundtable discussion of clinical dilemmas in atopic dermatitis (AD), case studies will be used to illustrate the topics of continuous management for long-term control of inflammation, treating to patient goals, and the spectrum of therapy from topical to systemic treatment. The speakers will also review the evolving landscape of therapeutic targets in AD. JAK INHIBITION A Promising Direction for Inflammatory Dermatological Diseases Friday, 11 October :00-18:30 Rooms: N109-N110, North Convention Center, Floor 1 In this panel discussion, the speakers will discuss the emerging role of Janus kinase (JAK) inhibitors in dermatological diseases, with an emphasis on atopic dermatitis (AD). The speakers will also discuss the clinical rationale for the approach of JAK inhibition, including the fundamental role of JAKs in their role of regulating cytokine networks, their role in the regulation of itch in AD, and the future directions for treatment of dermatological diseases. Attendance at these presentations is limited to healthcare professionals. Please visit us at BOOTH E34 and BOOTH E39 PP-INP-ESP-0010 August Pfizer Inc. All rights reserved.